<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth - Williams, MJ - 2022 | Cochrane Library</title> <meta content="Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth - Williams, MJ - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006764.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth - Williams, MJ - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006764.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006764.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth" name="citation_title"/> <meta content="Myfanwy J Williams" name="citation_author"/> <meta content="University of Liverpool" name="citation_author_institution"/> <meta content="Jenny A Ramson" name="citation_author"/> <meta content="Fiona C Brownfoot" name="citation_author"/> <meta content="Mercy Hospital for Women" name="citation_author_institution"/> <meta content="fiona.brownfoot@gmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD006764.pub4" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/08/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006764.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006764.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006764.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenal Cortex Hormones; Betamethasone [adverse effects]; *Chorioamnionitis; Dexamethasone [adverse effects]; Infant, Premature; Lung; *Premature Birth [epidemiology, prevention &amp; control]; *Respiratory Distress Syndrome, Newborn [prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006764.pub4&amp;doi=10.1002/14651858.CD006764.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="UDgTyLGV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006764\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006764\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","pt","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006764.pub4",title:"Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth",firstPublishedDate:"Aug 9, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006764.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006764.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006764.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006764.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006764.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006764.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006764.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006764.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006764.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006764.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15147 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006764.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0233"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0018"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0019"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0071"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-sec-0225"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/appendices#CD006764-sec-0238"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/table_n/CD006764StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/table_n/CD006764StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information#CD006764-cr-0004">Myfanwy J Williams</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information#CD006764-cr-0005">Jenny A Ramson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information#CD006764-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Fiona C Brownfoot</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information/en#CD006764-sec-0243">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 August 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006764.pub4">https://doi.org/10.1002/14651858.CD006764.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006764-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006764-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006764-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006764-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006764-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD006764-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006764-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006764-abs-0001" lang="en"> <section id="CD006764-sec-0001"> <h3 class="title" id="CD006764-sec-0001">Background</h3> <p>Despite the widespread use of antenatal corticosteroids to prevent respiratory distress syndrome (RDS) in preterm infants, there is currently no consensus as to the type of corticosteroid to use, dose, frequency, timing of use or the route of administration.  </p> </section> <section id="CD006764-sec-0002"> <h3 class="title" id="CD006764-sec-0002">Objectives</h3> <p>To assess the effects on fetal and neonatal morbidity and mortality, on maternal morbidity and mortality, and on the child and adult in later life, of administering different types of corticosteroids (dexamethasone or betamethasone), or different corticosteroid dose regimens, including timing, frequency and mode of administration. </p> </section> <section id="CD006764-sec-0003"> <h3 class="title" id="CD006764-sec-0003">Search methods</h3> <p>For this update, we searched Cochrane Pregnancy and Childbirth Group's Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (9 May 2022) and reference lists of retrieved studies. </p> </section> <section id="CD006764-sec-0004"> <h3 class="title" id="CD006764-sec-0004">Selection criteria</h3> <p>We included all identified published and unpublished randomised controlled trials or quasi‐randomised controlled trials comparing any two corticosteroids (dexamethasone or betamethasone or any other corticosteroid that can cross the placenta), comparing different dose regimens (including frequency and timing of administration) in women at risk of preterm birth. We planned to exclude cross‐over trials and cluster‐randomised trials. We planned to include studies published as abstracts only along with studies published as full‐text manuscripts. </p> </section> <section id="CD006764-sec-0005"> <h3 class="title" id="CD006764-sec-0005">Data collection and analysis</h3> <p>At least two review authors independently assessed study eligibility, extracted data and assessed the risk of bias of included studies. Data were checked for accuracy. We assessed the certainty of the evidence using GRADE. </p> </section> <section id="CD006764-sec-0006"> <h3 class="title" id="CD006764-sec-0006">Main results</h3> <p>We included 11 trials (2494 women and 2762 infants) in this update, all of which recruited women who were at increased risk of preterm birth or had a medical indication for preterm birth. All trials were conducted in high‐income countries. </p> <p><b>Dexamethasone versus betamethasone</b> </p> <p>Nine trials (2096 women and 2319 infants) compared dexamethasone versus betamethasone. All trials administered both drugs intramuscularly, and the total dose in the course was consistent (22.8 mg or 24 mg), but the regimen varied. We assessed one new study to have no serious risk of bias concerns for most outcomes, but other studies were at moderate (six trials) or high (two trials) risk of bias due to selection, detection and attrition bias. Our GRADE assessments ranged between high‐ and low‐certainty, with downgrades due to risk of bias and imprecision.  </p> <p><i>Maternal outcomes</i> </p> <p>The only maternal primary outcome reported was chorioamnionitis (death and puerperal sepsis were not reported). Although the rate of chorioamnionitis was lower with dexamethasone, we did not find conclusive evidence of a difference between the two drugs (risk ratio (RR) 0.71, 95% confidence interval (CI) 0.48 to 1.06; 1 trial, 1346 women; moderate‐certainty evidence). The proportion of women experiencing maternal adverse effects of therapy was lower with dexamethasone; however, there was not conclusive evidence of a difference between interventions (RR 0.63, 95% CI 0.35 to 1.13; 2 trials, 1705 women; moderate‐certainty evidence). </p> <p><i>Infant outcomes</i> </p> <p>We are unsure whether the choice of drug makes a difference to the risk of any known death after randomisation, because the 95% CI was compatible with both appreciable benefit and harm with dexamethasone (RR 1.03, 95% CI 0.66 to 1.63; 5 trials, 2105 infants; moderate‐certainty evidence). The choice of drug may make little or no difference to the risk of RDS (RR 1.06, 95% CI 0.91 to 1.22; 5 trials, 2105 infants; high‐certainty evidence). While there may be little or no difference in the risk of intraventricular haemorrhage (IVH), there was substantial unexplained statistical heterogeneity in this result (average (a) RR 0.71, 95% CI 0.28 to 1.81; 4 trials, 1902 infants; I² = 62%; low‐certainty evidence). We found no evidence of a difference between the two drugs for chronic lung disease (RR 0.92, 95% CI 0.64 to 1.34; 1 trial, 1509 infants; moderate‐certainty evidence), and we are unsure of the effects on necrotising enterocolitis, because there were few events in the studies reporting this outcome (RR 5.08, 95% CI 0.25 to 105.15; 2 studies, 441 infants; low‐certainty evidence). </p> <p><i>Longer‐term child outcomes</i> </p> <p>Only one trial consistently followed up children longer term, reporting  at two years' adjusted age. There is probably little or no difference between dexamethasone and betamethasone in the risk of neurodevelopmental disability at follow‐up (RR 1.02, 95% CI 0.85 to 1.22; 2 trials, 1151 infants; moderate‐certainty evidence). It is unclear whether the choice of drug makes a difference to the risk of visual impairment (RR 0.33, 95% CI 0.01 to 8.15; 1 trial, 1227 children; low‐certainty evidence). There may be little or no difference between the drugs for hearing impairment (RR 1.16, 95% CI 0.63 to 2.16; 1 trial, 1227 children; moderate‐certainty evidence), motor developmental delay (RR 0.89, 95% CI 0.66 to 1.20; 1 trial, 1166 children; moderate‐certainty evidence) or intellectual impairment (RR 0.97, 95% CI 0.79 to 1.20; 1 trial, 1161 children; moderate‐certainty evidence). However, the effect estimate for cerebral palsy is compatible with both an important increase in risk with dexamethasone, and no difference between interventions (RR 2.50, 95% CI 0.97 to 6.39; 1 trial, 1223 children; low‐certainty evidence). </p> <p>No trials followed the children beyond early childhood.</p> <p><b>Comparisons of different preparations and regimens of corticosteroids</b> </p> <p>We found three studies that included a comparison of a different regimen or preparation of either dexamethasone or betamethasone (oral dexamethasone 32 mg versus intramuscular dexamethasone 24 mg; betamethasone acetate plus phosphate versus betamethasone phosphate; 12‐hourly betamethasone versus 24‐hourly betamethasone). The certainty of the evidence for the main outcomes from all three studies was very low, due to  small sample size and  risk of bias. Therefore, we were limited in our ability to draw conclusions from any of these studies. </p> </section> <section id="CD006764-sec-0007"> <h3 class="title" id="CD006764-sec-0007">Authors' conclusions</h3> <p>Overall, it remains unclear whether there are important differences between dexamethasone and betamethasone, or between one regimen and another.  </p> <p>Most trials compared dexamethasone versus betamethasone. While for most infant and early childhood outcomes there may be no difference between these drugs, for several important outcomes for the mother, infant and child the evidence was inconclusive and did not rule out significant benefits or harms. </p> <p>The evidence on different antenatal corticosteroid regimens was sparse, and does not support the use of one particular corticosteroid regimen over another.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006764-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006764-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006764-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006764-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006764-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006764-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006764-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006764-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD006764-abs-0009">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006764-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006764-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006764-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006764-abs-0002" lang="en"> <h3>Different corticosteroid treatments before early birth for improving outcomes for babies  </h3> <p><b>What is the issue?</b> </p> <p>Babies born early (before 37 weeks of pregnancy, which is considered <i>preterm</i> birth) are at increased risk of health problems. These include lung problems (respiratory distress syndrome), bleeding of the brain (intraventricular haemorrhage) and death. Medicines called corticosteroids are given to the mother while still pregnant to help stop these problems occurring and there is high‐quality evidence that they are effective in preventing many of these issues. These medicines work by maturing the baby's lungs before birth. There are different types of corticosteroid and they can be given in different ways and in different doses. While we know that giving mothers at risk of early birth corticosteroids has benefits for the baby, we do not know which type of corticosteroid is most beneficial and least harmful for mother and baby. </p> <p><b>Why is this important?</b> </p> <p>Since there is no clear or agreed best type or dose, hospitals may vary in how they give this medicine. This review assessed all available evidence from randomised controlled trials (where the treatments people receive are decided at random; these trials usually give the most reliable evidence about treatment effects) to determine which medicine and way of giving the medicine is best for mother and baby. We  also wanted to find out what effect the medicines have once the babies have grown into children and adults. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence on 9 May 2022, and identified 18 trials. We checked all trials for trustworthiness and did not include trials where we had doubts. We included 11 trials (2494 women and 2762 babies). One of these trials included over 1500 babies, finished in 2013 and was at low risk of bias. The other trials were smaller, older and at moderate or high risk of bias. </p> <p>Nine trials compared the two corticosteroids most commonly used before early birth, dexamethasone and betamethasone. For the mother, while there may be no difference between these medicines, we could not rule out the possibility that the risk of both infection and side effects were lower with dexamethasone (moderate‐quality evidence). For the baby, we are unsure whether the choice of medicine make a difference to the risk of any death after the start of the trial (moderate‐quality evidence). The choice of medicine probably  makes little or no difference to the risk of respiratory distress syndrome (high‐quality evidence) and chronic lung disease (moderate‐quality evidence). We found that there may be little or no difference between dexamethasone and betamethasone in the risk of intraventricular haemorrhage (low‐quality evidence). We are uncertain whether the choice of medicine makes a difference to the risk of necrotising enterocolitis (inflammation of the small and large intestines), because this happened so rarely in the trials (low‐quality evidence). </p> <p>One large trial attempted to monitor all children longer term, reporting results when children were two years of age. This trial found that overall there is probably little or no difference in the risk of neurodevelopmental disability (illnesses that affect how the brain functions) at two years of age (moderate‐quality evidence). The choice of medicine may make little or no difference to specific developmental outcomes including  hearing impairment (moderate‐quality evidence), developmental delay (moderate‐quality evidence) or learning difficulties (moderate‐quality evidence). It is unclear whether the choice of medicine makes a difference to sight impairment (low‐quality evidence). We are also unsure whether dexamethasone increases the risk of cerebral palsy (a group of disorders that affect the ability to move and maintain balance and posture) because there were  few events in the one study looking at this. We need information from more children to accurately assess the differences between these medicines for this outcome (low‐quality evidence). </p> <p>Three trials compared different ways of giving corticosteroids. One trial compared two ways of giving dexamethasone (by mouth or injection into the muscle), another trial compared different preparations of betamethasone and a third trial compared two ways of giving betamethasone (different time intervals between doses). Because these trials were small and at moderate risk of bias, we do not know whether their findings give a good indication of how best to give these medicines. </p> <p><b>What does this mean?</b> </p> <p>Although we found that the effects of dexamethasone and betamethasone are probably similar for many outcomes, we are not sure which is the best corticosteroid in the context of early birth. We found no trials that reported the effects of these medicines beyond two years of age, so we cannot comment on their long‐term effect on the child's health. </p> <p>We did not find much evidence on the best way to give corticosteroids, so we are unable to say whether one way might be better than another. </p> <p>We need more studies to establish which is the best medicine and what is the best way to give it, and babies in these trials need to be monitored over a long period to see any effects on child and adult development. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006764-sec-0233" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006764-sec-0233"></div> <h3 class="title" id="CD006764-sec-0234">Implications for practice</h3> <section id="CD006764-sec-0234"> <p>We found no clear differences between dexamethasone and betamethasone. For some important outcomes for the woman (chorioamnionitis and adverse effects of therapy), it is possible that dexamethasone may have some benefits over betamethasone, but the evidence was not conclusive, and evidence was missing on other key outcomes. In terms of outcomes for the baby and child, there may be no difference between dexamethasone and betamethasone for many outcomes; however, there are uncertainties for some important neonatal outcomes (IVH, necrotising enterocolitis) that do not rule out differences, and one early childhood outcome (cerebral palsy) does not rule out harm with dexamethasone. We do not know about the longer‐term impact of these medications for the older child or into adulthood.  </p> <p>We found insufficient evidence to support the use of one particular corticosteroid regimen over another.  </p> </section> <h3 class="title" id="CD006764-sec-0235">Implications for research</h3> <section id="CD006764-sec-0235"> <p>For the comparison of dexamethasone and betamethasone, while this review includes important evidence from one recent large study, there remain some important uncertainties about the relative benefits and harms of these two drugs, which may warrant further research. We note that unresolved questions regarding the drug regimen are also relevant to any trials that compare one type of corticosteroid with another. </p> <p>Our search identified one trial that is investigating the safety and efficacy of antenatal corticosteroids in the late pre‐term period (34 weeks 0 days to 36 weeks 6 days' gestational age) in low‐income countries (<a href="./references#CD006764-bbs2-0037" title="CTRI/2021/03/032429. Improving newborn survival in preterm birth [WHO ACTION-III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes – WHO ACTION-III]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/03/032429 (first received 24 November 2021). [CENTRAL: CN-02280513] ISRCTN11434567. Antenatal corticosteroids for women at risk of birth in the late preterm period to improve newborn outcomes [ACTION III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes]. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN11434567 (first received 7 June 2021). [CENTRAL: CN-02280191] PACTR202105463874444. The WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborns) Trials [ACTION III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes]. trialsearch.who.int/Trial2.aspx?TrialID=PACTR202105463874444 (first received 18 May 2021). [CENTRAL: CN-02281089] ">WHO ACTION III</a>). The trial is aiming to recruit 13,500 women across five countries. All countries include the same three‐arm comparison of a standard dose and regimen of dexamethasone (4 × 6 mg, 12‐hourly), with a lower dose betamethasone phosphate regimen (4 × 2 mg, 12‐hourly), and similar placebo.  </p> <p>We found sparse evidence on different antenatal corticosteroid regimens (route, drug preparation, total dose in course, dose, number of doses, dosing interval). Our search identified three ongoing studies that are investigating the safety and effectiveness of a half dose in the initial course of betamethasone, with women randomised after the receipt of a first dose (12 mg or 11.4 mg) to receive 24 hours later either placebo or the standard second dose (12 mg or 11.4 mg) in the course. Two studies are related (the SNACS trial), being a small pilot of 30 women for which results were as yet unavailable (<a href="./references#CD006764-bbs2-0033" title="NCT04494529. Single dose antenatal corticosteroids (SNACS) for women at risk of preterm birth [Single dose antenatal corticosteroids (SNACS) pilot randomized control trial for women at risk of preterm birth]. clinicaltrials.gov/show/NCT04494529 (first received 31 July 2020). [CENTRAL: CN-02145746] ">NCT04494529</a>), and the full study of 3254 women (<a href="./references#CD006764-bbs2-0034" title="NCT05114096. Single dose of antenatal corticosteroids for pregnancies at risk of preterm delivery (SNACS). clinicaltrials.gov/show/NCT05114096 (first received 9 November 2021). [CENTRAL: CN-02339354] ">NCT05114096</a>). The other is another large study (the BETADOSE trial) of over 3000 women that at the time of writing we are aware is due to publish results soon (<a href="./references#CD006764-bbs2-0035" title="EUCTR2016-001486-90-FR. BETADOSE: dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth: a randomized, multicenter, double blind placebo-controlled non inferiority trial [Dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth: a randomized, multicentre, double blind placebo-controlled non inferiority trial. BETADOSE – BETADOSE]. trialsearch.who.int/Trial2.aspx?TrialID=EUCTR2016-001486-90-FR (first received 27 April 2016). [CENTRAL: CN-02169007] NCT02897076. Dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth [Dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth: a randomized, multicentre, double blind placebo-controlled non inferiority trial]. clinicaltrials.gov/show/NCT02897076 (first received 7 September 2016). [CENTRAL: CN-01520740] SchmitzT , AlbertiC , UrsinoM , BaudO , AupiaisC , BETADOSE study group and the GROG (Groupe de Recherche en Gynecologie Obstetrique). Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE). BMC Pregnancy and Childbirth2019;19(1):67. [CENTRAL: CN-01787973] [EMBASE: 626359019] [PMID: 30755164]SchmitzT , DoretM , SentilhesL , AlbertiC , UrsinoM , AupiaisC , et al. Dose reduction of antenatal betamethasone in women at risk of very preterm delivery (BETADOSE trial). American Journal of Obstetrics and Gynecology2021;224(2 Suppl):S723-4. [CENTRAL: CN-02247756] [EMBASE: 2010870067]">Schmitz 2019</a>). We found another ongoing study that is investigating slightly lower doses of dexamethasone in comparison with the standard dose, although the available details were somewhat unclear (<a href="./references#CD006764-bbs2-0036" title="TCTR20200729002. Effect of different doses of steroid on respiratory distress syndrome in moderate to late preterm neonates born between 320-366 weeks of gestation: a randomized controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=TCTR20200729002 (first received 29 July 2020). [CENTRAL: CN-02189966] ">TCTR20200729002</a>).  </p> <p>No ongoing studies directly address the safety concerns raised elsewhere regarding the preparation of betamethasone that women receive. While the <a href="./references#CD006764-bbs2-0037" title="CTRI/2021/03/032429. Improving newborn survival in preterm birth [WHO ACTION-III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes – WHO ACTION-III]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/03/032429 (first received 24 November 2021). [CENTRAL: CN-02280513] ISRCTN11434567. Antenatal corticosteroids for women at risk of birth in the late preterm period to improve newborn outcomes [ACTION III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes]. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN11434567 (first received 7 June 2021). [CENTRAL: CN-02280191] PACTR202105463874444. The WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborns) Trials [ACTION III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes]. trialsearch.who.int/Trial2.aspx?TrialID=PACTR202105463874444 (first received 18 May 2021). [CENTRAL: CN-02281089] ">WHO ACTION III</a> trial compares a standard dose of dexamethasone versus a lower dose of betamethasone in the late preterm period, no other ongoing studies directly investigate the concerns in <a href="./references#CD006764-bbs2-0058" title="JobeAH , KempM , SchmidtA , TakahashiT , NewnhamJ , MiladM . Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatric Research2021;89:318-25. [DOI: doi.org/10.1038/s41390-020-01249-w]">Jobe 2021</a> regarding the potentially improved safety profile of substantially lower doses of corticosteroids. </p> <p>Only one trial in the review reliably reported outcomes beyond the neonatal period (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). We urge trial investigators to follow up both women and children longer term so that the full impact of different corticosteroids and regimens can be comprehensively assessed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006764-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006764-sec-0008"></div> <div class="table" id="CD006764-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Dexamethasone compared to betamethasone – maternal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone</b> –<b>maternal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital  </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> betamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chorioamnionitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.71</b><br/>(0.48 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1346<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000<br/>(40 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Puerperal sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Maternal adverse effects of therapy</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.63</b><br/>(0.35 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1705<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000<br/>(12 to 37) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit while also crossing line of no effect. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. It was also free of risk of bias concerns. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.  </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006764-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dexamethasone compared to betamethasone – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone</b> –<b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital<b> </b> </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> betamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation</b> (fetal, neonatal, child, child as adult) </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.03</b><br/>(0.66 to 1.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2105<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000<br/>(21 to 52) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.06</b><br/>(0.91 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2105<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000<br/>(215 to 288) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Average RR 0.71</b><br/>(0.28 to 1.81) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1901<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000<br/>(15 to 95) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.92</b><br/>(0.64 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1509<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000<br/>(46 to 97) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 5.08</b><br/>(0.25 to 105.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>441<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable, 0/223 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2/218</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit and appreciable harm.<br/><sup>b</sup>Although some studies contributing to the pooled effect estimate had limitations in study design, a sensitivity analysis limited only to studies free of concerns relating to risk of bias (this included only <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>, a large, multicentre study) revealed that inclusion of these studies did not significantly change the effect estimate; therefore, we have not downgraded for risk of bias.<br/><sup>c</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit and appreciable harm. Also downgraded one level for serious risk of bias and substantial unexplained statistical heterogeneity: trials contributing almost half the weight to this analysis were at risk of bias, and their inclusion qualitatively impacted the effect estimate. We also had concerns about unexplained statistical heterogeneity (I² = 62%). Although there were insufficient trials to investigate this heterogeneity through prespecified subgroup analyses, it is possible that this heterogeneity was related to risk of bias; therefore, we downgraded once only. We note that <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> reported very different results from other trials, and when trial was excluded, there was no heterogeneity in the effect estimate; this trial was at risk of bias for missing outcome data, as it did not report this outcome for all babies (100/181 with betamethasone versus 105/178 with dexamethasone) and it is not explicit in the trial report why this is so. The effect estimate if <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> is excluded is RR 1.06, 95% CI 0.66 to 1.68.<br/><sup>d</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit and appreciable harm. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. It was also free of risk of bias concerns. Therefore, although data were provided by a single study, we did not downgrade the effect estimate further for this outcome.<br/><sup>e</sup>Downgraded two levels for very serious imprecision: few events; 95% CIs included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006764-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Dexamethasone compared to betamethasone – child outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone</b> –<b>child outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital  </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> betamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurodevelopmental disability at follow‐up (childhood)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.02</b><br/>(0.85 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1151<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Most children were followed up at 2 years of age (adjusted for prematurity); 12 were followed up at 18 months. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>289 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>295 per 1000<br/>(246 to 353) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Visual impairment</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.33</b><br/>(0.01 to 8.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1227<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/>(0 to 13) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hearing impairment</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b><br/>(0.63 to 2.16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1227<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000<br/>(18 to 63) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Developmental delay</b> –<b>motor (mild, moderate or severe)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.89</b><br/>(0.66 to 1.20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1166<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/>(89 to 162) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intellectual impairment: developmental delay – cognitive or language (mild, moderate or severe)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.97</b><br/>(0.79 to 1.20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1161<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>234 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>227 per 1000<br/>(185 to 281) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cerebral palsy</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.50</b><br/>(0.97 to 6.39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1223<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000<br/>(10 to 63) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations in study design: for the study contributing most or all of the weight to this effect estimate, there was loss to follow‐up greater than 20% in each group. Although this attrition is understandable for longer‐term outcomes, we do not know what happened many babies, and it is possible that the effect could differ substantively based on their outcomes.<br/><sup>b</sup>Downgraded two levels for very serious imprecision and risk of attrition bias: few events and  95% confidence intervals included appreciable benefit and appreciable harm; there was approximately 20% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis. <br/><sup>c</sup>Downgraded one level for serious imprecision and risk of attrition bias: 95% confidence intervals included appreciable benefit and appreciable harm; there was approximately 20% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.<br/><sup>d</sup>Downgraded one level for serious imprecision and risk of attrition bias: 95% confidence intervals included appreciable benefit while also crossing line of no effect; there was approximately 23% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.<br/><sup>e</sup>Downgraded two levels for very serious imprecision and risk of attrition bias: few events; 95% confidence intervals included appreciable harm and crosses line of no effect; there was approximately 20% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.  </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006764-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Dexamethasone: oral compared to intramuscular – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone: oral compared to intramuscular for accelerating fetal lung maturation for women at risk of preterm birth</b> –<b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> oral dexamethasone </p> <p><b>Comparison:</b> intramuscular dexamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with intramuscular dexamethasone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with oral dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation</b> (fetal, neonatal, child, child as adult) </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.48</b><br/>(0.45 to 4.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All deaths reported by this study were neonatal, and babies were not followed up longer term. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<br/>(21 to 233) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.15</b><br/>(0.75 to 1.77) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>298 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1000<br/>(223 to 527) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 4.24</b><br/>(0.96 to 18.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>101 per 1000<br/>(23 to 448) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 5.09</b><br/>(0.63 to 41.45) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000<br/>(8 to 493) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome,</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations in study design: the single study contributing data for this outcome was at risk of bias due to unclear concealment of allocation and likely lack of blinding of participants or personnel. We also downgraded two levels for very serious imprecision: few events, single study with small sample size; 95% confidence intervals included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006764-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Betamethasone acetate plus phosphate compared to betamethasone phosphate – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Betamethasone acetate + phosphate compared to betamethasone phosphate for accelerating fetal lung maturation for women at risk of preterm birth</b> – <b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> betamethasone acetate + phosphate </p> <p><b>Comparison:</b> betamethasone phosphate </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone phosphate</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone acetate + phosphate</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation (fetal, neonatal, child, child as adult)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.32</b><br/>(0.01 to 7.69) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All deaths reported by this study were neonatal, and babies were not followed up longer term. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/>(0 to 226) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.19</b><br/>(0.01 to 3.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/>(1 to 230) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.32</b><br/>(0.01 to 7.69) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/>(0 to 226) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Necrotising enterocolitis</b>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious risk of bias: single small study contributing data for this outcome was at risk of bias due to unclear concealment of allocation and lack of blinding of participants and most personnel. We also downgraded two levels for very serious imprecision: few events, single study with small sample size; 95% confidence intervals included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006764-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Betamethasone 12‐hourly compared to 24‐hourly dosing – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Betamethasone 12‐hourly compared to 24‐hourly dosing</b> –<b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital  </p> <p><b>Intervention:</b> betamethasone 12‐hourly dosing </p> <p><b>Comparison:</b> betamethasone 24‐hourly dosing </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone 24‐hourly dosing </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone 12‐hourly dosing</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation (fetal, neonatal, child, child as adult)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b><br/>(0.46 to 1.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>255<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All deaths reported by this study were perinatal, and babies were not followed up longer term. Compared to the other comparisons in this review, there was also a high death rate in this trial in both groups, which may not be representative of other contexts. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>128 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000<br/>(59 to 240) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.95</b><br/>(0.67 to 1.36) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>364 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>345 per 1000<br/>(244 to 495) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.40</b><br/>(0.73 to 2.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>130 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000<br/>(95 to 351) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.77</b><br/>(0.48 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<br/>(126 to 326) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 9.08</b><br/>(0.54 to 153.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable, 0/76</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10/177</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious risk of bias: single study contributing data for this outcome was at risk of bias due to lack of blinding of participants and personnel, and we also had concerns about baseline imbalances and missing outcome data. We also downgraded two levels for very serious imprecision: small sample size; 95% confidence intervals included appreciable benefit and appreciable harm.<br/><sup>b</sup>Downgraded one level for serious risk of bias: single study contributing data for this outcome was at risk of bias due to lack of blinding of participants and personnel, and we also had concerns about baseline imbalances and missing outcome data. We also downgraded two levels for very serious imprecision: few events, small sample size; 95% confidence intervals included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006764-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006764-sec-0009"></div> <section id="CD006764-sec-0010"> <h3 class="title" id="CD006764-sec-0010">Description of the condition</h3> <p>Preterm birth (less than 37 weeks' gestation) poses a significant global health burden. National rates vary, and range from 5% to 19%, with over 80% of all preterm births occurring in south Asia and sub‐Saharan Africa (<a href="./references#CD006764-bbs2-0043" title="ChawanpaiboonS , VogelJP , MollerAB , LumbiganonP , PetzoldM , HoganD , et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Global Health2019;7:e37-e46. [DOI: 10.1016/S2214-109X(18)30451-0]">Chawanpaiboon 2019</a>). Preterm infants, especially those born before 32 weeks' gestation, are at high risk of respiratory distress syndrome (RDS), a serious complication that remains one of the most common causes of early neonatal death and disability (<a href="./references#CD006764-bbs2-0053" title="HaramK , MortensenJH , WollenAL . Preterm delivery: an overview. Acta Obstetricia et Gynecologica Scandinavica2003;82:687-704.">Haram 2003</a>; <a href="./references#CD006764-bbs2-0072" title="PatelRM . Short and long-term outcomes for extremely preterm infants. American Journal of Perinatology2016;33(3):318-28. [DOI: 10.1055/s-0035-1571202]">Patel 2016</a>). Those infants born preterm who do survive the neonatal period are at a significantly increased risk of long‐term neurological disability (<a href="./references#CD006764-bbs2-0059" title="JohnsonA , TownshendP , YudkinP , BullD , WilkinsonAR . Functional abilities at age 4 years of children born before 29 weeks gestation. BMJ1993;306:1715-8.">Johnson 1993</a>; <a href="./references#CD006764-bbs2-0068" title="MwanikiMK , AtienoM , LawnJE , NewtonCR . Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet2012;379:445-52. [DOI: 10.1016/S0140- 6736(11)61577-8]">Mwaniki 2012</a>; <a href="./references#CD006764-bbs2-0076" title="SaigalS , DoyleLW . An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet2007;371(9608):261-9.">Saigal 2007</a>). RDS develops as a consequence of surfactant deficiency and immature lung development. The risk of RDS and neonatal mortality reduces as gestation increases, reflecting maturity of organ systems (<a href="./references#CD006764-bbs2-0048" title="DoyleLW , Victorian Infant Collaborative Study Group. Outcome at 5 years of age of children 23 to 27 weeks gestation: refining the prognosis. Pediatrics2001;108(1):134-41.">Doyle 2001</a>; <a href="./references#CD006764-bbs2-0066" title="MoiseAA , WeardenME , KozinetzCA , GestAL , WeltySE , HansenTN . Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics1995;95:845-50.">Moise 1995</a>; <a href="./references#CD006764-bbs2-0076" title="SaigalS , DoyleLW . An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet2007;371(9608):261-9.">Saigal 2007</a>). Treatments that may reduce the incidence of RDS in infants born preterm, including antenatal corticosteroids, have therefore received considerable attention. One recent Cochrane Review that compared antenatal corticosteroid for fetal lung maturation versus placebo concluded that the available evidence supports the continued use of a single course of antenatal corticosteroids (<a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a>).  </p> </section> <section id="CD006764-sec-0011"> <h3 class="title" id="CD006764-sec-0011">Description of the intervention</h3> <section id="CD006764-sec-0012"> <h4 class="title">Corticosteroid type</h4> <p>Currently either betamethasone or dexamethasone are the recommended corticosteroids used in clinical practice (<a href="./references#CD006764-bbs2-0049" title="NormanJ , ShennanA , JacobssonB , StockSJ . FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. International Journal of Gynecology and Obstetrics2021;155:26-30. [DOI: 10.1002/ijgo.13836]">FIGO 2021</a>). Betamethasone is available in two forms: betamethasone sodium phosphate, a solution with a short biological half‐life of 36 to 72 hours; and betamethasone acetate, a suspension with a relatively long half‐life (<a href="./references#CD006764-bbs2-0057" title="JobeAH , SollRF . Choice and dose of corticosteroid for antenatal treatments. American Journal of Obstetrics and Gynecology2004;190:878-81.">Jobe 2004</a>; <a href="./references#CD006764-bbs2-0060" title="KatzungBG . Basic and Clinical Pharmacology. New York (NY): McGraw Hill, 2004.">Katzung 2004</a>; <a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). These forms of betamethasone are often used in combination to maximise the drug's efficiency while reducing the number of injections given to the mother (<a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). Dexamethasone generally comes in the form of dexamethasone sodium phosphate (<a href="./references#CD006764-bbs2-0039" title="BallardPL , BallardRA . Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. American Journal of Obstetrics and Gynecology1995;173:254-62.">Ballard 1995</a>; <a href="./references#CD006764-bbs2-0057" title="JobeAH , SollRF . Choice and dose of corticosteroid for antenatal treatments. American Journal of Obstetrics and Gynecology2004;190:878-81.">Jobe 2004</a>; <a href="./references#CD006764-bbs2-0060" title="KatzungBG . Basic and Clinical Pharmacology. New York (NY): McGraw Hill, 2004.">Katzung 2004</a>; <a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). </p> <p>Both betamethasone and dexamethasone can cross the placenta in their active form and have comparable properties (<a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). The chemical composition of betamethasone and dexamethasone are virtually identical except for the configuration of a methyl group in position 16 (<a href="./references#CD006764-bbs2-0040" title="Bar-LevMR , Maayan-MetzgerA , MatokI , HeymanZ , SivanE , KuintJ . Short term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone. Obstetrics and Gynecology2004;104(3):484-8.">Bar‐Lev 2004</a>; <a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). Some dexamethasone preparations contain a sulphite preservative (<a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). Sulphites have been linked to neurotoxicity in the newborn (<a href="./references#CD006764-bbs2-0040" title="Bar-LevMR , Maayan-MetzgerA , MatokI , HeymanZ , SivanE , KuintJ . Short term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone. Obstetrics and Gynecology2004;104(3):484-8.">Bar‐Lev 2004</a>; <a href="./references#CD006764-bbs2-0041" title="BaudO , Foix-L'HeliasL , KaminskiM , AudibertF , JarreauPH , PapiernikE , et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. New England Journal of Medicine1999;341:1190-6.">Baud 1999</a>; <a href="./references#CD006764-bbs2-0050" title="GoldenbergRL , WrightLL . Repeated courses of antenatal corticosteroids. Obstetrics and Gynecology2001;97:316-7.">Goldenberg 2001</a>; <a href="./references#CD006764-bbs2-0079" title="WalfischA , HallakM , MazorM . Multiple courses of antenatal steroids: risks and benefits. Obstetrics and Gynecology2001;98:491-7.">Walfisch 2001</a>). </p> <p>The optimal type of corticosteroid to use for antenatal treatment remains unclear. The previous version of this review indicated that it was uncertain whether one corticosteroid has advantages over another (<a href="./references#CD006764-bbs2-0081" title="BrownfootFC , GagliardiDI , BainE , MiddletonP , CrowtherCA . Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD006764. [DOI: 10.1002/14651858.CD006764.pub3]">Brownfoot 2013</a>). While the authors found that dexamethasone may be associated with a reduced risk of intraventricular haemorrhage (IVH) and a shorter stay in the neonatal intensive care unit (NICU) when compared with betamethasone, there were no differences for other infant outcomes, and none of the included studies reported any primary or secondary maternal outcomes.  </p> <p>The long‐term outcomes related to corticosteroid use have largely been positive. The <a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a> Cochrane Review concluded that overall, antenatal corticosteroid treatment was probably associated with less developmental delay in childhood. It is not known if the long‐term outcomes vary by type of corticosteroid used. While follow‐up at 30 years following use showed no clinical differences in adults who were exposed or not exposed to betamethasone in utero (<a href="./references#CD006764-bbs2-0047" title="DalzielSR , LimVK , LambertA , McCarthyD , ParagV , RodgersA , et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trials. BMJ2005;331(7518):665.">Dalziel 2005</a>), there have been no similar long‐term follow‐up studies reported on dexamethasone use. When this review was previously updated, there were no published data on the long‐term effects of antenatal betamethasone compared directly with dexamethasone. </p> </section> <section id="CD006764-sec-0013"> <h4 class="title">Corticosteroid dose, timing and frequency</h4> <p>The optimal corticosteroid dose to use, timing of use and frequency of administration similarly remains unclear. The common regimens of two doses of betamethasone 12 mg given intramuscularly 24 hours apart, and two doses of dexamethasone 12 mg given intramuscularly 24 hours apart were recently recommended by the International Federation of Gynecology and Obstetrics (<a href="./references#CD006764-bbs2-0049" title="NormanJ , ShennanA , JacobssonB , StockSJ . FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. International Journal of Gynecology and Obstetrics2021;155:26-30. [DOI: 10.1002/ijgo.13836]">FIGO 2021</a>), although four doses of dexamethasone 6 mg given intramuscularly 12 hours apart has also been recommended (<a href="./references#CD006764-bbs2-0069" title="National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA1995;273(5):413-8.">NIH 1995</a>). This total dose (24 mg) corresponds to a high occupancy of steroid receptors in fetal tissues. While the benefits of corticosteroids are well‐known, there is concern regarding their potential for adverse effects, particularly at high doses. There is a suggestion that the current antenatal doses used may be higher than needed (<a href="./references#CD006764-bbs2-0058" title="JobeAH , KempM , SchmidtA , TakahashiT , NewnhamJ , MiladM . Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatric Research2021;89:318-25. [DOI: doi.org/10.1038/s41390-020-01249-w]">Jobe 2021</a>; <a href="./references#CD006764-bbs2-0077" title="SchmidtAF , ParanthamanSK , BridgesPB , FilutaA , LippsD , KempM , et al. Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques. Scientific Reports2019;9(1):1-10. [DOI: 10.1038/s41598-019-45171-6]">Schmidt 2019</a>). Similarly, the rationale for two doses of betamethasone and either two or four doses of dexamethasone and the effects of using different formulations for the initial and subsequent injections remain unclear (<a href="./references#CD006764-bbs2-0057" title="JobeAH , SollRF . Choice and dose of corticosteroid for antenatal treatments. American Journal of Obstetrics and Gynecology2004;190:878-81.">Jobe 2004</a>; <a href="./references#CD006764-bbs2-0071" title="HeyE , editor. The Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life 6th Edition (NNF6). Oxford (UK): BMJ Books/Wiley Blackwell, 2011.">NNF6 2011</a>). </p> </section> <section id="CD006764-sec-0014"> <h4 class="title">Corticosteroid route</h4> <p>The optimal route of administration of antenatal betamethasone and dexamethasone is also uncertain. Both drugs may be administered as intramuscular injections. Betamethasone can be given intra‐amniotically (<a href="./references#CD006764-bbs2-0062" title="LefebvreY , MarierR , AmyotG , BilodeauR , HotteR , RaynaultP , et al. Maternal, fetal and intra-amniotic hormonal and biologic changes resulting from a single dose of hydrocortisone injected in the intra-amniotic compartment. American Journal of Obstetrics and Gynecology1976;125(5):609-12.">Lefebvre 1976</a>; <a href="./references#CD006764-bbs2-0067" title="MurphyBE . The absorption by the human fetus of intra-amniotically injected cortisol. Journal of Steroid Biochemistry1982;16(3):415-7.">Murphy 1982</a>) and intravenously (<a href="./references#CD006764-bbs2-0073" title="PetersenMC , CollierCB , AshleyJJ , McBrideWG , NationRL . Disposition of betamethasone in parturient women after intravenous administration. European Journal of Clinical Pharmacology1983;25(6):803-10.">Petersen 1983</a>), and dexamethasone can be given orally (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>). </p> </section> <section id="CD006764-sec-0015"> <h4 class="title">Repeat doses of corticosteroid</h4> <p>The reduction in the incidence of RDS by antenatal corticosteroid therapy is effective up to seven days after treatment (<a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a>). One Cochrane Review assessed whether, for women who remain undelivered and at risk of preterm birth, antenatal corticosteroids need to be repeated seven days after the initial course (<a href="./references#CD006764-bbs2-0046" title="CrowtherCA , McKinlayJD , MiddletonP , HardingJE . Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD003935. [DOI: 10.1002/14651858.CD003935.pub4]">Crowther 2015</a>); therefore, this review will not cover repeat steroid courses compared with a single course. </p> </section> </section> <section id="CD006764-sec-0016"> <h3 class="title" id="CD006764-sec-0016">How the intervention might work</h3> <p>Corticosteroids act by altering gene expression resulting in glucocorticoid effects, including gluconeogenesis (synthesis of glucose from non‐carbohydrate metabolites); proteolysis (breakdown of proteins); lipolysis (breakdown of lipids); suppression of immune responses; and mineralocorticoid effects (regulation of electrolyte excretion), including hypertension, sodium and water retention, and potassium loss (<a href="./references#CD006764-bbs2-0038" title="Anonymous. Corticosteroids. In: RossiS , editors(s). Australian Medicines Handbook. Adelaide (Australia): AMH, 2006:496-500.">AMH 2006</a>). In fetal lungs, the action of corticosteroids leads to an increase in protein production, biosynthesis of phospholipids and the appearance of surfactant (<a href="./references#CD006764-bbs2-0039" title="BallardPL , BallardRA . Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. American Journal of Obstetrics and Gynecology1995;173:254-62.">Ballard 1995</a>). </p> <p><a href="./references#CD006764-bbs2-0063" title="LigginsGC . Premature delivery of foetal lambs infused with corticosteroids. Journal of Endocrinology1969;45:515-23.">Liggins 1969</a> demonstrated that the lungs of lambs born preterm became functionally mature following antenatal corticosteroid administration. Following these initial animal studies, Liggins and other investigators conducted several clinical trials to assess the effects of corticosteroids before preterm birth in humans. </p> <p>The <a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a> Cochrane Review showed that a single course of antenatal corticosteroids reduced the incidence of RDS, perinatal death and neonatal death, and probably reduced IVH and childhood developmental delay. For the mother, corticosteroid use did not increase the risk of death, chorioamnionitis or endometritis (<a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a>). Contrary to the concern that corticosteroid treatment may increase infection in those with preterm prelabour rupture of membranes (<a href="./references#CD006764-bbs2-0056" title="ImseisHM , IamsJD . Glucocorticoid use in patients with preterm premature rupture of fetal membranes. Seminars in Perinatology1996;20(5):439-50.">Imseis 1996</a>), or increase the rate of stillbirth in those with pregnancy‐related hypertension (<a href="./references#CD006764-bbs2-0064" title="LigginsGC . Prenatal glucocorticoid treatment: prevention of respiratory distress syndrome. In: MooreTD , editors(s). Lung maturation and the prevention of hyaline membrane disease. Report of the Seventieth Ross Conference on Paediatric Research; 1976; Columbus (OH). 1976:97-103.">Liggins 1976</a>), subgroup analyses in this Cochrane Review suggested that antenatal corticosteroid treatment might not increase the risk of these complications (<a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a>). Corticosteroids have become the standard of care for women at risk of preterm birth before 32 to 34 weeks' gestation in many countries (<a href="./references#CD006764-bbs2-0057" title="JobeAH , SollRF . Choice and dose of corticosteroid for antenatal treatments. American Journal of Obstetrics and Gynecology2004;190:878-81.">Jobe 2004</a>; <a href="./references#CD006764-bbs2-0069" title="National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA1995;273(5):413-8.">NIH 1995</a>). </p> <p>Despite their widespread use, there is currently variation in clinical practice as to the type of corticosteroid used, the dose and frequency given, and the route of administration of corticosteroid doses. </p> </section> <section id="CD006764-sec-0017"> <h3 class="title" id="CD006764-sec-0017">Why it is important to do this review</h3> <p>Determining the optimal corticosteroid and optimal regimens is very important since most pregnant women at risk of preterm birth will be considered candidates for antenatal corticosteroid treatment (<a href="./references#CD006764-bbs2-0070" title="NIH Consensus Panel. Antenatal corticosteroids revisited. NIH Consensus Statement2000;17(2):1-10.">NIH 2000</a>), and these numbers may continue to grow as rates of preterm birth are increasing in a number of countries (<a href="./references#CD006764-bbs2-0044" title="ChowSS . Report of the Australian and New Zealand Neonatal Network 2010. Sydney (Australia): Australian and New Zealand Neonatal Network, 2013.">Chow 2013</a>; <a href="./references#CD006764-bbs2-0051" title="GoldenbergR , CulhaneJF , IamsJ , RomeroR . Epidemiology and causes of preterm birth. Lancet2007;371:73-82.">Goldenberg 2007</a>). </p> <p>There is considerable variation reported between countries as to whether health practitioners prefer dexamethasone or betamethasone, with many likely reasons for these differences including availability and costs (dexamethasone is cheaper than betamethasone so is widely used in low‐ and middle‐income countries) (<a href="./references#CD006764-bbs2-0054" title="Henderson-SmartDJ , LumbiganonP , FestinMR , HoJJ , MohammadH , McDonaldSJ , et al. Optimising reproductive and child health outcomes by building evidence-based research and practice in South East Asia (SEA-ORCHID): study protocol. BMC Medical Research Methodology2007;7:43.">Henderson‐Smart 2007</a>; <a href="./references#CD006764-bbs2-0075" title="SaengwareeP , LiabsuetrakulT . Changing practice on corticosteroids. Journal of the Medical Association of Thailand2005;88:307-13.">Saengwaree 2005</a>), impact of inconsistent findings from observational studies (<a href="./references#CD006764-bbs2-0041" title="BaudO , Foix-L'HeliasL , KaminskiM , AudibertF , JarreauPH , PapiernikE , et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. New England Journal of Medicine1999;341:1190-6.">Baud 1999</a>; <a href="./references#CD006764-bbs2-0061" title="LeeBH , StollBJ , McDonaldSA , HigginsRD , for the National Institute of Child Health and Human Development Neonatal Research Network. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics2006;117(5):1503-10.">Lee 2006</a>), and influence of opinion leaders (<a href="./references#CD006764-bbs2-0057" title="JobeAH , SollRF . Choice and dose of corticosteroid for antenatal treatments. American Journal of Obstetrics and Gynecology2004;190:878-81.">Jobe 2004</a>). </p> <p>This review updates a previously published Cochrane Review on different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth (<a href="./references#CD006764-bbs2-0081" title="BrownfootFC , GagliardiDI , BainE , MiddletonP , CrowtherCA . Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD006764. [DOI: 10.1002/14651858.CD006764.pub3]">Brownfoot 2013</a>). That review found that dexamethasone may have some benefits compared to betamethasone such as less IVH and a shorter length of stay in NICU. Few other conclusions about optimal antenatal corticosteroids or regimens could be made, and thus the review concluded that high‐quality evidence from randomised controlled trials (RCT) on types of corticosteroids, dosage and other variations in regimen was urgently needed in this area. </p> <p>Despite the widespread use of antenatal corticosteroids to prevent RDS in preterm infants, there is still no consensus as to the type of corticosteroid to use, or the dose, frequency, timing of use or the route of administration. We aimed to assess studies that compared different regimens of corticosteroid type, dose, timing, frequency of dose per treatment course and route of administration. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006764-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006764-sec-0018"></div> <p>To assess the effects on fetal and neonatal morbidity and mortality, on maternal morbidity and mortality, and on the child and adult in later life, of administering different types of corticosteroids (dexamethasone or betamethasone), or different corticosteroid dose regimens, including timing, frequency and mode of administration. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006764-sec-0019" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006764-sec-0019"></div> <section id="CD006764-sec-0020"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006764-sec-0021"> <h4 class="title">Types of studies</h4> <p>We included all identified published and unpublished RCTs or quasi‐RCTs comparing any two corticosteroids (dexamethasone or betamethasone or any other corticosteroid that can cross the placenta), comparing different dose regimens (including frequency and timing of administration) in women at risk of preterm birth. We excluded cross‐over trials and cluster‐randomised trials. We included studies published as abstracts only along with studies published as full‐text manuscripts. </p> </section> <section id="CD006764-sec-0022"> <h4 class="title">Types of participants</h4> <p>Women with a singleton or multiple pregnancy expected to give birth preterm (before 37 weeks) as a result of spontaneous preterm labour, preterm prelabour rupture of membranes or indicated preterm birth. </p> </section> <section id="CD006764-sec-0023"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD006764-list-0001"> <li> <p>Different types of corticosteroids including dexamethasone, betamethasone, hydrocortisone or any other corticosteroid that can cross the placenta </p> </li> <li> <p>Different corticosteroid regimens including dose, frequency, timing and route of administration</p> </li> </ul> </p> <p>We excluded trials that compared the effect of corticosteroids with other interventions and trials assessing repeat corticosteroid doses versus a single corticosteroid dose. </p> </section> <section id="CD006764-sec-0024"> <h4 class="title">Types of outcome measures</h4> <p>These cover outcomes of maternal morbidity, perinatal morbidity and mortality, child morbidity and mortality, child as adult morbidity and mortality, and the use of health services by the mother and by the neonate or child. </p> <p>They are divided into primary outcomes, thought to be the most clinically relevant, and secondary outcomes of importance, including possible complications and also additional measures of effectiveness. Groups include: women, fetuses/neonates, children, children as adults and health services. </p> <section id="CD006764-sec-0025"> <h5 class="title">Primary outcomes</h5> <section id="CD006764-sec-0026"> <h6 class="title">For the woman</h6> <p> <ul id="CD006764-list-0002"> <li> <p>Death</p> </li> <li> <p>Chorioamnionitis (however defined by authors)</p> </li> <li> <p>Puerperal sepsis (however defined by authors)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0027"> <h6 class="title">For the fetus/neonate</h6> <p> <ul id="CD006764-list-0003"> <li> <p>Any known death after randomisation (i.e. fetal, neonatal, child, child as adult)</p> </li> <li> <p>Respiratory distress syndrome (RDS)</p> </li> <li> <p>Intraventricular haemorrhage (IVH) (diagnosed by ultrasound or diagnosed by autopsy)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0028"> <h6 class="title">For the child</h6> <p> <ul id="CD006764-list-0004"> <li> <p>Death</p> </li> <li> <p>Neurodevelopmental disability at follow‐up (blindness, deafness, moderate/severe cerebral palsy (however defined by authors), or developmental delay/intellectual impairment (defined as developmental quotient or intelligence quotient less than –2 standard deviations below population mean) or variously defined) </p> </li> </ul> </p> </section> <section id="CD006764-sec-0029"> <h6 class="title">For the child as an adult</h6> <p> <ul id="CD006764-list-0005"> <li> <p>Death</p> </li> <li> <p>Neurodevelopmental disability at follow‐up (blindness, deafness, moderate/severe cerebral palsy (however defined by authors), or developmental delay/intellectual impairment (defined as developmental quotient or intelligence quotient less than –2 standard deviations below population mean) or variously defined) </p> </li> </ul> </p> </section> </section> <section id="CD006764-sec-0030"> <h5 class="title">Secondary outcomes</h5> <section id="CD006764-sec-0031"> <h6 class="title">For the woman</h6> <p> <ul id="CD006764-list-0006"> <li> <p>Fever after trial entry requiring the use of antibiotics</p> </li> <li> <p>Intrapartum fever requiring the use of antibiotics</p> </li> <li> <p>Postnatal fever requiring the use of antibiotics</p> </li> <li> <p>Admission to intensive care unit</p> </li> <li> <p>Adverse effects of therapy</p> </li> <li> <p>Glucose intolerance (however defined by authors)</p> </li> <li> <p>Hypertension (however defined by authors)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0032"> <h6 class="title">For the fetus/neonate</h6> <p> <ul id="CD006764-list-0007"> <li> <p>Fetal death</p> </li> <li> <p>Neonatal death (up to 28 days after birth)</p> </li> <li> <p>Apgar score less than 7 at five minutes</p> </li> <li> <p>Interval between trial entry and birth</p> </li> <li> <p>Birthweight</p> </li> <li> <p>Low birthweight</p> </li> <li> <p>Mean length at birth</p> </li> <li> <p>Mean head circumference at birth</p> </li> <li> <p>Mean skin fold thickness at birth</p> </li> <li> <p>Small‐for‐gestational age (however defined by authors)</p> </li> <li> <p>Mean placental weight</p> </li> <li> <p>Neonatal blood pressure</p> </li> <li> <p>Admission to NICU</p> </li> <li> <p>Need for inotropic support (days)</p> </li> <li> <p>Need for mechanical ventilation/continuous positive airways pressure</p> </li> <li> <p>Mean duration of mechanical ventilation/continuous positive airways pressure (days)</p> </li> <li> <p>Air leak syndrome</p> </li> <li> <p>Need for oxygen supplementation</p> </li> <li> <p>Duration of oxygen supplementation (days)</p> </li> <li> <p>Surfactant use</p> </li> <li> <p>Severity of RDS</p> </li> <li> <p>Chronic lung disease (need for continuous supplemental oxygen at 28 days' postnatal age or 36 weeks' postmenstrual age, whichever was later) </p> </li> <li> <p>Bronchopulmonary dysplasia (variously defined)</p> </li> <li> <p>Severe IVH</p> </li> <li> <p>Periventricular leukomalacia</p> </li> <li> <p>Systemic infection in first 48 hours of life (neonatal sepsis)</p> </li> <li> <p>Proven infection while in the NICU</p> </li> <li> <p>Necrotising enterocolitis</p> </li> <li> <p>Retinopathy of prematurity</p> </li> <li> <p>Patent ductus arteriosus</p> </li> <li> <p>Hypothalamo‐pituitary‐adrenal (HPA) axis function (however defined by authors)</p> </li> <li> <p>Biophysical parameters (however defined by the authors)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0033"> <h6 class="title">For the child</h6> <p> <ul id="CD006764-list-0008"> <li> <p>Mean weight</p> </li> <li> <p>Mean length</p> </li> <li> <p>Mean head circumference</p> </li> <li> <p>Mean skin fold thickness</p> </li> <li> <p>Abnormal lung function (however defined by authors)</p> </li> <li> <p>Mean blood pressure</p> </li> <li> <p>Glucose intolerance (however defined by authors)</p> </li> <li> <p>HPA axis function (however defined by authors)</p> </li> <li> <p>Dyslipidaemia (however defined by authors)</p> </li> <li> <p>Any neurodisability</p> </li> <li> <p>Visual impairment (however defined by authors)</p> </li> <li> <p>Hearing impairment (however defined by authors)</p> </li> <li> <p>Developmental delay (mild, moderate or severe: defined as developmental quotient less than –1 standard deviations below population mean) </p> </li> <li> <p>Developmental delay (moderate or severe: defined as developmental quotient less than –2 standard deviations below population mean) </p> </li> <li> <p>Intellectual impairment (moderate or severe: defined as intelligence quotient less than –2 standard deviations below population mean) </p> </li> <li> <p>Intellectual impairment (mild, moderate or severe: defined as intelligence quotient less than –1 standard deviations below population mean) </p> </li> <li> <p>Cerebral palsy (however defined by authors)</p> </li> <li> <p>Behavioural/learning difficulties (however defined by authors)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0034"> <h6 class="title">For the child as an adult</h6> <p> <ul id="CD006764-list-0009"> <li> <p>Death</p> </li> <li> <p>Mean weight</p> </li> <li> <p>Mean head circumference</p> </li> <li> <p>Mean length</p> </li> <li> <p>Mean skin fold thickness</p> </li> <li> <p>Abnormal lung function (however defined by authors)</p> </li> <li> <p>Mean blood pressure</p> </li> <li> <p>Glucose intolerance (however defined by authors)</p> </li> <li> <p>HPA axis function (however defined by authors)</p> </li> <li> <p>Dyslipidaemia (however defined by authors)</p> </li> <li> <p>Mean age at puberty</p> </li> <li> <p>Bone density (however defined by authors)</p> </li> <li> <p>Educational achievement (completion of high school, or however defined by authors)</p> </li> <li> <p>Any neurodisability</p> </li> <li> <p>Visual impairment (however defined by authors)</p> </li> <li> <p>Hearing impairment (however defined by authors)</p> </li> <li> <p>Intellectual impairment (defined as intelligence quotient less than –2 standard deviations below population mean) </p> </li> <li> <p>Behavioural/learning difficulties (however defined by authors)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0035"> <h6 class="title">For health services</h6> <p> <ul id="CD006764-list-0010"> <li> <p>Mean length of antenatal hospitalisation for women (days)</p> </li> <li> <p>Mean length of postnatal hospitalisation for women (days)</p> </li> <li> <p>Mean length of neonatal hospitalisation (days)</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD006764-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD006764-sec-0037"> <h4 class="title">Electronic searches</h4> <p>For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (9 May 2022) </p> <p>The Register is a database containing over 33,000 reports of controlled trials in the field of pregnancy and childbirth. It represents over 30 years of searching. For full current search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, see <a href="https://pregnancy.cochrane.org/pregnancy-and-childbirth-groups-trials-register" target="_blank">pregnancy.cochrane.org/pregnancy-and-childbirth-groups-trials-register</a>. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ul id="CD006764-list-0011"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL), which includes centralised searches of ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP); </p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ul> </p> <p>These search results are screened and the full text of all relevant trial reports identified through the searching activities described above. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searched the Register for this review using this topic number rather than keywords. This resulted in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD006764-bbs1-0001" title="">Included studies</a>; <a href="./references#CD006764-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD006764-bbs1-0003" title="">Studies awaiting classification</a>; <a href="./references#CD006764-bbs1-0004" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO ICTRP (<a href="https://trialsearch.who.int/Default.aspx" target="_blank">trialsearch.who.int/Default.aspx</a>) for unpublished, planned and ongoing trial reports on 9 May 2022 using the search methods detailed in <a href="./appendices#CD006764-sec-0239">Appendix 1</a>. </p> </section> <section id="CD006764-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any  language or date restrictions.</p> </section> </section> <section id="CD006764-sec-0039"> <h3 class="title" id="CD006764-sec-0039">Data collection and analysis</h3> <p>For methods used in the previous version of this review, see <a href="./references#CD006764-bbs2-0081" title="BrownfootFC , GagliardiDI , BainE , MiddletonP , CrowtherCA . Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD006764. [DOI: 10.1002/14651858.CD006764.pub3]">Brownfoot 2013</a>. </p> <p>For this update, we used the following methods for assessing the 25 reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD006764-sec-0040"> <h4 class="title">Selection of studies</h4> <p>At least two review authors independently assessed all the potential studies identified by the search strategy for inclusion. We resolved any disagreement through discussion or consultation with another review author. </p> <p>At least two review authors evaluated all studies against predefined criteria to select studies that, based on available information, were deemed sufficiently trustworthy to be included in the analysis. We resolved any disagreement through discussion or consultation with another review author. The criteria are defined in the Trustworthiness Screening Tool, a screening tool developed by Cochrane Pregnancy and Childbirth and are described below (see <a href="http://pregnancy.cochrane.org/news/identifying-and-handling-potentially-untrustworthy-trials-pregnancy-and-childbirth-cochrane" target="_blank">pregnancy.cochrane.org/news/identifying-and-handling-potentially-untrustworthy-trials-pregnancy-and-childbirth-cochrane</a>). </p> <section id="CD006764-sec-0041"> <h5 class="title">Research governance</h5> <p> <ul id="CD006764-list-0012"> <li> <p>Are there any retraction notices or expressions of concern listed on the Retraction Watch Database relating to this study? </p> </li> <li> <p>Was the study prospectively registered (for those studies published after 2010)? If not, was there a plausible reason? </p> </li> <li> <p>When requested, did the trial authors provide/share the protocol or ethics approval letter (or both)? </p> </li> <li> <p>Did the trial authors engage in communication with the Cochrane Review authors within the agreed timelines? </p> </li> <li> <p>Did the trial authors provide individual participant data upon request? If not, was there a plausible reason? </p> </li> </ul> </p> </section> <section id="CD006764-sec-0042"> <h5 class="title">Baseline characteristics</h5> <p> <ul id="CD006764-list-0013"> <li> <p>Is the study free from characteristics of the study participants that appear too similar (e.g. distribution of the mean (standard deviation) excessively narrow or excessively wide, as noted by <a href="./references#CD006764-bbs2-0042" title="CarlisleJB . Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trial in anaesthetic and general medical journals. Anaesthesia2017;72:944-52.">Carlisle 2017</a>)? </p> </li> </ul> </p> </section> <section id="CD006764-sec-0043"> <h5 class="title">Feasibility</h5> <p> <ul id="CD006764-list-0014"> <li> <p>Is the study free from characteristics that could be implausible (e.g. large numbers of women with a rare condition (such as severe cholestasis in pregnancy) recruited within 12 months)? </p> </li> <li> <p>In cases with (close to) zero losses to follow‐up, is there a plausible explanation?</p> </li> </ul> </p> </section> <section id="CD006764-sec-0044"> <h5 class="title">Results</h5> <p> <ul id="CD006764-list-0015"> <li> <p>Is the study free from results that could be implausible (e.g. massive risk reduction for main outcomes with small sample size)? </p> </li> <li> <p>Do the numbers randomised to each group suggest that adequate randomisation methods were used (e.g. is the study free from issues such as unexpectedly even numbers of women 'randomised' including a mismatch between the numbers and the methods, if the authors say 'no blocking was used' but still end up with equal numbers, or if the authors say they used 'blocks of 4' but the final numbers differ by six)? </p> </li> </ul> </p> <p>Studies assessed as being potentially 'high risk' were excluded from the review. Where a study was classified as 'high risk', we attempted to contact the study authors to address any possible lack of information/concerns. In cases where we could not obtain contact details for the study authors, or where adequate information remained unavailable, the study remained 'awaiting classification' and the reasons and communications with the trial author (or lack of) were described in detail. </p> </section> <section id="CD006764-sec-0045"> <h5 class="title">Abstracts</h5> <p>We planned to include data from abstracts only if, in addition to the trustworthiness assessment, the study authors confirmed in writing that the data to be included in the review had come from the final analysis and would not change. If such information was not available/provided, the study remained in 'awaiting classification' (as above). However, we included no trials reported only as abstracts and no data from abstracts that were not in the final trial reports. </p> <p>See <a href="#CD006764-fig-0001">Figure 1</a> for details of how to apply the trustworthiness screening criteria. </p> <div class="figure" id="CD006764-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Applying the trustworthiness screening tool criteria. TST: Trustworthiness Screening Tool." data-id="CD006764-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Applying the trustworthiness screening tool criteria. TST: Trustworthiness Screening Tool. </p> </div> </div> </div> </section> </section> <section id="CD006764-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, at least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third review author. We entered data into Review Manager software and checked them for accuracy (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009021.pub2/full#CD009021-bbs2-0078" target="_blank">Review Manager 2011</a>). </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> <p>Note: one review author was also an author on the A*STEROID trial (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). Two other review authors performed data extraction for that trial. </p> </section> <section id="CD006764-sec-0047"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006764-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third author. </p> <p>Note: one review author was also an author on the A*STEROID trial (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). Two other review authors performed risk of bias assessments for that trial. </p> <section id="CD006764-sec-0048"> <h5 class="title">1. Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the methods used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006764-list-0016"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0049"> <h5 class="title">2. Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal the allocation sequence and determined whether intervention allocation could have been foreseen in advance of, or during, recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006764-list-0017"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0050"> <h5 class="title">3.1. Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study, the methods, if any, used to blind study participants and personnel from knowledge of which intervention a participant received. We considered studies to be at a low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We considered studies be at high risk of bias if there was no blinding or incomplete blinding, and the outcome was likely to be influenced by lack of blinding. We considered studies to be at unclear risk if there was insufficient information to permit a judgement of 'low risk' or 'high risk'. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006764-list-0018"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0051"> <h5 class="title">3.2. Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We considered studies to be at a low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We considered studies be at high risk of bias if there was no blinding or incomplete blinding, and the outcome was likely to be influenced by lack of blinding. We considered studies to be at unclear risk if there was insufficient information to permit a judgement of 'low risk' or 'high risk'. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD006764-list-0019"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0052"> <h5 class="title">4. Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study and for each outcome or class of outcomes the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported or was supplied by the trial authors, we included missing data in the analyses which we undertook. </p> <p> We assessed the methods as:</p> <p> <ul id="CD006764-list-0020"> <li> <p>low risk of bias (e.g. where there was no missing data or where reasons for missing data were balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; 'as treated' analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0053"> <h5 class="title">5. Selective reporting bias (checking for reporting bias)</h5> <p>We described for each included study how the possibility of selective outcome reporting bias was examined by us and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD006764-list-0021"> <li> <p>low risk of bias (where it was clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review had been reported); </p> </li> <li> <p>high risk of bias (where not all the study's prespecified outcomes had been reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0054"> <h5 class="title">6. Other sources of bias (checking for bias due to problems not covered by 1. to 5. above) </h5> <p>We described for each included study any important concerns we had about other possible sources of bias. We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD006764-list-0022"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD006764-sec-0055"> <h5 class="title">7. Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at a high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006764-bbs2-0055" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). With reference to 1. to 6. above, we assessed the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses – see <a href="#CD006764-sec-0065">Sensitivity analysis</a>.  </p> </section> </section> <section id="CD006764-sec-0056"> <h4 class="title">Measures of treatment effect</h4> <section id="CD006764-sec-0057"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as risk ratio (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD006764-sec-0058"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference (MD) when trials measured outcomes using the same method. If necessary, we would have used the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD006764-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>We considered cross‐over trials and cluster‐randomised trials inappropriate for this research question. </p> <p>The unit of randomisation was per woman: for maternal outcomes, we used the number of women as the denominator; where possible, for fetal and neonatal outcomes where some women had multiple pregnancies,  we used the number of fetuses as the denominator. </p> </section> <section id="CD006764-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>In cases where trial data were missing, we first sought information from the original trial investigators. Details of trial authors contacted and the questions asked of them are contained in the <a href="./references#CD006764-sec-0254" title="">Characteristics of included studies</a> table.  </p> <p>We recognise that some study outcomes may be applicable only to a subset of participants, for instance morbidity outcomes can only occur after live birth. However, if the denominator is not based on the intention‐to‐treat (ITT) principle (i.e. if it omits those who died before birth), this could potentially bias the analysis, as the comparison is then not between the randomised groups. Since we could not be certain that predelivery fetal deaths were unrelated to the intervention, we judged that the more appropriate method would be to use numbers randomised as the denominator for all our outcomes related to the fetus/neonate. </p> <p>In the absence of appropriate statistical methods in the individual trials to account for missing data, in the following situations we deemed it appropriate to use the denominator reported by the trial rather than the number randomised in order to avoid making  potentially misleading assumptions about the outcomes for those women and fetuses with missing data: </p> <p> <ul id="CD006764-list-0023"> <li> <p>where there was no explanation for women who were lost to follow‐up before giving birth and were not included in the analysis of the individual trials; </p> </li> <li> <p>where women were not included in trial analysis because they were randomised in error (e.g. multiple pregnancy in a singleton pregnancy‐only trial); </p> </li> <li> <p>where women or babies were not included in the trial analysis for outcomes recorded postdischarge (e.g. developmental outcomes at two years); </p> </li> <li> <p>where continuous data were reported as mean and standard deviation (as changing the total used to calculate these would introduce errors). </p> </li> </ul> </p> </section> <section id="CD006764-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if the I² statistic was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.  </p> </section> <section id="CD006764-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if there are 10 or more studies in the meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD006764-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager 5 (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009021.pub2/full#CD009021-bbs2-0078" target="_blank">RevMan 2011</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect (i.e. where trials were examining the same intervention, and the trials' populations and methods were judged sufficiently similar). Where there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or where there was substantial statistical heterogeneity, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average range of possible treatment effects and we have discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we would not have combined trials. </p> <p>Where we have used random‐effects analyses, we have presented the results as the average treatment effect with its 95% CI, and the estimates of Tau² and I² statistic. </p> </section> <section id="CD006764-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed separate comparisons for different types of corticosteroids; and different preparations, timings and routes of administration.  </p> <p>For comparison of dexamethasone versus betamethasone, the dosing regimen varied between trials. To aid understanding of the characteristics of the included studies, we presented the results subgrouped by dosing regimen. We did not prespecify subgroup analyses by dosing regimen, and, in any case, there were too few trials in any one dosing regimen subgroup to support meaningful subgroup analyses.  </p> <p>For the 2022 update, where data were available, we planned to perform the following  subgroup analyses (for primary outcomes only) because we believe that it is possible that these characteristics may affect health outcomes with this intervention: </p> <p> <ul id="CD006764-list-0024"> <li> <p>singleton versus multiple pregnancy;</p> </li> <li> <p>preterm prelabour rupture of membranes at trial entry (yes or no);</p> </li> <li> <p>gestational age at trial entry (24 to 26 weeks, 27 to 29 weeks, 30 to 34 weeks, 35 to 37 weeks); </p> </li> <li> <p>pregnancy‐induced hypertension syndrome at trial entry (yes or no);</p> </li> <li> <p>chorioamnionitis at trial entry (yes or no; post hoc, i.e. not prespecified in the protocol); </p> </li> <li> <p>fetal growth restriction at trial entry (yes or no; post hoc, i.e. not prespecified in the protocol); </p> </li> <li> <p>pregestational and gestational diabetes at trial entry (yes or no; post hoc, i.e. not prespecified in the protocol). </p> </li> </ul> </p> <p>However, we were unable to undertake meaningful subgroup analyses for these clinical characteristics. For all our primary outcomes, only a maximum of five trials reported any of our primary outcomes. Furthermore, all analyses were dominated by results that could not be distinguished according to these clinical characteristics, because for most trials the trial inclusion criteria did not enable allocation to one or the other subgroup (most trials would have been allocated to a mixed/unclear subgroup), or the results were not presented stratified by the relevant covariate, or both.  </p> <p>Where we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and, if it was, used random‐effects analysis to produce it.  </p> <p>We planned to assess subgroup differences by interaction tests available in Review Manager 5 (<a href="./references#CD006764-bbs2-0074" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We would have reported the results of the subgroup analysis quoting the Chi²statistic and P value, and the interaction test I² value. </p> </section> <section id="CD006764-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>We planned sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, by excluding studies with clearly inadequate allocation of concealment, rated at 'high risk of bias' for this component. However, only one quasi‐randomised trial was included in this version of the review and since no other trials reported the same outcomes as this trial, a sensitivity analysis by adequacy of allocation could not be carried out.  </p> </section> <section id="CD006764-sec-0066"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We assessed the certainty of the evidence using the GRADE approach to assess certainty relating to the following outcomes for the main comparisons, dexamethasone versus betamethasone (<a href="./references#CD006764-bbs2-0078" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). </p> <section id="CD006764-sec-0067"> <h5 class="title">For the woman</h5> <p> <ul id="CD006764-list-0025"> <li> <p>Death</p> </li> <li> <p>Chorioamnionitis (however defined by authors)</p> </li> <li> <p>Puerperal sepsis (however defined by authors)</p> </li> <li> <p>Adverse effects of therapy</p> </li> </ul> </p> </section> <section id="CD006764-sec-0068"> <h5 class="title">For the fetus/neonate</h5> <p> <ul id="CD006764-list-0026"> <li> <p>Any known death after randomisation (i.e. fetal, neonatal, child, child as adult)</p> </li> <li> <p>RDS</p> </li> <li> <p>IVH (diagnosed by ultrasound or diagnosed by autopsy)</p> </li> <li> <p>Chronic lung disease</p> </li> <li> <p>Necrotising enterocolitis</p> </li> </ul> </p> </section> <section id="CD006764-sec-0069"> <h5 class="title">For the child</h5> <p> <ul id="CD006764-list-0027"> <li> <p>Neurodevelopmental disability at follow‐up (blindness, deafness, moderate/severe cerebral palsy (however defined by authors), or developmental delay/intellectual impairment (defined as developmental quotient or intelligence quotient less than –2 standard deviations below population mean) or variously defined) </p> </li> <li> <p>Visual impairment (however defined by authors)</p> </li> <li> <p>Hearing impairment (however defined by authors)</p> </li> <li> <p>Developmental delay (mild, moderate or severe: defined as developmental quotient less than –1 standard deviations below population mean) </p> </li> <li> <p>Intellectual impairment (mild, moderate or severe: defined as developmental quotient less than –1 standard deviations below population mean) </p> </li> <li> <p>Cerebral palsy (however defined by authors)</p> </li> </ul> </p> </section> <section id="CD006764-sec-0070"> <h5 class="title">For the child as an adult</h5> <p> <ul id="CD006764-list-0028"> <li> <p>Neurodevelopmental disability at follow‐up (blindness, deafness, moderate/severe cerebral palsy (however defined by authors), or developmental delay/intellectual impairment (defined as developmental quotient or intelligence quotient less than –2 standard deviations below population mean) or variously defined) </p> </li> </ul> </p> <p>We used GRADEpro GDT to import data from Review Manager 5 to create summary of findings tables (<a href="./references#CD006764-bbs2-0052" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 7 February 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>; <a href="./references#CD006764-bbs2-0074" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We produced a summary of the intervention effect and a measure of quality for each of the above outcomes using the GRADE approach, which uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the certainty of the body of evidence for each outcome. The evidence can be downgraded from 'high certainty' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.  </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006764-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006764-sec-0071"></div> <section id="CD006764-sec-0072"> <h3 class="title">Description of studies</h3> <section id="CD006764-sec-0073"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD006764-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD006764-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006764-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The updated search in May 2022 identified 33 trial reports to assess. While preparing the review, we  identified two further reports relating to <a href="./references#CD006764-bbs2-0019" title="ISRCTN16613220. Is there a difference between 2 doses of 12 mg of dexamethasone given 12 hours apart compared with 4 doses of 6 mg dexamethasone given 12 hours apart in terms of the dosing regimen's impact on causing high blood sugar in the mother when dexamethasone is given to minimise risk of prematurity complications? [Antenatal dexamethasone regimen in mild gestational diabetes: a randomized controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN16613220 (first received 13 February 2018). [CENTRAL: CN-01895411] SukarnaN , TanPC , HongJG , SulaimanS , OmarSZ . Glycemic control following two regimens of antenatal corticosteroids in mild gestational diabetes: a randomized controlled trial. Archives of Gynecology and Obstetrics2021;304:345-53. [DOI: 10.1007/s00404-020-05950-3]">Sukarna 2021</a> and <a href="./references#CD006764-bbs2-0030" title="NCT03446937. Effect of antenatal corticosteroids on neonatal morbidity. clinicaltrials.gov/show/NCT03446937 (27 February 2018). [CENTRAL: CN-01483469] YahyaA , SulaymanH , AbdulkadirI , BiliaminuB . Effect of antenatal corticosteroids in late preterm delivery: a randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology2021;128(Suppl 2):104-5. [CENTRAL: CN-02284999] [EMBASE: 635301573]">Yahya 2021 (TST)</a>. We also reassessed two pending trial reports from the previous version of the review (<a href="./references#CD006764-bbs2-0081" title="BrownfootFC , GagliardiDI , BainE , MiddletonP , CrowtherCA . Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD006764. [DOI: 10.1002/14651858.CD006764.pub3]">Brownfoot 2013</a>). <a href="./references#CD006764-bbs2-0028" title="Romejko-WolniewiczE , OleszczukL , Zaręba-SzczudlikJ , CzajkowskiK . Dosage regimen of antenatal steroids prior to preterm delivery and effects on maternal and neonatal outcomes. Journal of Maternal-Fetal and Neonatal Medicine2013;26(3):237-41. ">Romejko‐Wolniewicz 2013</a> remains in <a href="./references#CD006764-bbs1-0003" title="">Studies awaiting classification</a> and the study listed as Crowther 2010 in the ongoing studies section of  <a href="./references#CD006764-bbs2-0081" title="BrownfootFC , GagliardiDI , BainE , MiddletonP , CrowtherCA . Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD006764. [DOI: 10.1002/14651858.CD006764.pub3]">Brownfoot 2013</a>  is now an included study (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). </p> <p>Eleven studies met our inclusion criteria and were assessed as trustworthy for this update. </p> <p>The previous update of the review included 12 studies. However, two previously included studies are now awaiting classification following reassessment and trustworthiness screening (<a href="./references#CD006764-bbs2-0022" title="ChenCY , WangKG , ChangTY , ChenCP , LooJH . Effects of antenatal betamethasone and dexamethasone in preterm neonates. Taiwanese Journal of Obstetrics and Gynaecology2005;44(3):247-51. ">Chen 2005 (TST)</a>; <a href="./references#CD006764-bbs2-0024" title="DaneshA , JanghorbaniM , KhalatbariS . Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. Journal of Research in Medical Sciences2012;17(10):911-7. ">Danesh 2012 (TST)</a>). As a result of the updated search, we included one further study (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; consisting of nine new reports and one report previously awaiting classification). Our search also identified two new reports relating to previously included studies, which we added to the other references for these studies (<a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>). </p> <p>See <a href="./references#CD006764-sec-0254" title="">Characteristics of included studies</a> table for full details. All the trials had full reports available (i.e. none were published as abstract only), and all the data included in our analyses were from full reports (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> <p>Ten studies are now excluded. In addition to eight studies previously excluded from this review (<a href="./references#CD006764-bbs2-0012" title="EgermanRS , Pierce WF 4th, AndersenRN , UmstotES , CarrTL , SibaiBM . A comparison of the bioavailability of oral and intramuscular dexamethasone in women in late pregnancy. Obstetrics and Gynecology1997;89(2):276-80. ">Egerman 1997</a>; <a href="./references#CD006764-bbs2-0014" title="KurzC , ArbeiterK , ObermairA , SalzerH , SalzerHR , LohningerA . L-carnitine-betamethasone combination vs betamethasone for prevention of respiratory distress syndrome. Zeitschrift fur Geburtshilfe und Perinatologie1993;197:215-9. ">Kurz 1993</a>; <a href="./references#CD006764-bbs2-0015" title="LiuJ , WangQ , ZhaoJH , ChenYH , QinGL . The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. Journal of Tropical Pediatrics2006;52(5):355-9. ">Liu 2006</a>; <a href="./references#CD006764-bbs2-0016" title="RomagueraJ , LynchL , AdamsonK . The ineffectiveness of dexamethasone to accelerate the progression of L-S ratio. Acta Obstetricia et Gynecologica Scandinavica Supplement1997;76(167:1):38. ">Romaguera 1997</a>; <a href="./references#CD006764-bbs2-0017" title="SalzerH , HussleinP , BinstorferE , WagnerG , SimbrunerG , PopovCH , et al. First clinical trial of combination of carnitine and dexamethasone for the induction of lung maturity. 8th European Congress of Perinatal Medicine; 1982 Sept 7-10; Brussels, Belgium. ">Salzer 1982</a>; <a href="./references#CD006764-bbs2-0018" title="ShanksA , GrossG , ShimT , AllsworthJ , MogaC , SadovskyY , et al. Antenatal steroids for enhancement of fetal lung maturity after 34 weeks: lung maturity and antenatal steroids (LUMAS) study. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S58. ShanksA , GrossG , ShimT , AllsworthJ , SadovskyY , BildiriciI . Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles. American Journal of Obstetrics and Gynecology2010;203(1):47.e1-47.e5. ">Shanks 2010</a>; <a href="./references#CD006764-bbs2-0020" title="Vytiska-BinstorferE , SalzerH , LangerM , LohningerA , SimbrunerG . Clinical randomised trial: stimulation of fetal surfactant production by carnitine combined with a reduced betamethasone dose. Archives of Gynaecology1985;237(Suppl 1):399. ">Vytiska‐Binstorfer 1985</a>; <a href="./references#CD006764-bbs2-0021" title="WhittGG , BusterJE , KillamAP , ScraggWH . A comparison of two glucocorticoid regimens for acceleration of fetal lung maturation in premature labour. American Journal of Obstetrics and Gynecology1976;124:479-82. ">Whitt 1976</a>), we excluded two further trials: <a href="./references#CD006764-bbs2-0013" title="IRCT2014090912789N6. Impact of betamethasone on preterm infants outcomes [Comparing the impact of one versus two doses of betamethasone on preterm infants outcomes: a clinical trial study]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2014090912789N6 (first received 20 October 2014). [CENTRAL: CN-01862384] ">IRCT2014090912789N6</a> (one new report) because the trial was neither randomised nor quasi‐randomised; and <a href="./references#CD006764-bbs2-0019" title="ISRCTN16613220. Is there a difference between 2 doses of 12 mg of dexamethasone given 12 hours apart compared with 4 doses of 6 mg dexamethasone given 12 hours apart in terms of the dosing regimen's impact on causing high blood sugar in the mother when dexamethasone is given to minimise risk of prematurity complications? [Antenatal dexamethasone regimen in mild gestational diabetes: a randomized controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN16613220 (first received 13 February 2018). [CENTRAL: CN-01895411] SukarnaN , TanPC , HongJG , SulaimanS , OmarSZ . Glycemic control following two regimens of antenatal corticosteroids in mild gestational diabetes: a randomized controlled trial. Archives of Gynecology and Obstetrics2021;304:345-53. [DOI: 10.1007/s00404-020-05950-3]">Sukarna 2021</a> (two new reports) because the population did not meet our inclusion criteria (included women up to 38 weeks' gestation). See <a href="./references#CD006764-sec-0255" title="">Characteristics of excluded studies</a> table. </p> <p>Nine studies are awaiting classification: <a href="./references#CD006764-bbs2-0028" title="Romejko-WolniewiczE , OleszczukL , Zaręba-SzczudlikJ , CzajkowskiK . Dosage regimen of antenatal steroids prior to preterm delivery and effects on maternal and neonatal outcomes. Journal of Maternal-Fetal and Neonatal Medicine2013;26(3):237-41. ">Romejko‐Wolniewicz 2013</a> was awaiting classification in the previous update, pending information requested from the trial authors; it was unclear whether <a href="./references#CD006764-bbs2-0023" title="ChhatralaJJ , ChawadaR . Comparative study of dexamethasone and betamethasone for women at risk of preterm birth. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2015;4(4):1000-3. ">Chhatrala 2015</a> (one report) was a randomised trial; as stated above, two previously included studies did not meet all the trustworthiness screening criteria (<a href="./references#CD006764-bbs2-0022" title="ChenCY , WangKG , ChangTY , ChenCP , LooJH . Effects of antenatal betamethasone and dexamethasone in preterm neonates. Taiwanese Journal of Obstetrics and Gynaecology2005;44(3):247-51. ">Chen 2005 (TST)</a>; <a href="./references#CD006764-bbs2-0024" title="DaneshA , JanghorbaniM , KhalatbariS . Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. Journal of Research in Medical Sciences2012;17(10):911-7. ">Danesh 2012 (TST)</a>), and five studies identified in the new search also did not meet all the trustworthiness screening criteria (<a href="./references#CD006764-bbs2-0025" title="GuptaP , SharmaS , KumarV . A randomised controlled trial of 12 hours vs 24 hours betamethasone dosing interval in preterm premature rupture of membranes for prevention of respiratory distress syndrome (RDS) in neonates. Journal of Medical Science and Clinical Research2019;7(8):669-74. [CENTRAL: CN-02218250] ">Gupta 2019 (TST)</a>; <a href="./references#CD006764-bbs2-0026" title="IRCT201402072624N11. Betamethasone administration in preterm labor [A comparison between the effect of the two methods of 12 versus 24 hours interval of betamethasone administration on neonatal respiratory distress syndrome in women with preterm labor distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201402072624N11 (first received 25 March 2014). [CENTRAL: CN-01880680] KashanianM , EshraghiN , SheikhansariN , BordbarA , KhatamiE . Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. Journal of Obstetrics and Gynaecology2018;38(6):770-6. [CENTRAL: CN-01665275] [EMBASE: 621208178] [PMID: 29526138]">Kashanian 2018 (TST)</a>; <a href="./references#CD006764-bbs2-0027" title="RasoolA , FarooqU , NazirQU , DuraniHB . Efficacy of two regimens of dexamethasone for Management of preterm labour: pilot study. Journal of Ayub Medical College, Abbottabad2017;29(3):393-7. [CENTRAL: CN-01914063] [PMID: 29076668]">Rasool 2017 (TST)</a>; <a href="./references#CD006764-bbs2-0029" title="IRCT201212307513N2. A comparison between betamethasone and dexamethasone on biophysical profile in 28wk – 32wk pregnant women at risk of preterm labor [A comparison between betamethasone and dexamethasone on biophysical profile]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201212307513N2 (first received 27 December 2013). [CENTRAL: CN-01805875] TehraniHG , KhaniB , KomraniZ . Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor. Journal of Research in Medical Sciences2014;19(12):1124-8. [CENTRAL: CN-01077722] [EMBASE: 603145530]">Tehrani 2014 (TST)</a>; <a href="./references#CD006764-bbs2-0030" title="NCT03446937. Effect of antenatal corticosteroids on neonatal morbidity. clinicaltrials.gov/show/NCT03446937 (27 February 2018). [CENTRAL: CN-01483469] YahyaA , SulaymanH , AbdulkadirI , BiliaminuB . Effect of antenatal corticosteroids in late preterm delivery: a randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology2021;128(Suppl 2):104-5. [CENTRAL: CN-02284999] [EMBASE: 635301573]">Yahya 2021 (TST)</a>; nine new reports in total). We labelled all of the trials that, based on our assessments, did not meet these criteria '(TST)' for ease of reference. See below and <a href="./references#CD006764-sec-0256" title="">Characteristics of studies awaiting classification</a> table. </p> <p>Seven studies are ongoing (<a href="./references#CD006764-bbs2-0031" title="IRCT2015120415634N2. The effect of antenatal intramuscular administration of two doses of betamethasone every 12 hours on acute pulmonary complications in preterm infants born [Comparing of antenatal intramuscular administration of two doses of betamethasone every 12 hours with standard method every 24 hours on acute neonatal pulmonary complications in preterm infants born from women with preterm premature of membrane]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2015120415634N2 (first received 27 September 2017). [CENTRAL: CN-01886227] ">IRCT2015120415634N2</a>; <a href="./references#CD006764-bbs2-0032" title="NCT01697098. Dexamethasone for preterm labour [Dexamethasone dosing interval: 12 or 24 hours apart? A randomized, clinical trial]. clinicaltrials.gov/show/NCT01697098 (first received 2 October 2012). [CENTRAL: CN-01537911] ">NCT01697098</a>; <a href="./references#CD006764-bbs2-0033" title="NCT04494529. Single dose antenatal corticosteroids (SNACS) for women at risk of preterm birth [Single dose antenatal corticosteroids (SNACS) pilot randomized control trial for women at risk of preterm birth]. clinicaltrials.gov/show/NCT04494529 (first received 31 July 2020). [CENTRAL: CN-02145746] ">NCT04494529</a>; <a href="./references#CD006764-bbs2-0034" title="NCT05114096. Single dose of antenatal corticosteroids for pregnancies at risk of preterm delivery (SNACS). clinicaltrials.gov/show/NCT05114096 (first received 9 November 2021). [CENTRAL: CN-02339354] ">NCT05114096</a>; <a href="./references#CD006764-bbs2-0035" title="EUCTR2016-001486-90-FR. BETADOSE: dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth: a randomized, multicenter, double blind placebo-controlled non inferiority trial [Dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth: a randomized, multicentre, double blind placebo-controlled non inferiority trial. BETADOSE – BETADOSE]. trialsearch.who.int/Trial2.aspx?TrialID=EUCTR2016-001486-90-FR (first received 27 April 2016). [CENTRAL: CN-02169007] NCT02897076. Dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth [Dose reduction of antenatal betamethasone given to prevent the neonatal complications associated with very preterm birth: a randomized, multicentre, double blind placebo-controlled non inferiority trial]. clinicaltrials.gov/show/NCT02897076 (first received 7 September 2016). [CENTRAL: CN-01520740] SchmitzT , AlbertiC , UrsinoM , BaudO , AupiaisC , BETADOSE study group and the GROG (Groupe de Recherche en Gynecologie Obstetrique). Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE). BMC Pregnancy and Childbirth2019;19(1):67. [CENTRAL: CN-01787973] [EMBASE: 626359019] [PMID: 30755164]SchmitzT , DoretM , SentilhesL , AlbertiC , UrsinoM , AupiaisC , et al. Dose reduction of antenatal betamethasone in women at risk of very preterm delivery (BETADOSE trial). American Journal of Obstetrics and Gynecology2021;224(2 Suppl):S723-4. [CENTRAL: CN-02247756] [EMBASE: 2010870067]">Schmitz 2019</a>; <a href="./references#CD006764-bbs2-0036" title="TCTR20200729002. Effect of different doses of steroid on respiratory distress syndrome in moderate to late preterm neonates born between 320-366 weeks of gestation: a randomized controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=TCTR20200729002 (first received 29 July 2020). [CENTRAL: CN-02189966] ">TCTR20200729002</a>; <a href="./references#CD006764-bbs2-0037" title="CTRI/2021/03/032429. Improving newborn survival in preterm birth [WHO ACTION-III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes – WHO ACTION-III]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/03/032429 (first received 24 November 2021). [CENTRAL: CN-02280513] ISRCTN11434567. Antenatal corticosteroids for women at risk of birth in the late preterm period to improve newborn outcomes [ACTION III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes]. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN11434567 (first received 7 June 2021). [CENTRAL: CN-02280191] PACTR202105463874444. The WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborns) Trials [ACTION III: a multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes]. trialsearch.who.int/Trial2.aspx?TrialID=PACTR202105463874444 (first received 18 May 2021). [CENTRAL: CN-02281089] ">WHO ACTION III</a>; 12 reports). See <a href="./references#CD006764-sec-0257" title="">Characteristics of ongoing studies</a> table. </p> <section id="CD006764-sec-0074"> <h5 class="title">Screening eligible studies for trustworthiness</h5> <p>For this review update, we used the Cochrane Pregnancy and Childbirth's Trustworthiness Screening Tool for the first time (see <a href="#CD006764-sec-0040">Selection of studies</a> for a description of the tool; <a href="http://pregnancy.cochrane.org/news/identifying-and-handling-potentially-untrustworthy-trials-pregnancy-and-childbirth-cochrane" target="_blank">pregnancy.cochrane.org/news/identifying-and-handling-potentially-untrustworthy-trials-pregnancy-and-childbirth-cochrane</a>). We identified six new studies that met our inclusion criteria, in addition to 12 previously included studies. Of these 18 studies, we judged that seven did not meet the trustworthiness screening criteria. These included two formerly included studies (<a href="./references#CD006764-bbs2-0022" title="ChenCY , WangKG , ChangTY , ChenCP , LooJH . Effects of antenatal betamethasone and dexamethasone in preterm neonates. Taiwanese Journal of Obstetrics and Gynaecology2005;44(3):247-51. ">Chen 2005 (TST)</a>; <a href="./references#CD006764-bbs2-0024" title="DaneshA , JanghorbaniM , KhalatbariS . Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. Journal of Research in Medical Sciences2012;17(10):911-7. ">Danesh 2012 (TST)</a>), and five studies from the updated search (<a href="./references#CD006764-bbs2-0025" title="GuptaP , SharmaS , KumarV . A randomised controlled trial of 12 hours vs 24 hours betamethasone dosing interval in preterm premature rupture of membranes for prevention of respiratory distress syndrome (RDS) in neonates. Journal of Medical Science and Clinical Research2019;7(8):669-74. [CENTRAL: CN-02218250] ">Gupta 2019 (TST)</a>; <a href="./references#CD006764-bbs2-0026" title="IRCT201402072624N11. Betamethasone administration in preterm labor [A comparison between the effect of the two methods of 12 versus 24 hours interval of betamethasone administration on neonatal respiratory distress syndrome in women with preterm labor distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201402072624N11 (first received 25 March 2014). [CENTRAL: CN-01880680] KashanianM , EshraghiN , SheikhansariN , BordbarA , KhatamiE . Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. Journal of Obstetrics and Gynaecology2018;38(6):770-6. [CENTRAL: CN-01665275] [EMBASE: 621208178] [PMID: 29526138]">Kashanian 2018 (TST)</a>; <a href="./references#CD006764-bbs2-0027" title="RasoolA , FarooqU , NazirQU , DuraniHB . Efficacy of two regimens of dexamethasone for Management of preterm labour: pilot study. Journal of Ayub Medical College, Abbottabad2017;29(3):393-7. [CENTRAL: CN-01914063] [PMID: 29076668]">Rasool 2017 (TST)</a>; <a href="./references#CD006764-bbs2-0029" title="IRCT201212307513N2. A comparison between betamethasone and dexamethasone on biophysical profile in 28wk – 32wk pregnant women at risk of preterm labor [A comparison between betamethasone and dexamethasone on biophysical profile]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201212307513N2 (first received 27 December 2013). [CENTRAL: CN-01805875] TehraniHG , KhaniB , KomraniZ . Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor. Journal of Research in Medical Sciences2014;19(12):1124-8. [CENTRAL: CN-01077722] [EMBASE: 603145530]">Tehrani 2014 (TST)</a>; <a href="./references#CD006764-bbs2-0030" title="NCT03446937. Effect of antenatal corticosteroids on neonatal morbidity. clinicaltrials.gov/show/NCT03446937 (27 February 2018). [CENTRAL: CN-01483469] YahyaA , SulaymanH , AbdulkadirI , BiliaminuB . Effect of antenatal corticosteroids in late preterm delivery: a randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology2021;128(Suppl 2):104-5. [CENTRAL: CN-02284999] [EMBASE: 635301573]">Yahya 2021 (TST)</a>). </p> <p> <ul id="CD006764-list-0029"> <li> <p>We found no evidence of prospective registration for six studies conducted since 2010 (<a href="./references#CD006764-bbs2-0024" title="DaneshA , JanghorbaniM , KhalatbariS . Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. Journal of Research in Medical Sciences2012;17(10):911-7. ">Danesh 2012 (TST)</a>; <a href="./references#CD006764-bbs2-0025" title="GuptaP , SharmaS , KumarV . A randomised controlled trial of 12 hours vs 24 hours betamethasone dosing interval in preterm premature rupture of membranes for prevention of respiratory distress syndrome (RDS) in neonates. Journal of Medical Science and Clinical Research2019;7(8):669-74. [CENTRAL: CN-02218250] ">Gupta 2019 (TST)</a>; <a href="./references#CD006764-bbs2-0026" title="IRCT201402072624N11. Betamethasone administration in preterm labor [A comparison between the effect of the two methods of 12 versus 24 hours interval of betamethasone administration on neonatal respiratory distress syndrome in women with preterm labor distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201402072624N11 (first received 25 March 2014). [CENTRAL: CN-01880680] KashanianM , EshraghiN , SheikhansariN , BordbarA , KhatamiE . Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. Journal of Obstetrics and Gynaecology2018;38(6):770-6. [CENTRAL: CN-01665275] [EMBASE: 621208178] [PMID: 29526138]">Kashanian 2018 (TST)</a>; <a href="./references#CD006764-bbs2-0027" title="RasoolA , FarooqU , NazirQU , DuraniHB . Efficacy of two regimens of dexamethasone for Management of preterm labour: pilot study. Journal of Ayub Medical College, Abbottabad2017;29(3):393-7. [CENTRAL: CN-01914063] [PMID: 29076668]">Rasool 2017 (TST)</a>; <a href="./references#CD006764-bbs2-0029" title="IRCT201212307513N2. A comparison between betamethasone and dexamethasone on biophysical profile in 28wk – 32wk pregnant women at risk of preterm labor [A comparison between betamethasone and dexamethasone on biophysical profile]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201212307513N2 (first received 27 December 2013). [CENTRAL: CN-01805875] TehraniHG , KhaniB , KomraniZ . Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor. Journal of Research in Medical Sciences2014;19(12):1124-8. [CENTRAL: CN-01077722] [EMBASE: 603145530]">Tehrani 2014 (TST)</a>; <a href="./references#CD006764-bbs2-0030" title="NCT03446937. Effect of antenatal corticosteroids on neonatal morbidity. clinicaltrials.gov/show/NCT03446937 (27 February 2018). [CENTRAL: CN-01483469] YahyaA , SulaymanH , AbdulkadirI , BiliaminuB . Effect of antenatal corticosteroids in late preterm delivery: a randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology2021;128(Suppl 2):104-5. [CENTRAL: CN-02284999] [EMBASE: 635301573]">Yahya 2021 (TST)</a>. We note that while trial registration records were available for three of these studies, they were registered during enrolment (<a href="./references#CD006764-bbs2-0026" title="IRCT201402072624N11. Betamethasone administration in preterm labor [A comparison between the effect of the two methods of 12 versus 24 hours interval of betamethasone administration on neonatal respiratory distress syndrome in women with preterm labor distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201402072624N11 (first received 25 March 2014). [CENTRAL: CN-01880680] KashanianM , EshraghiN , SheikhansariN , BordbarA , KhatamiE . Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. Journal of Obstetrics and Gynaecology2018;38(6):770-6. [CENTRAL: CN-01665275] [EMBASE: 621208178] [PMID: 29526138]">Kashanian 2018 (TST)</a>; <a href="./references#CD006764-bbs2-0029" title="IRCT201212307513N2. A comparison between betamethasone and dexamethasone on biophysical profile in 28wk – 32wk pregnant women at risk of preterm labor [A comparison between betamethasone and dexamethasone on biophysical profile]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201212307513N2 (first received 27 December 2013). [CENTRAL: CN-01805875] TehraniHG , KhaniB , KomraniZ . Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor. Journal of Research in Medical Sciences2014;19(12):1124-8. [CENTRAL: CN-01077722] [EMBASE: 603145530]">Tehrani 2014 (TST)</a>; <a href="./references#CD006764-bbs2-0030" title="NCT03446937. Effect of antenatal corticosteroids on neonatal morbidity. clinicaltrials.gov/show/NCT03446937 (27 February 2018). [CENTRAL: CN-01483469] YahyaA , SulaymanH , AbdulkadirI , BiliaminuB . Effect of antenatal corticosteroids in late preterm delivery: a randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology2021;128(Suppl 2):104-5. [CENTRAL: CN-02284999] [EMBASE: 635301573]">Yahya 2021 (TST)</a>). </p> </li> <li> <p>For all six  studies, we also sought to confirm the method of randomisation: for five studies there were the same number of women in each group but the method was not described (<a href="./references#CD006764-bbs2-0024" title="DaneshA , JanghorbaniM , KhalatbariS . Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. Journal of Research in Medical Sciences2012;17(10):911-7. ">Danesh 2012 (TST)</a>; <a href="./references#CD006764-bbs2-0025" title="GuptaP , SharmaS , KumarV . A randomised controlled trial of 12 hours vs 24 hours betamethasone dosing interval in preterm premature rupture of membranes for prevention of respiratory distress syndrome (RDS) in neonates. Journal of Medical Science and Clinical Research2019;7(8):669-74. [CENTRAL: CN-02218250] ">Gupta 2019 (TST)</a>; <a href="./references#CD006764-bbs2-0026" title="IRCT201402072624N11. Betamethasone administration in preterm labor [A comparison between the effect of the two methods of 12 versus 24 hours interval of betamethasone administration on neonatal respiratory distress syndrome in women with preterm labor distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201402072624N11 (first received 25 March 2014). [CENTRAL: CN-01880680] KashanianM , EshraghiN , SheikhansariN , BordbarA , KhatamiE . Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. Journal of Obstetrics and Gynaecology2018;38(6):770-6. [CENTRAL: CN-01665275] [EMBASE: 621208178] [PMID: 29526138]">Kashanian 2018 (TST)</a>; <a href="./references#CD006764-bbs2-0027" title="RasoolA , FarooqU , NazirQU , DuraniHB . Efficacy of two regimens of dexamethasone for Management of preterm labour: pilot study. Journal of Ayub Medical College, Abbottabad2017;29(3):393-7. [CENTRAL: CN-01914063] [PMID: 29076668]">Rasool 2017 (TST)</a>; <a href="./references#CD006764-bbs2-0029" title="IRCT201212307513N2. A comparison between betamethasone and dexamethasone on biophysical profile in 28wk – 32wk pregnant women at risk of preterm labor [A comparison between betamethasone and dexamethasone on biophysical profile]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT201212307513N2 (first received 27 December 2013). [CENTRAL: CN-01805875] TehraniHG , KhaniB , KomraniZ . Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor. Journal of Research in Medical Sciences2014;19(12):1124-8. [CENTRAL: CN-01077722] [EMBASE: 603145530]">Tehrani 2014 (TST)</a>); and for one previously included study, neither the method of randomisation nor the number of women randomised to each group was reported (the study included twin births and maternal outcomes) (<a href="./references#CD006764-bbs2-0022" title="ChenCY , WangKG , ChangTY , ChenCP , LooJH . Effects of antenatal betamethasone and dexamethasone in preterm neonates. Taiwanese Journal of Obstetrics and Gynaecology2005;44(3):247-51. ">Chen 2005 (TST)</a>). </p> </li> </ul> </p> <p>In all cases we attempted to contact the trial authors; some authors replied but we considered that they did not provide adequate information; some authors did not reply; or contact details were unavailable (see <a href="./references#CD006764-sec-0256" title="">Characteristics of studies awaiting classification</a> table). </p> </section> </section> <section id="CD006764-sec-0075"> <h4 class="title">Included studies</h4> <p>We included 11 trials (2494 women and 2762 infants) in this update (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>; see <a href="./references#CD006764-sec-0254" title="">Characteristics of included studies</a> table). </p> <section id="CD006764-sec-0076"> <h5 class="title">Dates of the study, funding sources and declarations of interest</h5> <section id="CD006764-sec-0077"> <h6 class="title">Dates of the studies</h6> <p>The included studies took place between 1994 and 2013, although <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>, <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>, and <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a> did not report the dates of the study.  </p> </section> <section id="CD006764-sec-0078"> <h6 class="title">Funding sources</h6> <p>The National Health and Medical Research Council, Australia funded <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>. All the other studies did not report the funding sources. </p> </section> <section id="CD006764-sec-0079"> <h6 class="title">Declarations of interest</h6> <p><a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>, <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>, and <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a> declared that the authors had no competing interests. All the other studies did not report whether they had any conflicting interests. </p> </section> </section> <section id="CD006764-sec-0080"> <h5 class="title">Design</h5> <p>One trial was quasi‐randomised (<a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>). The other studies were RCTs.  </p> </section> <section id="CD006764-sec-0081"> <h5 class="title">Setting</h5> <p>All trials were conducted in hospital settings in high‐income countries. Three trials were conducted in the USA (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>); two in France (<a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>); two in Israel (<a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>); and one in each of Australia and New Zealand (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>), the Netherlands (<a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>), Poland (<a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>), and the UK (<a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>). </p> </section> <section id="CD006764-sec-0082"> <h5 class="title">Participants</h5> <p>All women were at increased risk of preterm birth or had a medical indication for preterm birth. The gestational age at trial entry varied between trials from 23 to 35 weeks of gestation. </p> </section> <section id="CD006764-sec-0083"> <h5 class="title">Interventions</h5> <section id="CD006764-sec-0084"> <h6 class="title">Dexamethasone versus betamethasone (comparison 1)</h6> <p>Nine trials compared intramuscular dexamethasone to intramuscular betamethasone (2096 women and 2319 infants), with new data for this update from one trial including 1346 women and 1509 infants (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>).  </p> <p>While the total dose in the course was consistently 22.8 mg or 24 mg of dexamethasone or betamethasone, the trials varied in terms of preparation (corticosteroid salt), dose, dosing interval and number of doses (for an overview of the interventions in each of the dexamethasone and betamethasone groups, see <a href="#CD006764-tbl-0007">Table 1</a>): </p> <div class="table" id="CD006764-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Dexamethasone versus betamethasone (comparison 1): summary of interventions used in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Dexamethasone group</b> </p> <p><b>(1037 women)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Betamethasone group</b> </p> <p><b>(1059 women)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Route</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All intramuscular</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All intramuscular</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Preparation</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Where specified:</i> </p> <p>Dexamethasone phosphate (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Varied. Where specified:</i> </p> <p>Betamethasone</p> <p> <ul id="CD006764-list-0030"> <li> <p>acetate/phosphate (941 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>)  </p> </li> <li> <p>phosphate (56 women: <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>) </p> </li> <li> <p>dipropionate (33 women: <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total dose in course</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Most received 24 mg</p> <p><i>except</i> 16 mg (82 women: <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All received 22.8 mg or 24 mg</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Dose</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 doses of 12 mg (778 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>) </p> <p>4 doses of 6 mg (219 women: <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> <p>4 doses of 4 mg (82 women: <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 doses of 11.4 mg or 12 mg (977 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> <p>4 doses of 6 mg (82 women: <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Dosing interval</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 hourly (703 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>) </p> <p>12 hourly (334 women: <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 hourly (787 women: <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>, betamethasone acetate/phosphate; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> <p>12 hourly (272 women: <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>, betamethasone phosphate) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Repeat weekly courses </b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allowed for 764 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allowed for 755 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a> </p> </td> </tr> </tbody> </table> </div> <p> <ul id="CD006764-list-0031"> <li> <p>dexamethasone phosphate 24 mg (6 mg, 12 hourly, 4 doses) versus betamethasone phosphate, acetate/phosphate or dipropionate 24 mg (12 mg, 24 hourly, 2 doses) (total 517 women and 577 infants; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>); </p> </li> <li> <p>dexamethasone (unspecified) 24 mg (12 mg, 12 hourly, 2 doses) and betamethasone 24 mg (unspecified; or betamethasone acetate/phosphate) (12 mg, 12 hourly, 2 doses) (total 91 women and 91 infants; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>); </p> </li> <li> <p>dexamethasone phosphate 16 mg (4 mg, 12 hourly, 4 doses) and betamethasone phosphate or acetate/phosphate 24 mg (6 mg, 12 hourly, 4 doses) (82 women and 82 infants; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>); </p> </li> <li> <p>dexamethasone phosphate 24 mg (12 mg, 12 hourly, 2 doses) and betamethasone acetate/phosphate 24 mg (12 mg, 24 hourly, 2 doses) (60 women and 60 infants; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>); </p> </li> <li> <p>dexamethasone phosphate 24 mg (12 mg, 24 hourly, 2 doses) versus betamethasone acetate/phosphate 22.8 mg (11.4 mg, 24 hourly, 2 doses) (1346 women and 1509 infants; <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). </p> </li> </ul> </p> </section> <section id="CD006764-sec-0085"> <h6 class="title">Comparisons of different regimens and preparations of dexamethasone or betamethasone (comparisons 2 to 4) </h6> <p>One trial compared different dexamethasone regimens: oral dexamethasone phosphate 32 mg (8 mg, 12 hourly, 4 doses) versus intramuscular dexamethasone phosphate 24 mg (6 mg, 12 hourly, 4 doses) (170 women and 183 infants; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>). </p> <p>The other two trials compared different preparations or regimens (or both) of betamethasone. One three‐arm trial compared two forms of betamethasone (acetate plus phosphate versus phosphate alone) (69 women and 69 infants; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). This trial also included a third group who received dexamethasone, which we have included in the comparison of dexamethasone versus betamethasone. The other trial compared dosing intervals of betamethasone acetate plus phosphate (12 mg, 24 hourly, 2 doses versus 12 mg, 12 hourly, 2 doses) (228 women and 260 infants) (<a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>).  </p> </section> <section id="CD006764-sec-0086"> <h6 class="title">Repeat courses</h6> <p>Five trials comparing dexamethasone versus betamethasone allowed repeat weekly courses of the allocated corticosteroid (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) (see <a href="#CD006764-tbl-0007">Table 1</a>). </p> </section> <section id="CD006764-sec-0087"> <h6 class="title">Primary outcomes in included studies</h6> <p>The primary outcomes varied between trials. The primary outcomes of six trials focused on neonatal outcomes including RDS, IVH and death (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>), and also child outcomes of neurodisability at 18 months (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>) or 24 months (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). The other five trials concentrated on biophysical parameters of the fetus (<a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> </section> </section> </section> <section id="CD006764-sec-0088"> <h4 class="title">Excluded studies</h4> <p>We excluded 10 trials (see <a href="./references#CD006764-sec-0255" title="">Characteristics of excluded studies</a> table): </p> <p> <ul id="CD006764-list-0032"> <li> <p>three compared L‐carnitine plus corticosteroid versus corticosteroid to assess the effect of L‐carnitine (<a href="./references#CD006764-bbs2-0014" title="KurzC , ArbeiterK , ObermairA , SalzerH , SalzerHR , LohningerA . L-carnitine-betamethasone combination vs betamethasone for prevention of respiratory distress syndrome. Zeitschrift fur Geburtshilfe und Perinatologie1993;197:215-9. ">Kurz 1993</a>; <a href="./references#CD006764-bbs2-0017" title="SalzerH , HussleinP , BinstorferE , WagnerG , SimbrunerG , PopovCH , et al. First clinical trial of combination of carnitine and dexamethasone for the induction of lung maturity. 8th European Congress of Perinatal Medicine; 1982 Sept 7-10; Brussels, Belgium. ">Salzer 1982</a>; <a href="./references#CD006764-bbs2-0020" title="Vytiska-BinstorferE , SalzerH , LangerM , LohningerA , SimbrunerG . Clinical randomised trial: stimulation of fetal surfactant production by carnitine combined with a reduced betamethasone dose. Archives of Gynaecology1985;237(Suppl 1):399. ">Vytiska‐Binstorfer 1985</a>); </p> </li> <li> <p>one compared thyroxine plus corticosteroid versus corticosteroid to assess the effects of thyroxine (<a href="./references#CD006764-bbs2-0016" title="RomagueraJ , LynchL , AdamsonK . The ineffectiveness of dexamethasone to accelerate the progression of L-S ratio. Acta Obstetricia et Gynecologica Scandinavica Supplement1997;76(167:1):38. ">Romaguera 1997</a>); </p> </li> <li> <p>one compared vitamin K plus corticosteroid versus corticosteroid, vitamin K and no treatment to assess the effects of vitamin K (<a href="./references#CD006764-bbs2-0015" title="LiuJ , WangQ , ZhaoJH , ChenYH , QinGL . The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. Journal of Tropical Pediatrics2006;52(5):355-9. ">Liu 2006</a>); </p> </li> <li> <p>one was a cross‐over trial (<a href="./references#CD006764-bbs2-0012" title="EgermanRS , Pierce WF 4th, AndersenRN , UmstotES , CarrTL , SibaiBM . A comparison of the bioavailability of oral and intramuscular dexamethasone in women in late pregnancy. Obstetrics and Gynecology1997;89(2):276-80. ">Egerman 1997</a>); </p> </li> <li> <p>one compared corticosteroids (either dexamethasone or betamethasone) versus placebo (<a href="./references#CD006764-bbs2-0018" title="ShanksA , GrossG , ShimT , AllsworthJ , MogaC , SadovskyY , et al. Antenatal steroids for enhancement of fetal lung maturity after 34 weeks: lung maturity and antenatal steroids (LUMAS) study. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S58. ShanksA , GrossG , ShimT , AllsworthJ , SadovskyY , BildiriciI . Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles. American Journal of Obstetrics and Gynecology2010;203(1):47.e1-47.e5. ">Shanks 2010</a>); </p> </li> <li> <p>one where the study population did not meet our inclusion criteria, as it included women up to 38 weeks' gestation (<a href="./references#CD006764-bbs2-0019" title="ISRCTN16613220. Is there a difference between 2 doses of 12 mg of dexamethasone given 12 hours apart compared with 4 doses of 6 mg dexamethasone given 12 hours apart in terms of the dosing regimen's impact on causing high blood sugar in the mother when dexamethasone is given to minimise risk of prematurity complications? [Antenatal dexamethasone regimen in mild gestational diabetes: a randomized controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN16613220 (first received 13 February 2018). [CENTRAL: CN-01895411] SukarnaN , TanPC , HongJG , SulaimanS , OmarSZ . Glycemic control following two regimens of antenatal corticosteroids in mild gestational diabetes: a randomized controlled trial. Archives of Gynecology and Obstetrics2021;304:345-53. [DOI: 10.1007/s00404-020-05950-3]">Sukarna 2021</a>); </p> </li> <li> <p>two trials were not randomised (<a href="./references#CD006764-bbs2-0013" title="IRCT2014090912789N6. Impact of betamethasone on preterm infants outcomes [Comparing the impact of one versus two doses of betamethasone on preterm infants outcomes: a clinical trial study]. trialsearch.who.int/Trial2.aspx?TrialID=IRCT2014090912789N6 (first received 20 October 2014). [CENTRAL: CN-01862384] ">IRCT2014090912789N6</a>; <a href="./references#CD006764-bbs2-0021" title="WhittGG , BusterJE , KillamAP , ScraggWH . A comparison of two glucocorticoid regimens for acceleration of fetal lung maturation in premature labour. American Journal of Obstetrics and Gynecology1976;124:479-82. ">Whitt 1976</a>). </p> </li> </ul> </p> </section> <section id="CD006764-sec-0089"> <h4 class="title">Studies awaiting classification</h4> <p>Nine studies are awaiting classification (see <a href="./references#CD006764-sec-0256" title="">Characteristics of studies awaiting classification</a> table). </p> </section> <section id="CD006764-sec-0090"> <h4 class="title">Ongoing studies</h4> <p>Seven studies are ongoing (see <a href="./references#CD006764-sec-0257" title="">Characteristics of ongoing studies</a> table). </p> </section> </section> <section id="CD006764-sec-0091"> <h3 class="title">Risk of bias in included studies</h3> <p>While one new study was at overall low risk of bias (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>), overall, the other trials were at moderate risk of bias (see <a href="#CD006764-fig-0003">Figure 3</a> and <a href="#CD006764-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD006764-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006764-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006764-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006764-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>For further details on the risk of bias in individual studies, see the risk of bias table within the <a href="./references#CD006764-sec-0254" title="">Characteristics of included studies</a> table. </p> <section id="CD006764-sec-0092"> <h4 class="title">Allocation</h4> <p>Methods of sequence generation and allocation concealment were both adequate in five trials (low risk; <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> <p>In four further trials, while methods of random sequence generation were adequate (low risk), methods to conceal allocation were unclear (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). One trial was at unclear risk of selection bias, with methods of sequence generation and allocation concealment being unclear (<a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>). </p> <p>In one trial, while the method of sequence generation was at low risk of bias, participants were allocated alternately (based on odd/even computer‐generated number), so allocation concealment was at high risk of bias (<a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>). </p> </section> <section id="CD006764-sec-0093"> <h4 class="title">Blinding</h4> <p>Four trials were at a low risk of performance bias, with blinding of women and personnel (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>). For one trial, the risk of performance bias was unclear, as blinding of women was not detailed (<a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>). The remaining six trials were at a high risk of performance bias, with no blinding of women and study personnel (or blinding considered unfeasible) (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> <p>Four trials were at a low risk of detection bias, with blinding of outcome assessment (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>). One trial was at high risk of detection bias, with no blinding of outcome assessors (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). The remaining six trials were at unclear risk of detection bias (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>;  <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> </section> <section id="CD006764-sec-0094"> <h4 class="title">Incomplete outcome data</h4> <p>Two trials were at low risk of attrition bias (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>).  </p> <p>While short‐term loss to follow‐up was minimal and well‐documented in <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>, there were losses of 20% to 25% in both groups for longer‐term outcomes, and, therefore, we assessed this trial at unclear risk of attrition bias overall.  </p> <p>Two trials did not document losses to follow‐up and were at unclear risk of attrition bias (<a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>). <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a> reported a 17% loss to follow‐up (6/30 from the dexamethasone group and 4/30 from the betamethasone group), and <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> assessed less than 60% of all infants for IVH and PVL. <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a> did not mention exclusions or attrition; however, all results were reported as a mean, and so it was not possible to know whether there were losses. In <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a> and <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>, losses were greater than 50% at the end of follow‐up for some of the biophysical parameters. </p> <p><a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a> was at high risk of attrition bias. In addition to documented losses to follow‐up for whom some outcomes are in fact reported, the report states that only babies in whom clinical evaluation was deemed relevant were assessed for some outcomes (e.g. IVH, ROP, CLD); however, it was unclear whether all babies were accounted for given inconsistent variation in denominators for these outcomes. </p> </section> <section id="CD006764-sec-0095"> <h4 class="title">Selective reporting</h4> <p>There was no obvious risk of selective reporting in two trials (low risk; <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). </p> <p>While two trials prespecified their outcomes in the manuscript methods, the risk of reporting bias was unclear, with outcome data reported incompletely for some clinical outcomes (e.g. "gestational age, birthweight and Apgar score at five minutes did not differ between the two groups") (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>), or one trial reported additional outcomes (<a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>). </p> <p>One trial reported all prespecified outcomes from the methods and trial registration; however, the authors registered the trial during recruitment and, therefore, we assessed risk of reporting bias as unclear (<a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>). </p> <p>The remaining five trials reported some important clinical outcomes; however, with no access to a trial protocol it was difficult to confidently assess selective reporting; therefore, we judged these studies at unclear risk of reporting bias (<a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> </section> <section id="CD006764-sec-0096"> <h4 class="title">Other potential sources of bias</h4> <p>For nine trials, groups were comparable at baseline and there were no other obvious sources of bias identified (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>).  </p> <p>Two trials were at unclear risk of other bias; <a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a> due to some baseline imbalances between groups regarding age and ethnicity, and <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a> because in the case of multiple pregnancy, one fetus only was randomly selected for analysis. </p> </section> </section> <section id="CD006764-sec-0097"> <h3 class="title" id="CD006764-sec-0097">Effects of interventions</h3> <p>See: <a href="./full#CD006764-tbl-0001"><b>Summary of findings 1</b> Dexamethasone compared to betamethasone – maternal outcomes</a>; <a href="./full#CD006764-tbl-0002"><b>Summary of findings 2</b> Dexamethasone compared to betamethasone – fetal/neonatal outcomes</a>; <a href="./full#CD006764-tbl-0003"><b>Summary of findings 3</b> Dexamethasone compared to betamethasone – child outcomes</a>; <a href="./full#CD006764-tbl-0004"><b>Summary of findings 4</b> Dexamethasone: oral compared to intramuscular – fetal/neonatal outcomes</a>; <a href="./full#CD006764-tbl-0005"><b>Summary of findings 5</b> Betamethasone acetate plus phosphate compared to betamethasone phosphate – fetal/neonatal outcomes</a>; <a href="./full#CD006764-tbl-0006"><b>Summary of findings 6</b> Betamethasone 12‐hourly compared to 24‐hourly dosing – fetal/neonatal outcomes</a> </p> <p>We included 11 trials involving 2494 women and 2762 babies.</p> <p>The results are presented by type of corticosteroid or method of administration compared:</p> <p> <ul id="CD006764-list-0033"> <li> <p>dexamethasone versus betamethasone (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>); </p> </li> <li> <p>oral versus intramuscular dexamethasone (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>); </p> </li> <li> <p>betamethasone acetate plus phosphate versus betamethasone phosphate (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>); </p> </li> <li> <p>betamethasone 12‐hourly doses versus betamethasone 24‐hourly doses (<a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>). </p> </li> </ul> </p> <section id="CD006764-sec-0098"> <h4 class="title">1. Dexamethasone versus betamethasone</h4> <p>Nine trials including 2096 women and 2319 infants compared dexamethasone versus betamethasone (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>). </p> <section id="CD006764-sec-0099"> <h5 class="title">Primary outcomes</h5> <section id="CD006764-sec-0100"> <h6 class="title">Women</h6> <section id="CD006764-sec-0101"> <p><b>Chorioamnionitis</b></p> <p>Although the rate of chorioamnionitis was lower with dexamethasone when compared with betamethasone, given the wide 95% CIs crossed the line of no effect, there was no conclusive evidence of difference (RR 0.71, 95% CI 0.48 to 1.06; 1 trial, 1346 women; anticipated absolute effects (AAE): 83 events per 1000 women with betamethasone, 24 fewer per 1000 women with dexamethasone, 95% CI 43 fewer to 5 more; moderate‐certainty evidence; <a href="./references#CD006764-fig-0005" title="">Analysis 1.1</a>; <a href="./full#CD006764-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD006764-sec-0102"> <p><b>Unreported outcomes</b></p> <p>No studies reported maternal death or puerperal sepsis.</p> </section> </section> <section id="CD006764-sec-0103"> <h6 class="title">Fetus/neonate</h6> <section id="CD006764-sec-0104"> <p><b>Any known death after randomisation</b></p> <p>When combining the evidence on any known death after randomisation, there is probably no difference between dexamethasone and betamethasone; however, given the wide 95% CIs, the evidence is not conclusive (RR 1.03, 95% CI 0.66 to 1.63; 5 trials, 2105 infants; AAE 32 per 1000 infants with betamethasone, 1 more per 1000 infants with dexamethasone (95% CI 11 fewer to 20 more); moderate‐certainty evidence; <a href="./references#CD006764-fig-0006" title="">Analysis 1.2</a>; <a href="./full#CD006764-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD006764-sec-0105"> <p><b>Respiratory distress syndrome</b></p> <p>There is little or no difference in the risk of RDS between dexamethasone and betamethasone (RR 1.06, 95% CI 0.91 to 1.22; 5 trials, 2105 infants; high‐certainty evidence; <a href="./references#CD006764-fig-0007" title="">Analysis 1.3</a>; <a href="./full#CD006764-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD006764-sec-0106"> <p><b>Intraventricular haemorrhage</b></p> <p>There was substantial statistical heterogeneity in the effect estimate for IVH (average risk ratio (aRR) 0.71, 95% CI 0.28 to 1.81; 4 trials, 1902 infants; AAE 52 per 100 infants with betamethasone, 15 fewer with dexamethasone (38 fewer to 42 more); low‐certainty evidence; <a href="./references#CD006764-fig-0008" title="">Analysis 1.4</a>; <a href="./full#CD006764-tbl-0002">summary of findings Table 2</a>; Tau² = 0.38; Chi² = 5.20, degrees of freedom (df) = 2 (P = 0.07); I² = 62%). There were too few trials contributing data to investigate this heterogeneity with subgroup analyses as planned. However, one trial reported a result that differed substantially from the other studies, suggesting a substantial decrease in risk with dexamethasone (<a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>). We noted that this trial did not report on IVH for all infants (IVH reported for 100/181 infants in dexamethasone group and 105/178 infants in betamethasone group), and sensitivity analysis removing this study eliminated the statistical heterogeneity and suggests that there may be little or no difference between drugs for this outcome (RR 1.06, 95% CI 0.66 to 1.68; I² = 0). The GRADE assessment (low) reflects our lack of confidence in the pooled effect estimate, as well as the wide 95% CIs.  </p> </section> </section> <section id="CD006764-sec-0107"> <h6 class="title">Child</h6> <section id="CD006764-sec-0108"> <p><b>Death after hospital discharge</b></p> <p>One trial reported death after hospital discharge, up to two years adjusted age (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). There were few events in each group, and the effect estimate had wide 95% CIs, so  we are uncertain whether the choice of dexamethasone versus betamethasone makes a difference to the risk of this outcome (RR 0.65, 95% CI 0.11 to 3.89; 1 trial, 1509 infants; <a href="./references#CD006764-fig-0009" title="">Analysis 1.5</a>). </p> </section> <section id="CD006764-sec-0109"> <p><b>Neurodevelopmental disability at follow‐up</b></p> <p>Two trials followed up children into childhood, however only one of them attempted to follow up all surviving infants (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). The results suggest that there is probably little or no difference between dexamethasone and betamethasone in the risk of neurodevelopmental disability at follow‐up (RR 1.02, 95% CI 0.85 to 1.22; 2 trials, 1151 infants; moderate‐certainty evidence; <a href="./references#CD006764-fig-0010" title="">Analysis 1.6</a>; <a href="./full#CD006764-tbl-0003">summary of findings Table 3</a>). <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> followed up children to two years' adjusted age (with balanced loss to follow‐up 22% with dexamethasone versus 26% with betamethasone), and children were considered to have a neurodevelopmental disability if they had cerebral palsy, were blind or deaf, or showed developmental delay (defined as a Bayley Infant and Toddler Development Scale, version 3 (BSID‐III) score in any of the cognitive, language and motor domains of greater than one standard deviation below the mean). <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>  followed up a subgroup of 12 children (eight in dexamethasone group versus four in betamethasone group) to 18 months (adjustment not mentioned), all of whom had been admitted to NICU as babies, and contributed only 0.4% to the weight of the pooled effect estimate.  </p> </section> </section> <section id="CD006764-sec-0110"> <h6 class="title">Child as an adult</h6> <p>The longest that any of the included trials followed up children was to two years of age (adjusted for prematurity), therefore, no studies reported primary outcomes for the child as an adult (death or neurodevelopmental disability at follow‐up). </p> </section> </section> <section id="CD006764-sec-0111"> <h5 class="title">Secondary outcomes</h5> <section id="CD006764-sec-0112"> <h6 class="title">Women</h6> <section id="CD006764-sec-0113"> <p><b>Fever after trial entry requiring the use of antibiotics</b></p> <p>For the mother, there is probably  little or no difference between dexamethasone and betamethasone in the risk of postnatal fever requiring the use of antibiotics (RR 0.96, 95% CI 0.76 to 1.23; 1 trial, 1346 women; <a href="./references#CD006764-fig-0011" title="">Analysis 1.7</a>). </p> </section> <section id="CD006764-sec-0114"> <p><b>Adverse effects of therapy</b></p> <p>The rate of maternal adverse effects of therapy was lower with dexamethasone; however, there was no conclusive evidence of a difference between interventions given the 95% CIs (RR 0.63, 95% CI 0.35 to 1.13; 2 trials, 1705 women; AAE 33 events per 1000 women with betamethasone, 12 fewer per 1000 women with dexamethasone (95% CI 22 fewer to 4 more); moderate‐certainty evidence; <a href="./references#CD006764-fig-0012" title="">Analysis 1.8</a>; <a href="./full#CD006764-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD006764-sec-0115"> <p><b>Unreported outcomes</b></p> <p>No studies reported intrapartum fever requiring the use of antibiotics, postnatal fever requiring the use of antibiotics, admission to intensive care unit, glucose intolerance or hypertension. </p> </section> </section> <section id="CD006764-sec-0116"> <h6 class="title">Fetus/neonate</h6> <section id="CD006764-sec-0117"> <p><b>Fetal death</b></p> <p>There may be little or no difference between dexamethasone and betamethasone in the risk of fetal death (RR 1.19, 95% CI 0.50 to 2.87; 1 trial, 1509 infants; <a href="./references#CD006764-fig-0013" title="">Analysis 1.9</a>). </p> </section> <section id="CD006764-sec-0118"> <p><b>Neonatal death</b></p> <p>There may be little or no difference between dexamethasone and betamethasone in the risk of neonatal death (RR 1.02, 95% CI 0.58 to 1.80; 5 trials, 2105 infants; <a href="./references#CD006764-fig-0014" title="">Analysis 1.10</a>). One neonate died four days after birth (<a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>), one neonate with severe intrauterine growth restriction (IUGR) died one day after caesarean section at 27 weeks' gestation (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>), and in the other trials contributing data, there was no further information about timing.  </p> </section> <section id="CD006764-sec-0119"> <p><b>Apgar score less than 7 at five minutes</b></p> <p>Only one small study reported Apgar score less than 7 at five minutes, and we are uncertain whether there is a difference between dexamethasone and betamethasone given the low number of babies, few events and very wide 95% CIs (RR 0.54, 95% CI 0.05 to  5.60; 1 trial, 50 infants; <a href="./references#CD006764-fig-0015" title="">Analysis 1.11</a>). </p> </section> <section id="CD006764-sec-0120"> <p><b>Birthweight</b></p> <p>The choice of corticosteroid may make no difference to mean birthweight (MD 0.03 kg, 95% CI –0.05 to 0.11; 5 trials, 2066 infants; <a href="./references#CD006764-fig-0016" title="">Analysis 1.12</a>). </p> </section> <section id="CD006764-sec-0121"> <p><b>Low birthweight</b></p> <p>The choice of corticosteroid may make no difference to whether the baby is at risk of being of low birthweight (RR 0.89, 95% CI 0.65 to 1.24; 1 trial, 105 infants; <a href="./references#CD006764-fig-0017" title="">Analysis 1.13</a>). </p> </section> <section id="CD006764-sec-0122"> <p><b>Mean length at birth</b></p> <p>There may be little difference in the mean length at birth between groups (MD 0.10 cm, 95% CI –0.47 to 0.67; 1 trial, 1489 infants; <a href="./references#CD006764-fig-0018" title="">Analysis 1.14</a>). </p> </section> <section id="CD006764-sec-0123"> <p><b>Mean head circumference at birth</b></p> <p>There may be little difference in the mean head circumference at birth between groups (MD 0.20 cm, 95% CI –0.18 to 0.58; 1 trial, 1489 infants; <a href="./references#CD006764-fig-0019" title="">Analysis 1.15</a>).  </p> </section> <section id="CD006764-sec-0124"> <p><b>Admission to neonatal intensive care</b></p> <p>There was substantial statistical heterogeneity in the effect estimate for admission to NICU (aRR 1.75, 95% CI 0.49 to 6.25; 2 trials, 1614 infants; <a href="./references#CD006764-fig-0020" title="">Analysis 1.16</a>; Tau² = 0.71; Chi² = 5.18, df = 1 (P = 0.02); I² = 81%). Only two studies contributed data, with one small study reporting few events but twice as many in the smaller dexamethasone group (8/36 in the dexamethasone group versus 4/69 in the betamethasone group) (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). It was not possible to investigate this heterogeneity with subgroup analyses given that only two trials contributed data. It is possible that differences in the reasons for preterm birth, or other clinical factors, contributed to this heterogeneity. Sensitivity analysis limited to <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>, a large multicentre study free of significant risk of bias concerns, gave an effect estimate RR of 1.02 (95% CI 0.89 to 1.17), suggesting that the choice of drug may make little or no difference to this outcome.  </p> </section> <section id="CD006764-sec-0125"> <p><b>Need for mechanical ventilation</b></p> <p>There is probably little or no difference between dexamethasone and betamethasone in the need for mechanical ventilation (RR 0.94, 95% CI 0.74 to 1.19; 1 trial, 1509 infants; <a href="./references#CD006764-fig-0021" title="">Analysis 1.17</a>). </p> </section> <section id="CD006764-sec-0126"> <p><b>Mean duration of mechanical ventilation</b></p> <p>There is probably little or no difference between dexamethasone and betamethasone in the mean duration of mechanical ventilation (MD –0.38 days, 95% CI –1.11 to 0.35; 1 trial, 1509 infants; <a href="./references#CD006764-fig-0022" title="">Analysis 1.18</a>). </p> </section> <section id="CD006764-sec-0127"> <p><b>Severity of respiratory distress syndrome</b></p> <p>There is probably no difference between dexamethasone and betamethasone for the risk of moderate/severe RDS (RR 1.06, 95% CI 0.80 to 1.39; 1 trial, 1509 infants; <a href="./references#CD006764-fig-0023" title="">Analysis 1.19</a>). </p> </section> <section id="CD006764-sec-0128"> <p><b>Chronic lung disease</b></p> <p>There is probably no difference between dexamethasone and betamethasone for the risk of chronic lung disease (RR 0.92, 95% CI 0.64 to 1.34; 1 trial, 1509 infants; moderate‐certainty evidence; <a href="./references#CD006764-fig-0024" title="">Analysis 1.20</a>; <a href="./full#CD006764-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD006764-sec-0129"> <p><b>Bronchopulmonary dysplasia</b></p> <p>There was substantial statistical heterogeneity in the analyses for bronchopulmonary dysplasia (aRR 2.50, 95% CI 0.10 to 61.34; 2 trials, 464 infants; <a href="./references#CD006764-fig-0025" title="">Analysis 1.21</a>); there was no clear explanation for the heterogeneity (Tau² = 4.40; Chi² = 4.89, df = 1 (P = 0.03); I² = 80%). <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> reported 18/178 events in the dexamethasone group versus 27/181 events in the betamethasone group, while <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a> reported 4/36 events in the dexamethasone group versus 0/69 events in the betamethasone group; for some other outcomes (e.g. admission to NICU; <a href="./references#CD006764-fig-0020" title="">Analysis 1.16</a>), <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a> differed from other trials in the high number of negative events for babies in the dexamethasone group. It is possible that limitations in the study design (risk of bias), differences in reasons for preterm birth or other clinical factors might explain this difference. </p> </section> <section id="CD006764-sec-0130"> <p><b>Severe intraventricular haemorrhage</b></p> <p>There were no clear differences between dexamethasone and betamethasone for the risk of severe IVH (RR 0.40, 95% CI 0.14 to 1.13; 4 trials, 1901 infants; <a href="./references#CD006764-fig-0026" title="">Analysis 1.22</a>). </p> </section> <section id="CD006764-sec-0131"> <p><b>Periventricular leukomalacia</b></p> <p>There were no clear differences between dexamethasone and betamethasone for the risk of periventricular leukomalacia (RR 0.64, 95% CI 0.18 to 2.25; 4 trials, 1901 infants; <a href="./references#CD006764-fig-0027" title="">Analysis 1.23</a>). </p> </section> <section id="CD006764-sec-0132"> <p><b>Systemic infection in first 48 hours of life (neonatal sepsis)</b></p> <p>There were no clear differences between dexamethasone and betamethasone for the risk of neonatal sepsis (RR 1.14, 95% CI 0.60 to 2.17; 1 trial, 359 infants; <a href="./references#CD006764-fig-0028" title="">Analysis 1.24</a>). </p> </section> <section id="CD006764-sec-0133"> <p><b>Necrotising enterocolitis</b></p> <p>There were no clear differences between dexamethasone and betamethasone for the risk of necrotising enterocolitis (RR 5.08, 95% CI 0.25 to 105.15; 2 studies, 441 infants; low‐certainty evidence; <a href="./references#CD006764-fig-0030" title="">Analysis 1.26</a>). </p> </section> <section id="CD006764-sec-0134"> <p><b>Retinopathy of prematurity</b></p> <p>There was substantial statistical heterogeneity in the analysis for retinopathy of prematurity (aRR 0.32, 95% CI 0.02 to 5.50; 2 trials, 1868 infants; <a href="./references#CD006764-fig-0031" title="">Analysis 1.27</a>; Tau² = 3.34; Chi² = 4.07, df = 1 (P = 0.04); I² = 75%). The results from the two studies reporting this outcome differed considerably (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> reported 0/763 events in the dexamethasone group versus 8/746 events in the betamethasone group; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> reported 26/178 events in the dexamethasone group versus 28/181 events in the betamethasone group), and we are not confident that the point estimate reflects the true difference between dexamethasone and betamethasone. </p> </section> <section id="CD006764-sec-0135"> <p><b>Patent ductus arteriosus</b></p> <p>There were no clear differences between dexamethasone and betamethasone for the risk of patent ductus arteriosus (RR 1.20, 95% CI 0.82 to 1.76; 2 trials, 1868 infants; <a href="./references#CD006764-fig-0032" title="">Analysis 1.28</a>). </p> </section> <section id="CD006764-sec-0136"> <p><b>Biophysical parameters</b></p> <p>Six trials reported a range of biophysical parameters for a small numbers of babies (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). </p> <p>In five trials there were some differences in biophysical parameters relating to fetal heart rate, fetal movements and fetal breathing (<a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>): </p> <p> <ul id="CD006764-list-0034"> <li> <p>the dexamethasone group had a lower fetal heart rate than the betamethasone group at day two in <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a> (MD –4.20 beats per minute, 95% CI –7.17 to –1.23; 1 trial, 46 infants; <a href="./references#CD006764-fig-0033" title="">Analysis 1.29</a>) and in <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a> (<a href="./references#CD006764-fig-0034" title="">Analysis 1.30</a>), but not in <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; </p> </li> <li> <p>the dexamethasone group had a higher level of fetal movements detected via ultrasound than the betamethasone group (MD 7.0 movements per hour, 95% CI 2.15 to 11.85; 1 trial, 33 infants; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-fig-0038" title="">Analysis 1.34</a>); </p> </li> <li> <p>at day two, the dexamethasone group had a higher breathing times than the betamethasone group (MD 32.00 seconds in 30 minutes, 95% CI 4.37 to 59.63; 1 trial, 46 infants; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-fig-0041" title="">Analysis 1.37</a>). </p> </li> </ul> </p> <p>However, <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> found no differences between groups for any biophysical measures. <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> reported on a small substudy involving 43/1346 women (47/1509 fetuses) from two study centres, for whom the clinical team felt delaying corticosteroids for pretreatment ultrasound would not compromise clinical care, there was no suspicion of abnormal fetal cardiac morphology and who were not taking medication with potential major fetal cardiovascular effect. This substudy reported on short‐term ultrasound and cardiotocography (CTG) effects of dexamethasone versus betamethasone, up to seven to 10 days after administration. The authors concluded that there was no evidence of a difference between dexamethasone and betamethasone for fetal or maternal Doppler studies, biophysical profile or CTG.  </p> <p>The other five trials also found no clear differences between betamethasone and dexamethasone for other biophysical parameters including: </p> <p> <ul id="CD006764-list-0035"> <li> <p>accelerations per hour (MD 2.80, 95% CI –0.15 to 5.75; 1 trial, 46 infants; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-fig-0035" title="">Analysis 1.31</a>); </p> </li> <li> <p>fetal movements in 30 minutes (MD 2.30, 95% CI –0.74 to 5.34; 1 trial, 46 infants; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-fig-0036" title="">Analysis 1.32</a>); </p> </li> <li> <p>fetal movement via maternal perception (MD 3.00 movements per hour, 95% CI –3.20 to 9.20; 1 trial, 33 infants; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-fig-0037" title="">Analysis 1.33</a>); and </p> </li> <li> <p>fetal breathing movements per hour (MD 0, 95% CI –2.05 to 2.05; 1 trial, 33 infants; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-fig-0040" title="">Analysis 1.36</a>). </p> </li> </ul> </p> <p><a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a> measured a range of fetal heart rate indicators but only reported them in graphical form; the trial authors reported that none of the indicators showed significant differences between dexamethasone and betamethasone.  </p> </section> <section id="CD006764-sec-0137"> <p><b>Unreported outcomes</b></p> <p>No studies reported the interval between trial entry, birth, mean skin fold thickness at birth, small‐for‐gestational age, mean placental weight, neonatal blood pressure, need for inotropic support (days), air leak syndrome, need for oxygen supplementation, duration of oxygen supplementation (days), surfactant use, proven infection while in the NICU or HPA axis function. </p> </section> </section> <section id="CD006764-sec-0138"> <h6 class="title">Child</h6> <p>For all of the childhood outcomes reported below, the effect estimates are based on data from one study, which followed up children at two years of age (adjusted for prematurity) (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). In this trial, there was loss to follow‐up of 20% to 25% in both groups for these longer‐term outcomes.  </p> <p><a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> reporting longer‐term secondary outcomes for the child measured motor developmental delay and intellectual impairment outcomes using the BSID‐III. </p> <section id="CD006764-sec-0139"> <p><b>Mean weight</b></p> <p>There may be little or no difference between dexamethasone and betamethasone for mean weight at two years adjusted age (MD 0 kg, 95% CI –0.23 to 0.23; 1 trial, 1208 children; <a href="./references#CD006764-fig-0042" title="">Analysis 1.38</a>). </p> </section> <section id="CD006764-sec-0140"> <p><b>Mean length</b></p> <p>There may be little or no difference between dexamethasone and betamethasone for mean height at two years' adjusted age (MD 0.20 cm, 95% CI –0.39 to 0.79; 1 trial, 1187 children; <a href="./references#CD006764-fig-0043" title="">Analysis 1.39</a>). </p> </section> <section id="CD006764-sec-0141"> <p><b>Mean head circumference</b></p> <p>There may be little or no difference between dexamethasone and betamethasone for mean head circumference at two years' adjusted age (MD 0.10 cm, 95% CI –0.14 to 0.34; 1 trial, 1188 children; <a href="./references#CD006764-fig-0044" title="">Analysis 1.40</a>). </p> </section> <section id="CD006764-sec-0142"> <p><b>Mean blood pressure</b></p> <p>There may be little or no difference between dexamethasone and betamethasone for mean systolic blood pressure (MD –0.60 mmHg, 95% CI –2.23 to 1.03; 1 trial, 724 children; <a href="./references#CD006764-fig-0045" title="">Analysis 1.41</a>); or mean diastolic blood pressure (MD –0.10 mmHg, 95% CI –1.67 to 1.47; 1 trial, 703 children; <a href="./references#CD006764-fig-0046" title="">Analysis 1.42</a>). </p> </section> <section id="CD006764-sec-0143"> <p><b>Visual impairment</b></p> <p>We found no clear differences between dexamethasone and betamethasone in the risk at two years' adjusted age of visual impairment (RR 0.33, 95% CI 0.01 to 8.15; 1 trial, 1227 children; AAE 2 per 1000 children with betamethasone versus 1 per 1000 children with dexamethasone, 95% CI 0 to 13 per 1000; low‐certainty evidence; <a href="./references#CD006764-fig-0047" title="">Analysis 1.43</a>; <a href="./full#CD006764-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD006764-sec-0144"> <p><b>Hearing impairment</b></p> <p>We found no clear differences between dexamethasone and betamethasone in the risk at two years' adjusted age of hearing impairment (RR 1.16, 95% CI 0.63 to 2.16; 1 trial, 1227 children; AAE 29 per 100 children with betamethasone, 5 more per 1000 children with dexamethasone, 95% CI 11 fewer to 34 more; moderate‐certainty evidence; <a href="./references#CD006764-fig-0048" title="">Analysis 1.44</a>; <a href="./full#CD006764-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD006764-sec-0145"> <p><b>Developmental delay (mild, moderate or severe)</b></p> <p>We found no clear differences between dexamethasone and betamethasone in motor developmental delay (mild, moderate or severe: defined as developmental quotient less than –1 standard deviations below population mean) (RR 0.89, 95% CI 0.66 to 1.20; 1 trial, 1166 children; AAE 135 per 1000 children with betamethasone, 15 fewer per 1000 with dexamethasone, 95% CI 46 fewer to 27 more; moderate‐certainty evidence; <a href="./references#CD006764-fig-0049" title="">Analysis 1.45</a>; <a href="./full#CD006764-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD006764-sec-0146"> <p><b>Developmental delay (moderate or severe)</b></p> <p>We found no clear differences between dexamethasone and betamethasone in motor developmental delay (moderate or severe: defined as developmental quotient less than –2 standard deviations below population mean) (RR 0.84, 95% CI 0.45 to 1.56; 1 trial, 1166 children; <a href="./references#CD006764-fig-0050" title="">Analysis 1.46</a>); </p> </section> <section id="CD006764-sec-0147"> <p><b>Intellectual impairment (moderate or severe)</b></p> <p>We found no clear differences between dexamethasone and betamethasone in intellectual impairment: cognitive or language developmental delay (moderate or severe: defined as developmental quotient less than –2 standard deviations below population mean) (RR 1.23, 95% CI 0.80 to 1.90; 1 trial, 1161 children; <a href="./references#CD006764-fig-0051" title="">Analysis 1.47</a>). </p> </section> <section id="CD006764-sec-0148"> <p><b>Intellectual impairment (mild, moderate or severe)</b></p> <p>We found no clear differences between dexamethasone and betamethasone in intellectual impairment: cognitive or language developmental delay (mild, moderate or severe: defined as developmental quotient less than –1 standard deviations below population mean) (RR 0.97, 95% CI 0.79 to 1.20; 1 trial, 1161 children; moderate‐certainty evidence; AAE 234 per 1000 children with betamethasone, 7 fewer per 1000 with dexamethasone, 95% CI 49 fewer to 47 more; <a href="./references#CD006764-fig-0052" title="">Analysis 1.48</a>; <a href="./full#CD006764-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD006764-sec-0149"> <p><b>Cerebral palsy</b></p> <p>For cerebral palsy, low‐certainty evidence suggested a result that was compatible with both no difference between the two drugs, and with an important increase in risk with dexamethasone (RR 2.50, 95% CI 0.97 to 6.39; 1 trial, 1223 children; AAE 10 per 1000 with betamethasone, 15 more per 1000 children with dexamethasone (95% CI 0 fewer to 53 more); <a href="./references#CD006764-fig-0053" title="">Analysis 1.49</a>; <a href="./full#CD006764-tbl-0003">summary of findings Table 3</a>). This result was downgraded for imprecision and risk of attrition bias (due to loss to follow‐up of about 80% in both groups). </p> </section> <section id="CD006764-sec-0150"> <p><b>Behavioural/learning difficulties</b></p> <p>In terms of other outcomes related to behavioural/learning difficulties, <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> compared educational achievement using mean BSID‐III scores between groups for three domains (cognitive, language and motor). There was little or no difference between children whose mothers had received dexamethasone versus betamethasone for any of the three domains: </p> <p> <ul id="CD006764-list-0036"> <li> <p>educational achievement (cognitive score) (MD 0.50, 95% CI –1.28 to 2.28; 1 trial, 1199 children; <a href="./references#CD006764-fig-0054" title="">Analysis 1.50</a>); </p> </li> <li> <p>educational achievement (language score) (MD 0.30, 95% CI –1.81 to 2.41; 1 trial, 1199 children; <a href="./references#CD006764-fig-0055" title="">Analysis 1.51</a>); and </p> </li> <li> <p>educational achievement (motor score) (MD 0.10, 95% CI –1.75 to 1.95; 1 trial, 1199 children; <a href="./references#CD006764-fig-0056" title="">Analysis 1.52</a>). </p> </li> </ul> </p> <p>A psychometrist performed these BSID‐III assessments. The trial collected additional follow‐up information directly from caregivers using the Child Behaviour Checklist (CBCL), and there was also little or no difference  in the total mean score between groups (MD –0.40, 95% CI –2.68 to 1.88; 1 trial, 1253 children; <a href="./references#CD006764-fig-0057" title="">Analysis 1.53</a>).  </p> </section> <section id="CD006764-sec-0151"> <p><b>Unreported outcomes</b></p> <p>The study did not report mean skin fold thickness, abnormal lung function, glucose intolerance, HPA axis function, dyslipidaemia or any neurodisability. </p> </section> </section> <section id="CD006764-sec-0152"> <h6 class="title">Child as an adult</h6> <p>No studies reported secondary outcomes for children as adults.</p> </section> <section id="CD006764-sec-0153"> <h6 class="title">Health services</h6> <section id="CD006764-sec-0154"> <p><b>Mean length of antenatal hospitalisation for women (days)</b></p> <p>For the mother, the choice of drug made little or no difference to the mean length of postnatal hospitalisation (MD –0.10 days, 95% CI –0.33 to 0.13; 1 trial, 1346 women; <a href="./references#CD006764-fig-0058" title="">Analysis 1.54</a>). </p> </section> <section id="CD006764-sec-0155"> <p><b>Mean length of postnatal hospitalisation for women (days)</b></p> <p>No studies reported mean length of postnatal hospitalisation for women.</p> </section> <section id="CD006764-sec-0156"> <p><b>Mean length of neonatal hospitalisation (days)</b></p> <p>For the baby, it is possible that the mean length of neonatal hospitalisation may be slightly lower with dexamethasone; however, the 95% CIs were also compatible with no difference (MD –1.50 days, 95% CI  –3.61 to 0.61; 1 trial, 1489 infants; <a href="./references#CD006764-fig-0059" title="">Analysis 1.55</a>).  </p> </section> </section> </section> </section> <section id="CD006764-sec-0157"> <h4 class="title">2. Dexamethasone (oral versus intramuscular injection)</h4> <p>One trial compared oral versus intramuscular dexamethasone. It recruited 170 women, with 165 women and 183 infants analysed (<a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>). This trial was stopped early at 39% enrolment after a blinded review of available outcomes, due to concerns that oral dexamethasone was associated with a higher risk of infant sepsis and IVH in babies born before 34 weeks' gestation. </p> <section id="CD006764-sec-0158"> <h5 class="title">Primary outcomes</h5> <section id="CD006764-sec-0159"> <h6 class="title">Women</h6> <p>The study reported no primary outcomes for women.</p> </section> <section id="CD006764-sec-0160"> <h6 class="title">Fetus/neonate</h6> <p>We assessed the effect estimates for all primary outcomes for the baby to be very low certainty, due to concerns about risk of bias (unclear concealment of allocation and likely lack of blinding of participants or personnel) and imprecision (small single study, few events, and wide 95% CIs). </p> <section id="CD006764-sec-0161"> <p><b>Any known death after randomisation</b></p> <p>We are unsure whether there are any true differences between oral and intramuscular dexamethasone in the risk of any known death after randomisation (all deaths reported by this study were neonatal, and babies were not followed up longer term; RR 1.48, 95% CI 0.45 to 4.90; 1 trial, 183 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0060" title="">Analysis 2.1</a>; <a href="./full#CD006764-tbl-0004">summary of findings Table 4</a>). </p> </section> <section id="CD006764-sec-0162"> <p><b>Respiratory distress syndrome</b></p> <p>We are unsure whether there are any true differences between oral and intramuscular dexamethasone in the risk of RDS (RR 1.15, 95% CI 0.75 to 1.77; 1 trial, 183 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0061" title="">Analysis 2.2</a>; <a href="./full#CD006764-tbl-0004">summary of findings Table 4</a>). </p> </section> <section id="CD006764-sec-0163"> <p><b>Intraventricular haemorrhage</b></p> <p>We are unsure whether there are any true differences between oral and intramuscular dexamethasone in the risk of IVH (RR 4.24, 95% CI 0.96 to 18.83; 1 trial, 183 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0062" title="">Analysis 2.3</a>; <a href="./full#CD006764-tbl-0004">summary of findings Table 4</a>). All instances of IVH (10 in the oral group and two in the intramuscular group) occurred in babies born before 34 weeks' gestation. </p> </section> </section> <section id="CD006764-sec-0164"> <h6 class="title">Child</h6> <p>Infants were not followed up into childhood or beyond. No studies reported primary outcomes for children. </p> </section> <section id="CD006764-sec-0165"> <h6 class="title">Child as an adult</h6> <p>No study reported primary outcomes for children as adults.</p> </section> </section> <section id="CD006764-sec-0166"> <h5 class="title">Secondary outcomes </h5> <section id="CD006764-sec-0167"> <h6 class="title">Women</h6> <p>No studies reported secondary outcomes for women.</p> </section> <section id="CD006764-sec-0168"> <h6 class="title">Fetus/neonate</h6> <section id="CD006764-sec-0169"> <p><b>Birthweight</b></p> <p>Due to concerns about risk of bias and imprecision, we are uncertain of the true effects of oral versus intramuscular dexamethasone for birthweight (MD 0.05 kg, 95% CI –0.17 to 0.27; 1 trial, 183 infants; <a href="./references#CD006764-fig-0063" title="">Analysis 2.4</a>). </p> </section> <section id="CD006764-sec-0170"> <p><b>Neonatal sepsis</b></p> <p>It is possible that treatment with oral dexamethasone may increase neonatal sepsis when compared with intramuscular dexamethasone; however, the evidence is very uncertain (RR 8.48, 95% CI 1.11 to 64.93; 1 trial, 183 infants; <a href="./references#CD006764-fig-0064" title="">Analysis 2.5</a>). All neonatal sepsis cases occurred in babies born before 34 weeks' gestation. </p> </section> <section id="CD006764-sec-0171"> <p><b>Necrotising enterocolitis</b></p> <p>We are uncertain of the true effects of oral versus intramuscular dexamethasone for necrotising enterocolitis (RR 5.09, 95% CI 0.63 to 41.45; 1 trial, 183 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0065" title="">Analysis 2.6</a>; <a href="./full#CD006764-tbl-0004">summary of findings Table 4</a>). </p> </section> <section id="CD006764-sec-0172"> <p><b>Unreported outcomes</b></p> <p>The study did not report fetal death, neonatal death (up to 28 days after birth), Apgar score less than 7 at five minutes, interval between trial entry and birth, low birthweight, mean length at birth, mean head circumference at birth, mean skin fold thickness at birth, small‐for‐gestational age, mean placental weight, neonatal blood pressure, admission to NICU, need for inotropic support (days), need for mechanical ventilation/continuous positive airways pressure, mean duration of mechanical ventilation/continuous positive airways pressure (days), air leak syndrome, need for oxygen supplementation, duration of oxygen supplementation (days), surfactant use, severity of RDS, chronic lung disease, bronchopulmonary dysplasia, severe IVH, periventricular leukomalacia, proven infection while in the NICU, retinopathy of prematurity, patent ductus arteriosus, HPA axis function or biophysical parameters. </p> </section> </section> <section id="CD006764-sec-0173"> <h6 class="title">Child</h6> <p>No studies reported secondary outcomes for children.</p> </section> <section id="CD006764-sec-0174"> <h6 class="title">Child as an adult</h6> <p>No studies reported secondary outcomes for children as adults.</p> </section> <section id="CD006764-sec-0175"> <h6 class="title">Health services</h6> <p>No studies reported secondary outcomes relating to health services. </p> </section> </section> </section> <section id="CD006764-sec-0176"> <h4 class="title">3. Betamethasone acetate plus phosphate versus betamethasone phosphate</h4> <p>Two arms of one small three‐arm trial, including 69 women and 69 infants (all mothers had singleton pregnancies) compared betamethasone acetate plus phosphate versus betamethasone phosphate (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). </p> <section id="CD006764-sec-0177"> <h5 class="title">Primary outcomes</h5> <section id="CD006764-sec-0178"> <h6 class="title">Women</h6> <p>The study reported no primary outcomes for women.</p> </section> <section id="CD006764-sec-0179"> <h6 class="title">Fetus/neonate</h6> <p>We assessed the effect estimates for all infant primary outcomes to be very low certainty due to risk of bias and imprecision. </p> <section id="CD006764-sec-0180"> <p><b>Any known death after randomisation (i.e. fetal, neonatal, child, child as adult)</b></p> <p>We are uncertain whether there are differences between these two preparations of betamethasone in the risk of any known death since randomisation (all deaths reported by this study were neonatal, and babies were not followed up longer term; RR 0.32, 95% CI 0.01 to 7.69; 1 trial, 69 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0066" title="">Analysis 3.1</a>; <a href="./full#CD006764-tbl-0005">summary of findings Table 5</a>). </p> </section> <section id="CD006764-sec-0181"> <p><b>Respiratory distress syndrome</b></p> <p>We are uncertain whether there are differences between these two preparations of betamethasone in the risk of RDS (RR 0.19, 95% CI 0.01 to 3.91; 1 trial, 69 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0067" title="">Analysis 3.2</a>; <a href="./full#CD006764-tbl-0005">summary of findings Table 5</a>). </p> </section> <section id="CD006764-sec-0182"> <p><b>Intraventricular haemorrhage</b></p> <p>We are uncertain whether there are differences between these two preparations of betamethasone in the risk of IVH (RR 0.32, 95% CI 0.01 to 7.69; 1 trial, 69 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0068" title="">Analysis 3.3</a>; <a href="./full#CD006764-tbl-0005">summary of findings Table 5</a>). </p> </section> </section> <section id="CD006764-sec-0183"> <h6 class="title">Child</h6> <section id="CD006764-sec-0184"> <p><b>Neurodevelopmental disability</b></p> <p>This trial followed up four children in the betamethasone phosphate group (who had been admitted to NICU as babies) to 18 months, and reported that none of those four children had a neurodevelopmental disability at 18 months. The trial did not follow up any infants in the betamethasone acetate plus phosphate group (because no babies in that group were admitted to NICU as babies), therefore we could not report an effect estimate for this outcome. No other outcomes relating to longer term follow‐up were reported.  </p> </section> <section id="CD006764-sec-0185"> <p><b>Unreported outcomes</b></p> <p>The study did not report death.</p> </section> </section> <section id="CD006764-sec-0186"> <h6 class="title">Child as an adult</h6> <p>The study reported no primary outcomes for children as adults.</p> </section> </section> <section id="CD006764-sec-0187"> <h5 class="title">Secondary outcomes</h5> <section id="CD006764-sec-0188"> <h6 class="title">Women</h6> <p>The study reported no secondary outcomes for women.</p> </section> <section id="CD006764-sec-0189"> <h6 class="title">Fetus/neonate</h6> <section id="CD006764-sec-0190"> <p><b>Birthweight</b></p> <p>We are uncertain if there are any difference  between infants exposed to betamethasone acetate plus phosphate versus betamethasone phosphate for  birthweight (MD –0.10 kg, 95% CI –0.44 to 0.24; 1 trial, 69 infants; <a href="./references#CD006764-fig-0069" title="">Analysis 3.4</a>). </p> </section> <section id="CD006764-sec-0191"> <p><b>Low birthweight</b></p> <p>We are uncertain if there are any difference between infants exposed to betamethasone acetate plus phosphate versus betamethasone phosphate for low birthweight (RR 1.21, 95% CI 0.86 to 1.72; 1 trial, 69 infants; <a href="./references#CD006764-fig-0070" title="">Analysis 3.5</a>). </p> </section> <section id="CD006764-sec-0192"> <p><b>Admission to neonatal intensive care unit</b></p> <p>We are uncertain if there are any difference between infants exposed to betamethasone acetate plus phosphate versus betamethasone phosphate for admission to NICU (RR 0.11, 95% CI 0.01 to 1.93; 1 trial, 69 infants; <a href="./references#CD006764-fig-0071" title="">Analysis 3.6</a>). No infants from the betamethasone acetate plus phosphate group were admitted to NICU compared with four in the betamethasone phosphate group, all four due to respiratory distress. </p> </section> <section id="CD006764-sec-0193"> <p><b>Bronchopulmonary dysplasia</b></p> <p>There were no instances of bronchopulmonary dysplasia (<a href="./references#CD006764-fig-0072" title="">Analysis 3.7</a>). </p> </section> <section id="CD006764-sec-0194"> <p><b>Periventricular leukomalacia</b></p> <p>There were no instances of periventricular leukomalacia (<a href="./references#CD006764-fig-0073" title="">Analysis 3.8</a>). </p> </section> <section id="CD006764-sec-0195"> <p><b>Biophysical parameters</b></p> <p>The study measured a range of fetal heart rate indicators but only reported them in graphical form. The trial authors reported that none of the indicators showed significant differences between the different betamethasone formulations. </p> </section> <section id="CD006764-sec-0196"> <p><b>Unreported outcomes</b></p> <p>The study did not report fetal death, neonatal death (up to 28 days after birth), Apgar score less than 7 at five minutes, interval between trial entry and birth, mean length at birth, mean head circumference at birth, mean skin fold thickness at birth, small‐for‐gestational age, mean placental weight, neonatal blood pressure, need for inotropic support (days), need for mechanical ventilation/continuous positive airways pressure, mean duration of mechanical ventilation/continuous positive airways pressure (days), air leak syndrome, need for oxygen supplementation, duration of oxygen supplementation (days), surfactant use, severity of RDS, chronic lung disease (need for continuous supplemental oxygen at 28 days' postnatal age or 36 weeks' postmenstrual age, whichever was later), severe IVH, systemic infection in first 48 hours of life (neonatal sepsis), proven infection while in the NICU, necrotising enterocolitis, retinopathy of prematurity, patent ductus arteriosus or HPA axis function. </p> </section> </section> <section id="CD006764-sec-0197"> <h6 class="title">Child</h6> <p>The study reported no secondary outcomes for children.</p> </section> <section id="CD006764-sec-0198"> <h6 class="title">Child as an adult</h6> <p>The study reported no secondary outcomes for children as adults.</p> </section> <section id="CD006764-sec-0199"> <h6 class="title">Health services</h6> <p>The study reported no secondary outcomes relating to health services. </p> </section> </section> </section> <section id="CD006764-sec-0200"> <h4 class="title">4. Betamethasone dosing interval: 12 hourly versus 24 hourly</h4> <p>One trial involving 228 women and 260 infants compared betamethasone 12 hourly versus 24 hourly, with women randomised on a 2:1 ratio (and stratified into four groups by gestational age at trial entry) (<a href="./references#CD006764-bbs2-0004" title="KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):201.e1-11. KhandelwalM , ChangE , HansenC , HunterK , MilcarekB . Betamethasone dosing interval −12 or 24 hours apart?American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S10-11. NCT00453141. Betamethasone dosing interval – 12 or 24 hours?clinicaltrials.gov/show/NCT00453141 (first received 28 March 2007). [CENTRAL: CN-01514761] ">Khandelwal 2012</a>).  </p> <section id="CD006764-sec-0201"> <h5 class="title">Primary outcomes</h5> <section id="CD006764-sec-0202"> <h6 class="title">Women</h6> <p>The study reported no primary outcomes for women.</p> </section> <section id="CD006764-sec-0203"> <h6 class="title">Fetus/neonate</h6> <section id="CD006764-sec-0204"> <p><b>Any known death after randomisation</b></p> <p>For any known death after randomisation, this trial reported perinatal deaths only, and did not follow up children longer term. Given the very low‐certainty evidence, it is unclear whether the betamethasone dosing interval made a difference to this outcome (RR 0.93, 95% CI 0.46 to 1.87; 1 trial, 255 infants; <a href="./references#CD006764-fig-0074" title="">Analysis 4.1</a>; <a href="./full#CD006764-tbl-0006">summary of findings Table 6</a>). We note that there was a much higher rate of perinatal death in both groups in this trial than for other studies included  in this review (compare <a href="./full#CD006764-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD006764-tbl-0004">summary of findings Table 4</a>; <a href="./full#CD006764-tbl-0005">summary of findings Table 5</a>; <a href="./full#CD006764-tbl-0006">summary of findings Table 6</a>). The authors did not comment on the rate of perinatal death in the study. </p> </section> <section id="CD006764-sec-0205"> <p><b>Respiratory distress syndrome</b></p> <p>We are uncertain whether the betamethasone dosing interval makes a difference to the risk of RDS (RR 0.95, 95% CI 0.67 to 1.36, 1 trial, 253 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0075" title="">Analysis 4.2</a>; <a href="./full#CD006764-tbl-0006">summary of findings Table 6</a>). </p> </section> <section id="CD006764-sec-0206"> <p><b>Intraventricular haemorrhage</b></p> <p>We are uncertain whether the betamethasone dosing interval makes a difference to the risk of IVH (RR 1.40, 95% CI 0.73 to 2.70; 1 trial, 253 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0076" title="">Analysis 4.3</a>; <a href="./full#CD006764-tbl-0006">summary of findings Table 6</a>). </p> </section> </section> <section id="CD006764-sec-0207"> <h6 class="title">Child</h6> <p>The study reported no primary outcomes for children.</p> </section> <section id="CD006764-sec-0208"> <h6 class="title">Child as an adult</h6> <p>The study reported no primary outcomes for children as adults.</p> </section> </section> <section id="CD006764-sec-0209"> <h5 class="title">Secondary outcomes</h5> <section id="CD006764-sec-0210"> <h6 class="title">Women</h6> <section id="CD006764-sec-0211"> <p><b>Maternal fever</b></p> <p>We are uncertain whether there is a difference between groups in the risk of maternal fever (defined as greater than 100.4 °F) (RR 0.71, 95% CI 0.25 to 2.02; 1 trial, 213 women; <a href="./references#CD006764-fig-0077" title="">Analysis 4.4</a>). </p> <p>The study did not report admission to intensive care unit, adverse effects of therapy, glucose intolerance or hypertension. </p> </section> </section> <section id="CD006764-sec-0212"> <h6 class="title">Fetus/neonate</h6> <section id="CD006764-sec-0213"> <p><b>Birthweight</b></p> <p>There may be little or no difference between groups for mean birthweight (MD 0.08 kg, 95% CI –0.15 to 0.31; 1 trial, 255 infants; <a href="./references#CD006764-fig-0078" title="">Analysis 4.5</a>). </p> </section> <section id="CD006764-sec-0214"> <p><b>Small‐for‐gestational age</b></p> <p>The evidence is unclear whether there is a difference in risk of the baby being small‐for‐gestational age (RR 0.61, 95% CI 0.36 to 1.05; 1 trial, 255 infants; <a href="./references#CD006764-fig-0079" title="">Analysis 4.6</a>). </p> </section> <section id="CD006764-sec-0215"> <p><b>Admission to neonatal intensive care unit</b></p> <p>It is possible that there may be a lower risk of admission to NICU with 12‐hourly regimen compared with the 24‐hourly regimen (RR 0.83, 95% CI 0.74 to 0.93; 1 trial, 253 infants; <a href="./references#CD006764-fig-0080" title="">Analysis 4.7</a>). </p> </section> <section id="CD006764-sec-0216"> <p><b>Chronic lung disease</b></p> <p>We are uncertain whether there are differences between the dosing regimens for chronic lung disease (RR 0.77, 95% CI 0.48 to 1.24; 1 trial, 253 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0081" title="">Analysis 4.8</a>; <a href="./full#CD006764-tbl-0006">summary of findings Table 6</a>). </p> </section> <section id="CD006764-sec-0217"> <p><b>Neonatal sepsis</b></p> <p>We are uncertain whether there are differences between the dosing regimens for neonatal sepsis (RR 1.15, CI 0.47 to 2.81; 1 trial, 253 infants; <a href="./references#CD006764-fig-0082" title="">Analysis 4.9</a>). </p> </section> <section id="CD006764-sec-0218"> <p><b>Proven infection while in the neonatal intensive care unit</b></p> <p>We are uncertain whether there are differences between the dosing regimens for neonatal antibiotic use of more than five days (RR 0.94, 95% CI 0.61 to 1.46; 1 trial, 253 infants; <a href="./references#CD006764-fig-0083" title="">Analysis 4.10</a>). </p> </section> <section id="CD006764-sec-0219"> <p><b>Necrotising enterocolitis</b></p> <p>We are uncertain whether there are differences between the dosing regimens for necrotising enterocolitis (RR 9.08, 95% CI 0.54 to 153.08; 1 trial, 253 infants; very low‐certainty evidence; <a href="./references#CD006764-fig-0084" title="">Analysis 4.11</a>; <a href="./full#CD006764-tbl-0006">summary of findings Table 6</a>). No infants in the 24‐hour group developed necrotising enterocolitis while 10 infants in the 12‐hour group developed this outcome. </p> </section> <section id="CD006764-sec-0220"> <p><b>Retinopathy of prematurity</b></p> <p>We are uncertain whether there are differences between the dosing regimens for retinopathy of prematurity (RR 1.01, 95% CI 0.53 to 1.95; 1 trial, 253 infants; <a href="./references#CD006764-fig-0085" title="">Analysis 4.12</a>). </p> </section> <section id="CD006764-sec-0221"> <p><b>Unreported outcomes</b></p> <p>The study did not report fetal death, neonatal death (up to 28 days after birth), Apgar score less than 7 at five minutes, interval between trial entry and birth, low birthweight, mean length at birth, mean head circumference at birth, mean skin fold thickness at birth, mean placental weight, neonatal blood pressure, need for inotropic support (days), need for mechanical ventilation/continuous positive airways pressure, mean duration of mechanical ventilation/continuous positive airways pressure (days), air leak syndrome, need for oxygen supplementation, duration of oxygen supplementation (days), surfactant use, severity of RDS, bronchopulmonary dysplasia (variously defined), severe IVH, periventricular leukomalacia, patent ductus arteriosus, HPA axis function or biophysical parameters. </p> </section> </section> <section id="CD006764-sec-0222"> <h6 class="title">Child</h6> <p>The study reported no secondary outcomes for children.</p> </section> <section id="CD006764-sec-0223"> <h6 class="title">Child as an adult</h6> <p>The study reported no secondary outcomes for children as adults.</p> </section> <section id="CD006764-sec-0224"> <h6 class="title">Health services</h6> <p>In this trial, women who received the 12‐hour dosing interval of betamethasone had a slightly shorter mean postpartum maternal length of stay than women who received the 24‐hour dosing interval (MD –0.73 days, 95% CI –1.28 to –0.18; 1 trial, 215 women; <a href="./references#CD006764-fig-0086" title="">Analysis 4.13</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006764-sec-0225" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006764-sec-0225"></div> <section id="CD006764-sec-0226"> <h3 class="title" id="CD006764-sec-0226">Summary of main results</h3> <p>This update includes 11 trials (2494 women and 2762 infants). We implemented the Cochrane Pregnancy and Childbirth's Trustworthiness Screening Tool for the first time, removing data from two previously included trials as a result (<a href="./references#CD006764-bbs2-0022" title="ChenCY , WangKG , ChangTY , ChenCP , LooJH . Effects of antenatal betamethasone and dexamethasone in preterm neonates. Taiwanese Journal of Obstetrics and Gynaecology2005;44(3):247-51. ">Chen 2005 (TST)</a>; <a href="./references#CD006764-bbs2-0024" title="DaneshA , JanghorbaniM , KhalatbariS . Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. Journal of Research in Medical Sciences2012;17(10):911-7. ">Danesh 2012 (TST)</a>), and adding one large new trial (the A*STEROID trial, <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>), adding 937 women and 1101 infants overall since the previous update. For the comparison of dexamethasone versus betamethasone, this affected most previously included outcomes while adding information on some maternal outcomes and longer‐term outcomes for the child. There was no new evidence on any other comparisons.  </p> <section id="CD006764-sec-0227"> <h4 class="title">Dexamethasone versus betamethasone</h4> <p>Nine trials including 2096 women and 2319 infants compared dexamethasone versus betamethasone, and while the route (intramuscular) and total dose in the course given was consistent, the dose, number of doses, dosing interval and drug preparation varied (see <a href="#CD006764-tbl-0007">Table 1</a>). While we did not identify clear evidence of a difference between the two drugs, there is some uncertainty around potential important differences for several maternal, infant and child outcomes. <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> found no conclusive evidence of a difference between the two drugs for chorioamnionitis. Although the point estimate suggested a risk reduction with dexamethasone, the 95% CIs included one (moderate‐certainty evidence). No included studies reported our other primary outcomes for the mother (death and puerperal sepsis). In terms of our main secondary outcomes, the rate of maternal adverse effects was lower with dexamethasone, but again we did not find conclusive evidence that there is a true difference between drugs (moderate‐certainty evidence). The only other secondary outcome reported for the mother was postnatal fever requiring antibiotics, and the choice of drug probably makes little or no difference to the risk of this outcome. </p> <p>For primary outcomes for the baby, the point estimate suggests that the choice of drug probably makes little or no difference to the risk of any death after randomisation; however, the 95% CI included the possibility for both appreciable benefit and appreciable harm with dexamethasone (moderate‐certainty evidence), while there is probably little or no difference to the risk of RDS (high‐certainty evidence). There may be little or no difference between dexamethasone and betamethasone in the risk of IVH; however, there was substantial unexplained statistical heterogeneity in the effect estimate. In terms of our main secondary outcomes for the baby, there may little or no difference between dexamethasone and betamethasone for chronic lung disease, but the analysis for necrotising enterocolitis was underpowered to identify any differences. For other secondary outcomes, analyses for some less common neonatal morbidity outcomes were underpowered to detect the true effect (e.g. Apgar score less than 7 at five minutes, bronchopulmonary dysplasia, neonatal sepsis, neonatal infection in the first 48 hours, severe IVH, retinopathy of prematurity), and there was also substantial unexplained statistical heterogeneity in the effect estimates for some  neonatal morbidity outcomes (bronchopulmonary dysplasia, retinopathy of prematurity).  </p> <p>Although extensively reported in several of the older included trials (<a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a> <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>), and also included in a small substudy of  <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>, the clinical significance of any differences in biophysical parameters such as fetal heart rate and respiratory rate was not clear (<a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>). <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a> found no differences between groups for any biophysical parameters, fetal or maternal Doppler studies, or CTG, although we note that this substudy included only a small subset of the total women randomised (and is accordingly described by the authors as a prospective cohort study). Some of the older trials found indications of a lower heart rate at day two, a longer duration of breathing time at day two, and more fetal movements detected via ultrasound for the dexamethasone group. Some authors suggest that the influence of antenatal corticosteroids on parameters such as fetal heart rate is not clinically important, being a transient physiological response (<a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>). </p> <p>Only one study attempted to follow up all children longer term, at two years of age adjusted for prematurity, and this study overwhelmingly drove the findings that there is probably little or no difference between dexamethasone and betamethasone in the risk of neurodevelopmental disability. The findings from this study found no clear differences to our other main longer‐term outcomes (visual impairment, hearing impairment, motor developmental delay, intellectual impairment), or to other secondary outcomes at the same time point (mean weight, height, head circumference, systolic or diastolic blood pressure, or most other developmental outcomes). However, the effect estimate for cerebral palsy is compatible with both an important increase in risk with dexamethasone, and no difference between interventions for this outcome (low‐certainty evidence). </p> </section> <section id="CD006764-sec-0228"> <h4 class="title">Comparisons of different regimens and preparations of dexamethasone or betamethasone</h4> <p>We found three studies that each included a comparison of a different regimen or preparation of either dexamethasone or betamethasone (dexamethasone 32 mg orally versus dexamethasone 24 mg intramuscularly; betamethasone acetate plus phosphate versus betamethasone phosphate; 12‐hourly betamethasone versus 24‐hourly betamethasone). While it is noteworthy that the first of these studies was stopped early due to safety concerns relating to oral dexamethasone, we were limited in our ability to draw conclusions from any of these studies due to their small sample size, concerns about risk of bias and limited number of outcomes reported.  </p> </section> </section> <section id="CD006764-sec-0229"> <h3 class="title" id="CD006764-sec-0229">Overall completeness and applicability of evidence</h3> <p>All trials were conducted in high‐income countries, which may limit the wider applicability of this review's findings. </p> <p>The gestational age at trial entry varied from 23 to 35 weeks of gestation. While women in all trials were at increased risk of preterm birth or had a medical indication for preterm birth, assessment of risk was not described in a number of studies. </p> <p>For comparison of dexamethasone versus betamethasone, the included studies did not report most of our outcomes for the mother, so it is impossible to provide a complete picture of the effect of choice of drug on the woman's health and well‐being. </p> <p>There are important uncertainties around some severe neonatal morbidities and one longer‐term developmental outcome (including some outcomes that we judged to be most important, namely IVH, necrotising enterocolitis and cerebral palsy), in large part due to rarity and associated imprecision or heterogeneity between trials, or both. Our analyses were further limited as not all studies reported these neonatal outcomes. Assessment of longer‐term outcomes is crucial to any review of the effectiveness and safety of antenatal corticosteroids for women and babies. Only one study attempted to follow up all infants longer term, but there was attrition at two‐year follow‐up. No studies provided data on longer‐term follow‐up.  </p> <p>Most of the data available focused on the type of corticosteroid used, with nine studies comparing the two most commonly used corticosteroids, dexamethasone and betamethasone (with some variation in frequency and timing of administration). Considering the full scope of this review, our ability to reach comprehensive conclusions was limited by the small number of comparisons of different antenatal corticosteroid regimens. Evidence about optimal doses, timing, frequency of administration and preparation of specific antenatal corticosteroids was sparse, with three small trials contributing data to three separate comparisons.  </p> </section> <section id="CD006764-sec-0230"> <h3 class="title" id="CD006764-sec-0230">Quality of the evidence</h3> <p>We included 11 trials (involving 2494 women and 2762 infants) in this review update, including one large trial that was at minimal risk of bias overall (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>), eight trials that we found to be at moderate risk of bias, and two further trials that we deemed to be at more serious risk of bias (<a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>). Our most common risk of bias concerns related to a lack of blinding of participants and personnel, missing outcome data and uncertainty about selective reporting bias. More serious worries related to selection bias (in <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a> the method of sequence generation was unclear, and <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a> was quasi‐randomised). </p> <p>Our GRADE assessments factored in these risk of bias concerns, as well as downgrades for imprecision, due to small sample size, few events or wide CIs.  </p> </section> <section id="CD006764-sec-0231"> <h3 class="title" id="CD006764-sec-0231">Potential biases in the review process</h3> <p>One review authors was also an author on the A*STEROID trial (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>). Two other review authors performed data extraction and risk of bias assessments for that trial.  </p> <p>To improve the reliability of the results reported in this review, and in line with current Cochrane Pregnancy and Childbirth group policy, we implemented the Cochrane Pregnancy and Childbirth's Trustworthiness Screening Tool for the first time in this review. We acknowledge that while the process involved was rigorous and systematic, it also involved a degree of subjective judgement, and it is possible that a different author team would have made different decisions about inclusion of studies and data. In this respect, the TST is similar to the assessment of risk of bias or the GRADE process; in all cases, we sought to be consistent and transparent, and thoroughly document our decisions and underlying rationale.  </p> </section> <section id="CD006764-sec-0232"> <h3 class="title" id="CD006764-sec-0232">Agreements and disagreements with other studies or reviews</h3> <p>One Cochrane Review comparing antenatal corticosteroids for fetal lung maturation versus placebo conducted subgroup analyses by type of corticosteroid therapy (<a href="./references#CD006764-bbs2-0065" title="McGoldrickE , StuartF , ParkerR , DalzielSR . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2020, Issue 12. Art. No: CD004454. [DOI: 10.1002/14651858.CD004454.pub4]">McGoldrick 2020</a>). While for most outcomes these analyses did not support the hypothesis that there is a difference between drugs, there may be some indication of a difference between dexamethasone and betamethasone for RDS, moderate/severe RDS and chorioamnionitis. For chorioamnionitis, the subgroup analyses suggested that the risk may be reduced with betamethasone but may be increased with dexamethasone, while conversely our results suggest there may be a reduction in risk with dexamethasone. However, for all three outcomes, the authors noted the observed differences may be due to chance. </p> <p>One recent systematic review and network meta‐analysis specifically investigated dexamethasone versus betamethasone for preterm birth (<a href="./references#CD006764-bbs2-0045" title="CiapponiA , KleinK , ColaciD , AlthabeA , BelizánJ , DeeganA , et al. Dexamethsone versus betamethasone for preterm birth: a systematic review and network meta-analysis. American Journal of Obstetrics and Gynecology2021;3(3):100312. [DOI: 10.1016/j.ajogmf.2021.100312]">Ciapponi 2021</a>). The authors concluded that their review identified no important differences between dexamethasone and betamethasone for most key neonatal and neurodevelopmental outcomes; however, they observed that there may be clinically important differences between these drugs for chorioamnionitis, fetal death, endometritis or puerperal sepsis, and RDS. Due to these uncertainties, which do not consistently align towards one drug or the other, the authors argued that further research is warranted. Although our review did not identify the same concerns relating to fetal death or RDS, we also found important uncertainties around some critical outcomes, with inconclusive evidence that may favour either dexamethasone (for chorioamnionitis, maternal adverse effects of therapy) or betamethasone (for cerebral palsy), and missing evidence on key outcomes including puerperal sepsis.  </p> <p>One recent review article raised concerns about the use of betamethasone acetate in antenatal corticosteroid therapy, and the size of the dose of antenatal corticosteroid (dexamethasone or betamethasone) that women receive (<a href="./references#CD006764-bbs2-0058" title="JobeAH , KempM , SchmidtA , TakahashiT , NewnhamJ , MiladM . Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatric Research2021;89:318-25. [DOI: doi.org/10.1038/s41390-020-01249-w]">Jobe 2021</a>). We found the evidence was inadequate to further understanding of these concerns. Most studies included in our review that compared dexamethasone versus betamethasone administered a betamethasone preparation that included betamethasone acetate, and all women in both groups received a similar total dose (22.8 mg to 24 mg). We only found one small three‐arm study that included a comparison of different betamethasone preparations (betamethasone acetate plus phosphate versus betamethasone phosphate), but it provided only very low‐certainty evidence for all reported outcomes (<a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>).  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006764-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Applying the trustworthiness screening tool criteria. TST: Trustworthiness Screening Tool." data-id="CD006764-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Applying the trustworthiness screening tool criteria. TST: Trustworthiness Screening Tool. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006764-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006764-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006764-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 1: Chorioamnionitis" data-id="CD006764-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 1: Chorioamnionitis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 2: Any known death after randomisation (fetal, neonatal, child, child as adult)" data-id="CD006764-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 2: Any known death after randomisation (fetal, neonatal, child, child as adult) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 3: Respiratory distress syndrome" data-id="CD006764-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 3: Respiratory distress syndrome </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 4: Intraventricular haemorrhage" data-id="CD006764-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 4: Intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 5: Death (childhood)" data-id="CD006764-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 5: Death (childhood) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 6: Neurodevelopmental disability at follow‐up (childhood)" data-id="CD006764-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 6: Neurodevelopmental disability at follow‐up (childhood) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 7: Maternal infection requiring use of antibiotics" data-id="CD006764-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 7: Maternal infection requiring use of antibiotics </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 8: Maternal adverse effects of therapy" data-id="CD006764-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 8: Maternal adverse effects of therapy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 9: Fetal death" data-id="CD006764-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 9: Fetal death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 10: Neonatal death" data-id="CD006764-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 10: Neonatal death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 11: Apgar score &lt; 7 at 5 minutes" data-id="CD006764-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 11: Apgar score &lt; 7 at 5 minutes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 12: Birthweight (mean; kg)" data-id="CD006764-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 12: Birthweight (mean; kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 13: Low birthweight" data-id="CD006764-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 13: Low birthweight </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 14: Length at birth (mean, cm)" data-id="CD006764-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 14: Length at birth (mean, cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 15: Head circumference at birth (mean, cm)" data-id="CD006764-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 15: Head circumference at birth (mean, cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 16: Neonatal intensive care unit admission" data-id="CD006764-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 16: Neonatal intensive care unit admission </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 17: Mechanical ventilation" data-id="CD006764-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 17: Mechanical ventilation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 18: Duration of mechanical ventilation (days, mean)" data-id="CD006764-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 18: Duration of mechanical ventilation (days, mean) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 19: Moderate/severe respiratory distress syndrome" data-id="CD006764-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 19: Moderate/severe respiratory distress syndrome </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 20: Chronic lung disease" data-id="CD006764-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 20: Chronic lung disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 21: Bronchopulmonary dysplasia" data-id="CD006764-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 21: Bronchopulmonary dysplasia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 22: Severe intraventricular haemorrhage" data-id="CD006764-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 22: Severe intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 23: Periventricular leukomalacia" data-id="CD006764-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 23: Periventricular leukomalacia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 24: Neonatal sepsis" data-id="CD006764-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 24: Neonatal sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 25: Neonatal infection in first 48 hours" data-id="CD006764-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 25: Neonatal infection in first 48 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 26: Necrotising enterocolitis" data-id="CD006764-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 26: Necrotising enterocolitis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 27: Retinopathy of prematurity" data-id="CD006764-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 27: Retinopathy of prematurity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 28: Patent ductus arteriosus" data-id="CD006764-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 28: Patent ductus arteriosus </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.29" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 29: Fetal heart rate, bpm (day 2)" data-id="CD006764-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.29.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.29.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 29: Fetal heart rate, bpm (day 2) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.29.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0034"> <p> <div class="table" id="CD006764-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Fetal heart rate (day 2)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Betamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>P value</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Magee 1997</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 mg: 2 × 12 mg; 12 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 mg: 2 × 12 mg; 12 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median change from baseline 1.5 beats per minute, interquartile range (IQR) –5.9 to 9.0 (22 participants) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median change from baseline –2.0 beats per minute, IQR –6.0 to 5.0 (20 participants)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not significant</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Senat 1998</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 mg: 4 × 4 mg; 12 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 mg: 4 × 6 mg; 12 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 142 beats per minute, IQR 137 to 149 (40 participants)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 147 beats per minute, IQR 141 to 154 (42 beats per minute)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.01 (for change data)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 30: Fetal heart rate (day 2) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0034">Navigate to figure in review</a></div> </div> <div class="figure" id="CD006764-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.31" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 31: Accelerations per hour" data-id="CD006764-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.31.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.31.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 31: Accelerations per hour </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.31.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.32" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 32: Fetal movements in 30 minutes" data-id="CD006764-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.32.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.32.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 32: Fetal movements in 30 minutes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.32.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.33" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 33: Fetal movements per hour (maternal perception)" data-id="CD006764-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.33.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.33.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 33: Fetal movements per hour (maternal perception) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.33.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.34" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 34: Fetal movements per hour (ultrasound)" data-id="CD006764-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.34.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.34.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 34: Fetal movements per hour (ultrasound) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.34.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0039"> <p> <div class="table" id="CD006764-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Fetal movements per hour</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Betamethasone</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Magee 1997</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 mg: 2 × 12 mg; 12 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 mg: 2 × 12 mg; 12 hourly</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 2.5, interquartile range (IQR) –27.0 to 32.0 (22 women)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 4.0, IQR –15.0 to 18.5 (20 women)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 35: Fetal movements per hour </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0039">Navigate to figure in review</a></div> </div> <div class="figure" id="CD006764-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.36" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 36: Fetal breathing movements per hour" data-id="CD006764-fig-0040" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.36.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.36.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 36: Fetal breathing movements per hour </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.36.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.37" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 37: Duration of breathing time at 2 days (seconds in 30 minutes)" data-id="CD006764-fig-0041" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.37.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.37.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 37: Duration of breathing time at 2 days (seconds in 30 minutes) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.37.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.38" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 38: Weight at 2 years (mean kg)" data-id="CD006764-fig-0042" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.38.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.38.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 38: Weight at 2 years (mean kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.38.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.39" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 39: Height at 2 years (mean cm)" data-id="CD006764-fig-0043" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.39.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.39.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 39: Height at 2 years (mean cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.39.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.40" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 40: Head circumference at 2 years (mean cm)" data-id="CD006764-fig-0044" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.40.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.40.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 40: Head circumference at 2 years (mean cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.40.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.41" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 41: Systolic blood pressure (child, mean mm Hg)" data-id="CD006764-fig-0045" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.41.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.41.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 41: Systolic blood pressure (child, mean mm Hg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.41.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.42" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 42: Diastolic blood pressure (child, mean mm Hg)" data-id="CD006764-fig-0046" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.42.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.42.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 42: Diastolic blood pressure (child, mean mm Hg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.42.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.43" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 43: Visual impairment" data-id="CD006764-fig-0047" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.43.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.43.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 43: Visual impairment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.43.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.44" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 44: Hearing impairment" data-id="CD006764-fig-0048" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.44.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.44.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 44: Hearing impairment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.44.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.45" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 45: Developmental delay – motor (mild/moderate/severe)" data-id="CD006764-fig-0049" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.45.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.45.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 45: Developmental delay – motor (mild/moderate/severe) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.45.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.46" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 46: Developmental delay – motor (moderate/severe only)" data-id="CD006764-fig-0050" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.46.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.46.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 46: Developmental delay – motor (moderate/severe only) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.46.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.47" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 47: Developmental delay – cognitive or language  (moderate/severe only)" data-id="CD006764-fig-0051" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.47.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.47.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 47: Developmental delay – cognitive or language  (moderate/severe only) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.47.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.48" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 48: Developmental delay – cognitive or language  (mild/moderate/severe)" data-id="CD006764-fig-0052" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.48.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.48.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 48: Developmental delay – cognitive or language  (mild/moderate/severe) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.48.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.49" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 49: Cerebral palsy" data-id="CD006764-fig-0053" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.49.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.49.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.49</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 49: Cerebral palsy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.49.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.50" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 50: Educational achievement – cognitive score (mean, BSID‐III)" data-id="CD006764-fig-0054" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.50.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.50.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.50</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 50: Educational achievement – cognitive score (mean, BSID‐III) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.50.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.51" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 51: Educational achievement – language score (mean, BSID‐III)" data-id="CD006764-fig-0055" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.51.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.51.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.51</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 51: Educational achievement – language score (mean, BSID‐III) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.51.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.52" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 52: Educational achievement – motor score (mean, BSID‐III)" data-id="CD006764-fig-0056" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.52.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.52.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.52</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 52: Educational achievement – motor score (mean, BSID‐III) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.52.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.53" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 53: Childhood behaviour checklist (mean total score)" data-id="CD006764-fig-0057" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.53.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.53.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.53</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 53: Childhood behaviour checklist (mean total score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.53.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.54" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 54: Postnatal length of stay (mean, days)" data-id="CD006764-fig-0058" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.54.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.54.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.54</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 54: Postnatal length of stay (mean, days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.54.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-001.55" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 55: Neonatal intensive care unit stay (mean; days)" data-id="CD006764-fig-0059" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.55.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-001.55.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.55</div> <div class="figure-caption"> <p>Comparison 1: Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes, Outcome 55: Neonatal intensive care unit stay (mean; days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-001.55.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 1: Neonatal death" data-id="CD006764-fig-0060" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 1: Neonatal death</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 2: Respiratory distress syndrome" data-id="CD006764-fig-0061" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 2: Respiratory distress syndrome </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 3: Intraventricular haemorrhage" data-id="CD006764-fig-0062" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 3: Intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 4: Birthweight (kg, mean)" data-id="CD006764-fig-0063" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 4: Birthweight (kg, mean) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 5: Neonatal sepsis" data-id="CD006764-fig-0064" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 5: Neonatal sepsis</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 6: Necrotising enterocolitis" data-id="CD006764-fig-0065" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Dexamethasone: oral versus intramuscular (IM), Outcome 6: Necrotising enterocolitis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 1: Neonatal death" data-id="CD006764-fig-0066" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 1: Neonatal death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 2: Respiratory distress syndrome" data-id="CD006764-fig-0067" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 2: Respiratory distress syndrome </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 3: Intraventricular haemorrhage" data-id="CD006764-fig-0068" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 3: Intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 4: Birthweight (mean, kg)" data-id="CD006764-fig-0069" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 4: Birthweight (mean, kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 5: Low birthweight" data-id="CD006764-fig-0070" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 5: Low birthweight </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 6: Neonatal intensive care unit admission" data-id="CD006764-fig-0071" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 6: Neonatal intensive care unit admission </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 7: Bronchopulmonary dysplasia" data-id="CD006764-fig-0072" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 7: Bronchopulmonary dysplasia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 8: Periventricular leukomalacia" data-id="CD006764-fig-0073" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p), Outcome 8: Periventricular leukomalacia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 1: Perinatal death" data-id="CD006764-fig-0074" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 1: Perinatal death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 2: Respiratory distress syndrome" data-id="CD006764-fig-0075" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 2: Respiratory distress syndrome </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 3: Intraventricular haemorrhage" data-id="CD006764-fig-0076" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 3: Intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 4: Maternal fever " data-id="CD006764-fig-0077" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 4: Maternal fever  </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 5: Birthweight (mean, kg)" data-id="CD006764-fig-0078" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 5: Birthweight (mean, kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 6: Small‐for‐gestational age" data-id="CD006764-fig-0079" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 6: Small‐for‐gestational age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 7: Neonatal intensive care unit admission" data-id="CD006764-fig-0080" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 7: Neonatal intensive care unit admission </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 8: Chronic lung disease" data-id="CD006764-fig-0081" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 8: Chronic lung disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 9: Neonatal sepsis" data-id="CD006764-fig-0082" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 9: Neonatal sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 10: Neonatal antibiotic use (&gt; 5 days)" data-id="CD006764-fig-0083" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 10: Neonatal antibiotic use (&gt; 5 days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 11: Necrotising enterocolitis" data-id="CD006764-fig-0084" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 11: Necrotising enterocolitis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 12: Retinopathy of prematurity" data-id="CD006764-fig-0085" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 12: Retinopathy of prematurity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006764-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/urn:x-wiley:14651858:media:CD006764:CD006764-CMP-004.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 13: Postpartum maternal length of stay (days, mean)" data-id="CD006764-fig-0086" src="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_t/tCD006764-CMP-004.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4: Betamethasone 12‐hourly versus 24‐hourly dosing , Outcome 13: Postpartum maternal length of stay (days, mean) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/media/CDSR/CD006764/image_n/nCD006764-CMP-004.13.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006764-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Dexamethasone compared to betamethasone – maternal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone</b> –<b>maternal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital  </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> betamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chorioamnionitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.71</b><br/>(0.48 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1346<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000<br/>(40 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Puerperal sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Maternal adverse effects of therapy</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.63</b><br/>(0.35 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1705<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000<br/>(12 to 37) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit while also crossing line of no effect. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. It was also free of risk of bias concerns. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Dexamethasone compared to betamethasone – maternal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006764-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dexamethasone compared to betamethasone – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone</b> –<b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital<b> </b> </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> betamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation</b> (fetal, neonatal, child, child as adult) </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.03</b><br/>(0.66 to 1.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2105<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>33 per 1000<br/>(21 to 52) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.06</b><br/>(0.91 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2105<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000<br/>(215 to 288) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Average RR 0.71</b><br/>(0.28 to 1.81) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1901<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000<br/>(15 to 95) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.92</b><br/>(0.64 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1509<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000<br/>(46 to 97) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 5.08</b><br/>(0.25 to 105.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>441<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable, 0/223 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2/218</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit and appreciable harm.<br/><sup>b</sup>Although some studies contributing to the pooled effect estimate had limitations in study design, a sensitivity analysis limited only to studies free of concerns relating to risk of bias (this included only <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>, a large, multicentre study) revealed that inclusion of these studies did not significantly change the effect estimate; therefore, we have not downgraded for risk of bias.<br/><sup>c</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit and appreciable harm. Also downgraded one level for serious risk of bias and substantial unexplained statistical heterogeneity: trials contributing almost half the weight to this analysis were at risk of bias, and their inclusion qualitatively impacted the effect estimate. We also had concerns about unexplained statistical heterogeneity (I² = 62%). Although there were insufficient trials to investigate this heterogeneity through prespecified subgroup analyses, it is possible that this heterogeneity was related to risk of bias; therefore, we downgraded once only. We note that <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> reported very different results from other trials, and when trial was excluded, there was no heterogeneity in the effect estimate; this trial was at risk of bias for missing outcome data, as it did not report this outcome for all babies (100/181 with betamethasone versus 105/178 with dexamethasone) and it is not explicit in the trial report why this is so. The effect estimate if <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a> is excluded is RR 1.06, 95% CI 0.66 to 1.68.<br/><sup>d</sup>Downgraded one level for serious imprecision: 95% confidence intervals included appreciable benefit and appreciable harm. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. It was also free of risk of bias concerns. Therefore, although data were provided by a single study, we did not downgrade the effect estimate further for this outcome.<br/><sup>e</sup>Downgraded two levels for very serious imprecision: few events; 95% CIs included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dexamethasone compared to betamethasone – fetal/neonatal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006764-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Dexamethasone compared to betamethasone – child outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone</b> –<b>child outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital  </p> <p><b>Intervention:</b> dexamethasone </p> <p><b>Comparison:</b> betamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurodevelopmental disability at follow‐up (childhood)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.02</b><br/>(0.85 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1151<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Most children were followed up at 2 years of age (adjusted for prematurity); 12 were followed up at 18 months. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>289 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>295 per 1000<br/>(246 to 353) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Visual impairment</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.33</b><br/>(0.01 to 8.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1227<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/>(0 to 13) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hearing impairment</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b><br/>(0.63 to 2.16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1227<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000<br/>(18 to 63) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Developmental delay</b> –<b>motor (mild, moderate or severe)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.89</b><br/>(0.66 to 1.20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1166<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1000<br/>(89 to 162) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intellectual impairment: developmental delay – cognitive or language (mild, moderate or severe)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.97</b><br/>(0.79 to 1.20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1161<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>234 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>227 per 1000<br/>(185 to 281) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cerebral palsy</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.50</b><br/>(0.97 to 6.39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1223<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children were followed up at 2 years of age (adjusted for prematurity).</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000<br/>(10 to 63) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations in study design: for the study contributing most or all of the weight to this effect estimate, there was loss to follow‐up greater than 20% in each group. Although this attrition is understandable for longer‐term outcomes, we do not know what happened many babies, and it is possible that the effect could differ substantively based on their outcomes.<br/><sup>b</sup>Downgraded two levels for very serious imprecision and risk of attrition bias: few events and  95% confidence intervals included appreciable benefit and appreciable harm; there was approximately 20% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis. <br/><sup>c</sup>Downgraded one level for serious imprecision and risk of attrition bias: 95% confidence intervals included appreciable benefit and appreciable harm; there was approximately 20% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.<br/><sup>d</sup>Downgraded one level for serious imprecision and risk of attrition bias: 95% confidence intervals included appreciable benefit while also crossing line of no effect; there was approximately 23% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.<br/><sup>e</sup>Downgraded two levels for very serious imprecision and risk of attrition bias: few events; 95% confidence intervals included appreciable harm and crosses line of no effect; there was approximately 20% loss to follow‐up in each group, which could have a substantial impact on the effect estimate. The single study that provided most or all of the data for this outcome was large and conducted across 14 maternity hospitals in two countries. Therefore, although data were provided by a single study, we did not downgrade the effect estimate for this outcome on that basis.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Dexamethasone compared to betamethasone – child outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006764-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Dexamethasone: oral compared to intramuscular – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone: oral compared to intramuscular for accelerating fetal lung maturation for women at risk of preterm birth</b> –<b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> oral dexamethasone </p> <p><b>Comparison:</b> intramuscular dexamethasone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with intramuscular dexamethasone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with oral dexamethasone</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation</b> (fetal, neonatal, child, child as adult) </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.48</b><br/>(0.45 to 4.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All deaths reported by this study were neonatal, and babies were not followed up longer term. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<br/>(21 to 233) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.15</b><br/>(0.75 to 1.77) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>298 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1000<br/>(223 to 527) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 4.24</b><br/>(0.96 to 18.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>101 per 1000<br/>(23 to 448) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 5.09</b><br/>(0.63 to 41.45) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>183<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000<br/>(8 to 493) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome,</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious limitations in study design: the single study contributing data for this outcome was at risk of bias due to unclear concealment of allocation and likely lack of blinding of participants or personnel. We also downgraded two levels for very serious imprecision: few events, single study with small sample size; 95% confidence intervals included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Dexamethasone: oral compared to intramuscular – fetal/neonatal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006764-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Betamethasone acetate plus phosphate compared to betamethasone phosphate – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Betamethasone acetate + phosphate compared to betamethasone phosphate for accelerating fetal lung maturation for women at risk of preterm birth</b> – <b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> betamethasone acetate + phosphate </p> <p><b>Comparison:</b> betamethasone phosphate </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone phosphate</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone acetate + phosphate</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation (fetal, neonatal, child, child as adult)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.32</b><br/>(0.01 to 7.69) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All deaths reported by this study were neonatal, and babies were not followed up longer term. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/>(0 to 226) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.19</b><br/>(0.01 to 3.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/>(1 to 230) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.32</b><br/>(0.01 to 7.69) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>69<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/>(0 to 226) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Necrotising enterocolitis</b>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No included studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious risk of bias: single small study contributing data for this outcome was at risk of bias due to unclear concealment of allocation and lack of blinding of participants and most personnel. We also downgraded two levels for very serious imprecision: few events, single study with small sample size; 95% confidence intervals included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Betamethasone acetate plus phosphate compared to betamethasone phosphate – fetal/neonatal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006764-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Betamethasone 12‐hourly compared to 24‐hourly dosing – fetal/neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Betamethasone 12‐hourly compared to 24‐hourly dosing</b> –<b>fetal/neonatal outcomes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women at risk of preterm birth </p> <p><b>Setting:</b> hospital  </p> <p><b>Intervention:</b> betamethasone 12‐hourly dosing </p> <p><b>Comparison:</b> betamethasone 24‐hourly dosing </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone 24‐hourly dosing </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with betamethasone 12‐hourly dosing</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any known death after randomisation (fetal, neonatal, child, child as adult)</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b><br/>(0.46 to 1.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>255<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All deaths reported by this study were perinatal, and babies were not followed up longer term. Compared to the other comparisons in this review, there was also a high death rate in this trial in both groups, which may not be representative of other contexts. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>128 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>119 per 1000<br/>(59 to 240) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Respiratory distress syndrome</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.95</b><br/>(0.67 to 1.36) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>364 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>345 per 1000<br/>(244 to 495) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Intraventricular haemorrhage</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.40</b><br/>(0.73 to 2.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>130 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000<br/>(95 to 351) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chronic lung disease</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.77</b><br/>(0.48 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<br/>(126 to 326) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Necrotising enterocolitis</b> </p> </td> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 9.08</b><br/>(0.54 to 153.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>253<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable, 0/76</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10/177</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for serious risk of bias: single study contributing data for this outcome was at risk of bias due to lack of blinding of participants and personnel, and we also had concerns about baseline imbalances and missing outcome data. We also downgraded two levels for very serious imprecision: small sample size; 95% confidence intervals included appreciable benefit and appreciable harm.<br/><sup>b</sup>Downgraded one level for serious risk of bias: single study contributing data for this outcome was at risk of bias due to lack of blinding of participants and personnel, and we also had concerns about baseline imbalances and missing outcome data. We also downgraded two levels for very serious imprecision: few events, small sample size; 95% confidence intervals included appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Betamethasone 12‐hourly compared to 24‐hourly dosing – fetal/neonatal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006764-tbl-0007"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Dexamethasone versus betamethasone (comparison 1): summary of interventions used in included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Dexamethasone group</b> </p> <p><b>(1037 women)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Betamethasone group</b> </p> <p><b>(1059 women)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Route</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All intramuscular</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All intramuscular</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Preparation</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Where specified:</i> </p> <p>Dexamethasone phosphate (<a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Varied. Where specified:</i> </p> <p>Betamethasone</p> <p> <ul id="CD006764-list-0030"> <li> <p>acetate/phosphate (941 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>)  </p> </li> <li> <p>phosphate (56 women: <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>) </p> </li> <li> <p>dipropionate (33 women: <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total dose in course</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Most received 24 mg</p> <p><i>except</i> 16 mg (82 women: <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All received 22.8 mg or 24 mg</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Dose</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 doses of 12 mg (778 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>) </p> <p>4 doses of 6 mg (219 women: <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> <p>4 doses of 4 mg (82 women: <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 doses of 11.4 mg or 12 mg (977 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> <p>4 doses of 6 mg (82 women: <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Dosing interval</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 hourly (703 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>) </p> <p>12 hourly (334 women: <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 hourly (787 women: <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0006" title="MulderEJ , DerksJB , VisserGH . Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. British Journal of Obstetrics and Gynaecology1997;104(11):1239-47. ">Mulder 1997</a>; <a href="./references#CD006764-bbs2-0008" title="RotmenschS , LiberatiM , VishneT , CelentanoC , Ben-RafaelZ , BellatiU . The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S185. RotmenschS , LiberatiM , VishneTH , CelentanoC , Ben-RafaelZ , BellatiU . The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomised trial. Acta Obstetricia et Gynecologica Scandinavica1999;78(6):493-500. ">Rotmensch 1999</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>, betamethasone acetate/phosphate; <a href="./references#CD006764-bbs2-0011" title="UrbanR , LemancewiczA , PrzepiescJ , UrbanJ , KretowskaM . Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal doppler flow velocity waveforms. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;120(2):170-4. ">Urban 2005</a>) </p> <p>12 hourly (272 women: <a href="./references#CD006764-bbs2-0003" title="ElimianA , GarryD , FigueroaR , SpitzerA , WiencekV , QuirkJG . Antenatal betamethasone compared with dexamethasone (Betacode Trial): a randomized controlled trial. Obstetrics and Gynecology2007;110(1):26-30. ElimianA , GarryD , FigueroaR , SpitzerAR , WiencekV , OgburnP , et al. 'Betacode Trial' antenatal betamethasone compared to dexamethasone: a randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S5. NCT00418353. Antenatal Betamethasone Compared to Dexamethasone – &quot;BETACODE TRIAL&quot;. clinicaltrials.gov/show/NCT00418353 (first received 2 January 2007). [CENTRAL: CN-02013509] ">Elimian 2007</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a>; <a href="./references#CD006764-bbs2-0010" title="SubtilD , TiberghienP , DevosP , TherbyD , LeclercG , VaastP , et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomised trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. American Journal of Obstetrics and Gynecology2003;188(2):524-31. SubtilD , TiberghienP , LeclercqG , TherbyD , DufourP , PuechF . Randomized trial comparing three different forms of antenatal corticotherapy on fetal heart rate. European Journal of Obstetrics, Gynecology, and Reproductive Biology2002;104:179. ">Subtil 2003</a>, betamethasone phosphate) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Repeat weekly courses </b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allowed for 764 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allowed for 755 women: <a href="./references#CD006764-bbs2-0001" title="ACTRN12612000282886. Fetal cardiovascular response to maternal corticosteroid administration: a comparison of dexamethasone versus betamethasone [Fetal cardiovascular response to maternal corticosteroid administration for fetal lung maturity: an observational comparison of dexamethasone versus betamethasone ultrasound and cardiotocograph effects within the A*STEROID randomised controlled trial]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12612000282886 (first received 9 March 2012). [CENTRAL: CN-01869021] CrowtherC , MiddletonP , AndersenC , AshwoodP , DoyleL , RobinsonJ , et al. Dexamethasone or betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability: the A*STEROID Trial. Journal of Paediatrics and Child Health2017;53(Suppl 2):22. [CENTRAL: CN-02082235] CrowtherC . Australasian antenatal study to evaluate the role of intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000631303 (first received 5 March 2009). CrowtherCA , AshwoodP , AndersenCC , MiddletonPF , TranT , DoyleLW , et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child &amp; Adolescent Health2019;3(11):769-80. [CENTRAL: CN-01996241] [EMBASE: 2003288219] [PMID: 31523039]CrowtherCA , HardingJE , MiddletonPF , AndersenCC , AshwoodP , RobinsonJS , et al. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy and Childbirth2013;13:104. [CENTRAL: CN-00964043] [PMID: 23642125]HenryA , MahajanA , CrowtherCA , LainchburyA , RobertsL , ShandAW , et al. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagnosis and Therapy2021;48(7):526-40. [CENTRAL: CN-02305173] [EMBASE: 2014012979] [PMID: 34350865]HenryA , ShandA , CrowtherC , PalmerA , WangYA , WelshAW . Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics &amp; Gynecology2013;42(Suppl 1):70. HoferOJ , HardingJE , TranT , CrowtherCA . Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID trial. PloS One2022;17(2):e0263927. [CENTRAL: CN-02375731] [EMBASE: 2017000898] [PMID: 35192656]HoferOJ , McKinlayC , TranT , CrowtherCA . Effect of maternal body mass index on neonatal health following the administration of antenatal corticosteroids. Journal of Paediatrics and Child Health2020;56(Suppl 1):21. [CENTRAL: CN-02213214] [EMBASE: 633765729]HoferOJ , McKinlayCJ , TranT , CrowtherCA . Antenatal corticosteroids, maternal body mass index and infant morbidity within the ASTEROID trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2021;61(3):380-5. [CENTRAL: CN-02214164] [EMBASE: 2007686034] [PMID: 33372291]">Crowther 2019</a>; <a href="./references#CD006764-bbs2-0002" title="EgermanRS , MercerB , DossJL , SibaiBM . A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S19. EgermanRS , MercerBM , DossJL , SibaiBM . A randomised controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. American Journal of Obstetrics and Gynecology1998;179(5):1120-3. EgermanRS , WalkerRA , DossJL , MercerB , SibaiBM , AndersenRN . A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S182. EgermanRS , WalkerRA , MercerBM , DossJL , SibaiBM , AndersenRA . Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester. American Journal of Obstetrics and Gynecology1998;179(5):1234-6. ">Egerman 1998</a>; <a href="./references#CD006764-bbs2-0005" title="MageeLA , DawesGS , MouldenM , RedmanCW . A randomised control comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. British Journal of Obstetrics and Gynaecology1997;104(11):1233-8. ">Magee 1997</a>; <a href="./references#CD006764-bbs2-0007" title="MushkatY , Ascher-LandsbergJ , KeiderR , CarmonE , PauznerD , DavidMP . The effects of betamethasone versus dexamethasone on fetal biophysical parameters. European Journal of Obstetrics, Gynecology, and Reproductive Biology2001;97:50-2. ">Mushkat 2001</a>; <a href="./references#CD006764-bbs2-0009" title="MinouiS , VilleY , SenatMV , MultonO , FernandezH , FrydmanR . Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor: a randomized study. Prenatal and Neonatal Medicine1996;1(Suppl 1):156. SenatMV , MinouiS , MultonO , FernandezH , FrydmanR , VilleY . Effects of dexamethasone and betamethasone on fetal heart rate variability in preterm labour a randomised study. British Journal of Obstetrics and Gynaecology1998;105:749-55. ">Senat 1998</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Dexamethasone versus betamethasone (comparison 1): summary of interventions used in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/full#CD006764-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006764-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.48, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.48, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Any known death after randomisation (fetal, neonatal, child, child as adult) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.66, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.38, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [0.13, 75.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.24 [0.14, 75.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.56, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.91, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.91, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.4 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.86, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.28, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.12, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.65, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Death (childhood) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.11, 3.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.11, 3.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Neurodevelopmental disability at follow‐up (childhood) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.85, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly)  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.08, 33.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.85, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Maternal infection requiring use of antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.76, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.76, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Maternal adverse effects of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.35, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.35, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Fetal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.50, 2.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.50, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.58, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.38, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [0.13, 75.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.24 [0.14, 75.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.4 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.42, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.05, 5.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.05, 5.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Birthweight (mean; kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.05, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.11, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.06, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.65, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.65, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Length at birth (mean, cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.47, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.47, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Head circumference at birth (mean, cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.18, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.18, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.49, 6.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.83 [1.24, 11.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.89, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.74, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.74, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Duration of mechanical ventilation (days, mean) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐1.11, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐1.11, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Moderate/severe respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.80, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.80, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.64, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.64, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 Bronchopulmonary dysplasia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [0.10, 61.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.1 Dexamethasone (24 mg: 4 × 6 mg, 12 hourly) vs betamethasone (24 mg: 2 × 12 mg, 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [0.10, 61.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Severe intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.14, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.06, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.3 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.14, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.18, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.09, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.3 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.14, 6.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 Neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.60, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.24.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.60, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 Neonatal infection in first 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.08, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.08, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.26 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>441</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.08 [0.25, 105.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.08 [0.25, 105.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.2 Dexamethasone (16 mg: 4 × 4 mg; 12 hourly) vs betamethasone (24 mg: 4 × 6 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.27 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.02, 5.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.58, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.00, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.28 Patent ductus arteriosus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.82, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.56, 2.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.2 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1509</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.78, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.29 Fetal heart rate, bpm (day 2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.20 [‐7.17, ‐1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.20 [‐7.17, ‐1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.30 Fetal heart rate (day 2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.31 Accelerations per hour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [‐0.15, 5.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.31.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg, 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [‐0.15, 5.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.32 Fetal movements in 30 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐0.74, 5.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.32.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐0.74, 5.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.33 Fetal movements per hour (maternal perception) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [‐3.20, 9.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.33.1 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [‐3.20, 9.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.34 Fetal movements per hour (ultrasound) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [2.15, 11.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.34.1 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [2.15, 11.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.35 Fetal movements per hour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.36 Fetal breathing movements per hour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐2.05, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.36.1 Dexamethasone (24 mg: 2 × 12 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐2.05, 2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.37 Duration of breathing time at 2 days (seconds in 30 minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>32.00 [4.37, 59.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.37.1 Dexamethasone (24 mg: 4 × 6 mg; 12 hourly) vs betamethasone (24 mg: 2 × 12 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>32.00 [4.37, 59.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.38 Weight at 2 years (mean kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.23, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.38.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.23, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.39 Height at 2 years (mean cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.39, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.39.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.39, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.40 Head circumference at 2 years (mean cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.14, 0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.40.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.14, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.41 Systolic blood pressure (child, mean mm Hg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>724</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐2.23, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.41.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>724</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐2.23, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.42 Diastolic blood pressure (child, mean mm Hg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>703</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.67, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.42.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>703</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.67, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.43 Visual impairment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.43.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.44 Hearing impairment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.63, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.44.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.63, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.45 Developmental delay – motor (mild/moderate/severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.66, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.45.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.66, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.46 Developmental delay – motor (moderate/severe only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.45, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.46.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.45, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.47 Developmental delay – cognitive or language  (moderate/severe only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.80, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.47.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.80, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.48 Developmental delay – cognitive or language  (mild/moderate/severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.79, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.48.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.79, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.49 Cerebral palsy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [0.97, 6.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.49.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [0.97, 6.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.50 Educational achievement – cognitive score (mean, BSID‐III) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐1.28, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.50.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐1.28, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.51 Educational achievement – language score (mean, BSID‐III) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐1.81, 2.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.51.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐1.81, 2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.52 Educational achievement – motor score (mean, BSID‐III) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐1.75, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.52.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐1.75, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.53 Childhood behaviour checklist (mean total score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐2.68, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.53.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐2.68, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.54 Postnatal length of stay (mean, days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.33, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.54.1 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.33, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.55 Neonatal intensive care unit stay (mean; days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐3.61, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.55.3 Dexamethasone (24 mg: 2 × 12 mg; 24 hourly) vs betamethasone (22.8 mg: 2 × 11.4 mg; 24 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐3.61, 0.61]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Dexamethasone versus betamethasone – subgrouped by regimen, all outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006764-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dexamethasone: oral versus intramuscular (IM)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.45, 4.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Dexamethasone: oral (32 mg: 4 × 8 mg, 12 hourly) vs IM (24 mg: 4 × 6 mg, 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.45, 4.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.75, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Dexamethasone: oral (32 mg: 4 × 8 mg, 12 hourly) vs IM (24 mg: 4 × 6 mg, 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.75, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.24 [0.96, 18.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Dexamethasone: oral (32 mg: 4 × 8 mg, 12 hourly) vs IM (24 mg: 4 × 6 mg, 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.24 [0.96, 18.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Birthweight (kg, mean) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.17, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Dexamethasone: oral (32 mg: 4 × 8 mg, 12 hourly) vs IM (24 mg: 4 × 6 mg, 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.17, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.48 [1.11, 64.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Dexamethasone: oral (32 mg: 4 × 8 mg, 12 hourly) vs IM (24 mg: 4 × 6 mg, 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.48 [1.11, 64.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.09 [0.63, 41.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Dexamethasone: oral (32 mg: 4 × 8 mg, 12 hourly) vs IM (24 mg: 4 × 6 mg, 12 hourly) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.09 [0.63, 41.45]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dexamethasone: oral versus intramuscular (IM)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006764-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 7.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 7.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 7.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 7.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Birthweight (mean, kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.44, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) and beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.44, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.86, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.86, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Bronchopulmonary dysplasia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.1 Beta a+p 24 mg (2 × 12 mg, 24 hourly) vs beta p 24 mg (4 × 6 mg, 12 hourly)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Betamethasone acetate + phosphate (beta a+p) versus betamethasone phosphate (beta p)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006764-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Betamethasone 12‐hourly versus 24‐hourly dosing </span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.46, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.46, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.67, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.67, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.73, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.73, 2.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Maternal fever  <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.25, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.25, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Birthweight (mean, kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.15, 0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.15, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.36, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.36, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.74, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.74, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Chronic lung disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.48, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.48, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.9 Neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.47, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.9.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.47, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.10 Neonatal antibiotic use (&gt; 5 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.61, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.10.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.61, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.11 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.08 [0.54, 153.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.11.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.08 [0.54, 153.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.12 Retinopathy of prematurity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.53, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.12.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.53, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.13 Postpartum maternal length of stay (days, mean) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.28, ‐0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.13.1 Betamethasone: 12 mg 12 hourly vs 12 mg 24 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.28, ‐0.18]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Betamethasone 12‐hourly versus 24‐hourly dosing </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006764.pub4/references#CD006764-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006764.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006764-note-0011">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006764-note-0020">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006764-note-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006764-note-0019">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD006764-note-0017">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006764-note-0016">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD006764-note-0015">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD006764-note-0014">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006764-note-0012">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006764-note-0013">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006764\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006764\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006764\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006764\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006764\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006764.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006764.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006764.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006764.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006764.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717481078"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006764.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717481082"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006764.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db8f2e8439365',t:'MTc0MDcxNzQ4MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 